There	O
are	O
eight	O
data	O
collection	O
time	O
points	O
(	O
here	O
forth	O
referred	O
to	O
as	O
phases	O
).	O

Search	O
Strategy	O
Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
terms	O
outlined	O
inTable	O
1	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t001_Table	O
1	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Database	O
search	O
strategy	O
.	O
Search	O
termsKeywords	O
searchedBOOLEAN	O
operatorTerm	O
1Pregnant	O
or	O
pregnancyPregnan	O
*	O
ANDTerm	O
2Fish	O
or	O
seafoodFishseafoodORANDTerm	O
3Neurodevelopment	O
or	O
neurodevelopmental	O
or	O
cognition	O
or	O
cognitiveNeurodevelopment	O
*	O
cogniti	O
*	O
OR	O
The	O
Dietitians	O
Association	O
of	O
Australia	O
Process	O
Manual	O
for	O
review	O
of	O
the	O
Australian	O
Dietary	O
Guidelines	O
[	O
15	O
]	O
was	O
the	O
basis	O
for	O
reviewing	O
the	O
articles	O
and	O
guided	O
the	O
concluding	O
evidence	O
statement	O
.	O

The	O
average	O
intake	O
of	O
food	O
items	O
from	O
the	O
FFQ	O
were	O
converted	O
into	O
average	O
intake	O
of	O
energy	O
and	O
nutrients	O
by	O
linkage	O
to	O
the	O
database	O
of	O
nutrients	O
created	O
by	O
the	O
Swedish	O
National	O
Food	O
Administration	O
[	O
27	O
].	O

Therefore	O
,	O
the	O
transcriptional	O
up	O
-	O
regulation	O
of	O
'	O
VEGF	O
signaling	O
'	O
reflects	O
the	O
effort	O
on	O
cell	O
maintenance	O
and	O
angiogenic	O
growth	O
in	O
LP	O
offspring	O
at	O
stage	O
188	O
dpn	O
.	O

Cluster	O
1	O
is	O
the	O
reference	O
group	O
.	O

Therefore	O
,	O
the	O
up	O
-	O
regulation	O
of	O
'	O
AMPK	O
signaling	O
'	O
in	O
developmental	O
periods	O
I	O
,	O
II	O
and	O
III	O
in	O
AP	O
offspring	O
accounts	O
for	O
metabolic	O
health	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
LP	O
offspring	O
.	O

Development	O
of	O
new	O
fusion	O
technologies	O
(	O
e	O
.	O
g	O
.,	O
nutrigenomics	O
)	O
with	O
genetic	O
,	O
epigenetic	O
,	O
and	O
nutritional	O
factors	O
may	O
be	O
more	O
efficient	O
to	O
optimize	O
IMF	O
deposition	O
and	O
improve	O
feed	O
efficiency	O
.	O

The	O
application	O
will	O
navigate	O
the	O
data	O
collectors	O
through	O
a	O
step	O
-	O
by	O
-	O
step	O
process	O
while	O
interviewing	O
the	O
pregnant	O
women	O
to	O
collect	O
all	O
required	O
information	O
to	O
be	O
collected	O
at	O
each	O
specific	O
visit	O
.	O

Gametogenesis	O
and	O
pre	O
-	O
conception	O
Spermatogenesis	O
occurs	O
continuously	O
in	O
adult	O
males	O
and	O
even	O
though	O
females	O
are	O
born	O
with	O
their	O
full	O
complement	O
of	O
oocytes	O
,	O
oocyte	O
maturation	O
occurs	O
in	O
a	O
continuous	O
cycle	O
throughout	O
the	O
reproductive	O
life	O
of	O
adult	O
females	O
.	O

The	O
maternal	O
baseline	O
depression	O
levels	O
were	O
evaluated	O
.	O

Dysfunction	O
of	O
DA	O
signalling	O
has	O
been	O
strongly	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
schizophrenia	O
[	O
13	O
].	O

Early	O
life	O
Early	O
embryo	O
and	O
germ	O
line	O
development	O
can	O
be	O
affected	O
by	O
in	O
utero	O
exposures	O
.	O

The	O
RT2	O
reactions	O
including	O
the	O
entire	O
RT1	O
reactions	O
,	O
mixed	O
with	O
5	O
µl	O
moloney	O
murine	O
leukemia	O
virus	O
reverse	O
transcriptase	O
(	O
M	O
-	O
MLV	O
)	O
5	O
×	O
buffer	O
(	O
250	O
mM	O
,	O
pH	O
=	O
8	O
.	O
3	O
)	O
Tris	O
–	O
HCl	O
,	O
15	O
mM	O
MgCl2	O
,	O
50	O
mM	O
dithiothreitol	O
and	O
375	O
mM	O
KCl	O
,	O
1	O
.	O
25	O
µl	O
of	O
10	O
mM	O
-	O
deoxyribonucleotide	O
tripho	O
-	O
sphate	O
,	O
1	O
µl	O
M	O
-	O
MLV	O
RNase	O
(	O
200	O
U	O
/	O
µl	O
)	O
and	O
0	O
.	O
5	O
µl	O
RNase	O
inhibitor	O
(	O
40	O
U	O
/	O
µl	O
).	O

Thus	B
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
Thai	O
people	O
is	O
generally	O
low	O
.	O

CC	O
and	O
RC	O
females	O
showed	O
a	O
lower	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
than	O
those	O
of	O
the	O
respective	O
CC	O
and	O
RC	O
males	O
.	O

Serum	O
visfatin	O
levels	O
were	O
measured	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
with	O
human	O
visfatin	O
(	O
ZellBio	O
GmbH	O
,	O
Germany	O
;	O
Ulm	O
kit	O
,	O
Cat	O
No	O
:	O
ZB	O
-	O
3408	O
-	O
H9648	O
).	O

Although	O
,	O
laboratories	O
at	O
the	O
health	O
facilities	O
in	O
developing	O
countries	O
usually	O
lack	O
the	O
capacity	O
to	O
conduct	O
quality	O
blood	O
test	O
,	O
they	O
could	O
be	O
strengthened	O
to	O
provide	O
reliable	O
estimations	O
of	O
red	O
blood	O
cell	O
indices	O
such	O
as	O
haemoglobin	O
,	O
haematocrit	O
,	O
mean	O
cell	O
volume	O
,	O
mean	O
cell	O
haemoglobin	O
,	O
and	O
mean	O
cell	O
haemoglobin	O
concentration	O
.	O

Perinatal	O
risk	O
factors	O
that	O
have	O
a	O
suggested	O
association	O
include	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
,	O
labor	O
induction	O
and	O
augmentation	O
,	O
maternal	O
infection	O
and	O
disease	O
(	O
i	O
.	O
e	O
.,	O
antiphospholipid	O
syndrome	O
),	O
antiepileptic	O
drugs	O
,	O
cocaine	O
use	O
,	O
and	O
oral	O
supplements	O
.	O

However	O
,	O
only	O
four	O
out	O
of	O
nineteen	O
participants	O
with	O
supplement	O
use	O
who	O
was	O
also	O
positive	O
for	O
Vitamin	O
D2	O
received	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
.	O

Increases	O
in	O
stress	O
were	O
related	O
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	O
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	O
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

Clear	O
diagnosis	O
of	O
GDM	O
after	O
OGTT	O
test	O
;	O
2	O
).	O

To	O
date	O
,	O
there	O
are	O
no	O
biomarkers	O
that	O
can	O
reliably	O
predict	O
which	O
newborn	O
will	O
develop	O
atopy	O
.	O

ANC	O
coverage	O
in	O
Cameroon	O
in	O
2007	O
stood	O
at	O
82	O
%	O
with	O
60	O
%	O
of	O
pregnant	O
women	O
having	O
four	O
or	O
more	O
visits	O
[	O
2	O
].	O

The	O
day	O
of	O
birth	O
was	O
defined	O
as	O
postnatal	O
day	O
0	O
(	O
PND	O
0	O
).	O

One	O
study	O
conducted	O
in	O
Poland	O
concluded	O
that	O
the	O
level	O
of	O
nutritional	O
knowledge	O
of	O
pregnant	O
women	O
regarding	O
mineral	O
and	O
vitamins	O
was	O
insufficient	O
,	O
without	O
focusing	O
on	O
the	O
relationship	O
with	O
their	O
intake	O
[	O
20	O
].	O

Some	O
cross	O
-	O
sectional	O
studies	O
show	O
the	O
same	O
positive	O
results	O
for	O
the	O
use	O
of	O
multivitamins	O
[	O
10	O
],	O
but	O
there	O
is	O
still	O
debate	O
as	O
to	O
whether	O
these	O
are	O
superior	O
to	O
iron	O
and	O
folic	O
acid	O
[	O
11	O
].	O

The	O
selective	O
knock	O
-	O
out	O
of	O
SIRT1	O
in	O
hypothalamic	O
AgRP	O
neurons	O
diminished	O
response	O
to	O
hunger	O
-	O
inducing	O
hormone	O
ghrelin	O
,	O
reduced	O
food	O
intake	O
,	O
consequently	O
causing	O
decreased	O
lean	O
mass	O
and	O
body	O
weight	O
(	O
23	O
).	O

Thus	B
,	O
a	O
similar	O
sncRNA	O
switch	O
,	O
this	O
time	O
back	O
to	O
increased	O
genome	O
protection	O
makes	B
functional	O-
sense	I
.	O

[	O
24	O
]	O
found	O
that	O
seafood	O
consumption	O
that	O
excluded	O
fish	O
intake	O
had	O
a	O
detrimental	O
effect	O
on	O
neurodevelopment	O
,	O
while	O
fish	O
intake	O
alone	O
led	O
to	O
improved	O
outcomes	O
.	O

[	O
20	O
]	O
and	O
defined	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
at	O
birth	O
as	O
WFA	O
z	O
-	O
scores	O
<	O
10th	O
percentile	O
and	O
large	O
for	O
gestational	O
age	O
as	O
WFA	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
.	O

The	O
children	O
of	O
mothers	O
participating	O
in	O
the	O
NICHD	O
trial	O
were	O
then	O
seen	O
at	O
yearly	O
follow	O
-	O
up	O
visits	O
for	O
three	O
years	O
between	O
the	O
ages	O
of	O
2	O
and	O
7	O
as	O
part	O
of	O
an	O
IRB	O
-	O
approved	O
follow	O
-	O
up	O
study	O
funded	O
by	O
the	O
Thrasher	O
Research	O
Fund	O
(	O
HR	O
#	O
19641	O
,	O
CTRC	O
protocol	O
870	O
).	O

Our	O
sample	O
testing	O
suggest	O
that	O
the	O
vitamin	O
D	O
group	O
maintained	O
above	O
mean	O
adequate	O
vitamin	O
D	O
concetrations	O
verses	O
consistently	B
low	O
concentrations	O
in	O
the	O
placebo	O
group	O
.	O

(	O
2015	O
)	O
*	O
Polycyclic	O
aromatic	O
hydrocarbons	O
(	O
PAHs	O
)	O
AdulthoodAdulthoodPBL	O
chromosomal	O
aberrationsDNA	O
methylationYang	O
et	O
al	O
.	O

To	O
estimate	O
the	O
total	O
intake	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
,	O
we	O
summarized	O
the	O
intake	O
of	O
α	O
-	O
linolenic	O
,	O
EPA	O
,	O
DHA	O
and	O
docosapentaenoic	O
acids	O
(	O
DPA	O
).	O

Furthermore	O
,	O
a	O
higher	O
proportion	O
of	O
the	O
women	O
in	O
the	O
middle	O
and	O
high	O
level	O
symptoms	O
groups	O
had	O
grown	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
than	O
women	O
in	O
the	O
low	O
level	O
symptoms	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Normal	O
Weight	O
Mothers	O
In	O
initial	O
,	O
unadjusted	O
analyses	O
,	O
few	O
significant	O
correlations	O
were	O
found	O
between	O
prenatal	O
behaviors	O
and	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
in	O
the	O
offspring	O
of	O
normal	O
weight	O
mothers	O
.	O

We	O
made	O
initial	O
comparisons	O
of	O
time	O
-	O
to	O
-	O
an	O
-	O
episode	O
between	O
the	O
two	O
groups	O
with	O
log	O
-	O
rank	O
tests	O
and	O
Kaplan	O
–	O
Meier	O
plots	O
.	O

Generalized	O
linear	O
models	O
were	O
fitted	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
of	O
GDM	O
associated	O
with	O
sleep	O
duration	O
and	O
snoring	O
,	O
respectively	O
.	O

Also	O
,	O
at	O
6	O
months	O
,	O
children	O
exposed	O
to	O
excessive	O
GWG	O
had	O
near	O
significant	O
(	O
P	O
=	O
.	O
06	O
)	O
higher	O
odds	O
of	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
weight	O
gain	O
(	O
OR	O
=	O
6	O
.	O
2	O
(	O
0	O
.	O
94	O
,	O
41	O
.	O
1	O
),	O
but	O
no	O
significant	O
association	O
was	O
seen	O
on	O
WFA	O
z	O
-	O
scores	O
(	O
0	O
.	O
45	O
±	O
0	O
.	O
14	O
versus	O
0	O
.	O
08	O
±	O
0	O
.	O
18	O
;	O
P	O
=	O
.	O
11	O
).	O

Iron	O
deficiency	O
in	O
nonpregnant	O
populations	O
can	O
be	O
measured	O
quite	O
precisely	O
using	O
laboratory	O
tests	O
such	O
as	O
serum	O
ferritin	O
,	O
serum	O
iron	O
,	O
transferrin	O
,	O
transferrin	O
saturation	O
,	O
and	O
transferrin	O
receptors	O
[	O
7	O
].	O

The	O
HDL	O
was	O
10	O
-	O
fold	O
reduced	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
indicates	O
a	O
significant	O
reduction	O
of	O
the	O
outlet	O
rate	O
of	O
fat	O
molecules	O
(	O
cholesterol	O
,	O
phospholipids	O
and	O
triglycerides	O
)	O
from	O
cells	O
.	O

Women	O
with	O
T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
had	O
a	O
lower	O
OR	O
for	O
SGA	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
compared	O
to	O
those	O
with	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

Such	O
differences	O
are	O
largely	O
driven	O
by	O
diverse	O
genetic	O
backgrounds	O
.	O

A	O
study	O
was	O
performed	O
to	O
understand	O
the	O
mechanism	O
re	O
sponsible	O
for	O
improved	O
MS	O
after	O
early	O
weaning	O
and	O
high	O
-	O
concentrate	O
feeding	O
in	O
Angus	O
and	O
Angus	O
×	O
Simmental	O
steers	O
[	O
55	O
].	O

Infants	O
of	O
overweight	O
/	O
obese	O
mothers	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
than	O
nonexposed	O
counterparts	O
,	O
but	O
the	O
postnatal	O
weight	O
trajectories	O
were	O
different	O
.	O

RMP	O
and	O
MG	O
commented	O
on	O
the	O
manuscript	O
.	O

Non	O
-	O
normally	O
distributed	O
variables	O
were	O
log	O
-	O
transformed	O
to	O
normalize	O
the	O
distribution	O
.	O

To	O
examine	O
whether	O
“	O
global	O
methylation	O
”	O
represented	O
as	O
an	O
average	O
of	O
gene	O
-	O
associated	O
methylation	O
identified	O
in	O
a	O
genomewide	O
manner	O
was	O
associated	O
with	O
infant	O
growth	O
,	O
we	O
tested	O
for	O
an	O
association	O
between	O
birth	O
weight	O
percentile	O
and	O
mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
loci	O
measured	O
using	O
the	O
Illumina	O
Infinium	O
array	O
in	O
a	O
subset	O
of	O
184	O
placenta	O
samples	O
.	O

Most	O
sleep	O
studies	O
,	O
however	O
,	O
have	O
excluded	O
pregnant	O
women	O
;	O
hence	B
very	O
little	O
is	O
known	O
about	O
how	O
insufficient	O
sleep	O
and	O
sleep	O
disordered	O
breathing	O
during	O
gestation	O
contribute	O
to	O
increased	O
risks	O
of	O
medical	O
complications	O
of	O
pregnancy	O
including	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
).	O

The	O
same	O
study	O
stressed	O
that	O
the	O
level	O
of	O
knowledge	O
about	O
food	O
sources	O
and	O
the	O
role	O
of	O
folic	O
acid	O
during	O
pregnancy	O
was	O
influenced	O
by	O
socio	O
-	O
demographic	O
factors	O
,	O
especially	O
the	O
level	O
of	O
education	O
[	O
38	O
].	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

(	O
2011	O
)*/†	O
Peng	O
et	O
al	O
.	O

Vitamin	O
D	O
deficiency	O
increases	O
the	O
risk	O
of	O
osteoporosis	O
[	O
3	O
]	O
and	O
fractures	O
[	O
4	O
],	O
while	O
in	O
its	O
most	O
severe	O
form	O
it	O
causes	O
rickets	O
in	O
children	O
[	O
5	O
]	O
and	O
osteomalacia	O
in	O
adults	O
[	O
6	O
].	O

By	O
clustering	O
,	O
we	O
hoped	O
to	O
uncover	O
biologically	O
meaningful	O
groups	O
of	O
CpG	O
loci	O
,	O
with	O
similar	O
methylation	O
patterns	O
,	O
which	O
may	O
share	O
biological	O
characteristics	O
such	O
as	O
comparable	O
functionality	O
in	O
certain	O
developmental	O
pathways	O
or	O
location	O
in	O
similar	O
genomic	O
regions	O
.	O

We	O
used	O
PyNAST	O
alignment	O
[	O
37	O
]	O
with	O
Greengenes	O
core	O
reference	O
[	O
38	O
,	O
39	O
]	O
to	O
build	O
OTU	O
tables	O
and	O
assign	O
taxonomy	O
[	O
39	O
,	O
40	O
].	O

A	O
recent	O
study	O
illustrates	O
that	O
the	O
neuropathology	O
of	O
some	O
individuals	O
who	O
are	O
diagnosed	O
as	O
having	O
ASD	O
may	O
actually	O
also	O
have	O
focal	O
cortical	O
dysplasias	O
,	O
which	O
could	O
explain	B
the	O
high	O
incidence	O
of	O
sensory	O
irregularities	O
and	O
seizures	O
in	O
ASD	O
diagnosed	O
patients	O
[	O
59	O
].	O

Animal	O
and	O
cell	O
culture	O
studies	O
have	O
suggested	O
a	O
potential	O
solution	O
:	O
zinc	O
supplementation	O
.	O
44Hudson	O
and	O
Lewis	O
want	O
to	O
see	O
if	O
zinc	O
supplementation	O
may	O
prevent	O
arsenic	O
from	O
damaging	O
DNA	O
repair	O
enzymes	O
in	O
women	O
enrolled	O
in	O
the	O
Navajo	O
Birth	O
Cohort	O
Study	O
,	O
and	O
they	O
have	O
identified	O
an	O
easy	O
way	O
to	O
do	O
this	O
.	O

in	O
their	O
study	O
used	O
a	O
dosage	O
of	O
14	O
,	O
000	O
IU	O
vitamin	O
D	O
supplement	O
per	O
week	O
,	O
equal	O
to	O
2000	O
IU	O
per	O
day	O
,	O
started	O
at	O
27	O
–	O
30	O
weeks	O
of	O
gestation	O
.	O

Confirmation	O
and	O
expansion	O
of	O
these	O
findings	O
in	O
additional	O
populations	O
,	O
with	O
additional	O
environmental	O
data	O
and	O
more	O
comprehensive	O
methylation	O
profiles	O
as	O
well	O
as	O
studies	O
of	O
the	O
mechanism	O
of	O
these	O
alterations	O
,	O
will	O
provide	O
additional	O
valuable	O
insights	O
into	O
the	O
epigenetic	O
mechanisms	O
controlling	O
fetal	O
growth	O
.	O

Taking	O
into	O
consideration	O
that	O
participants	O
may	O
opt	O
out	O
of	O
the	O
project	O
(	O
at	O
25	O
%	O
rate	O
),	O
it	O
is	O
calculated	O
that	O
a	O
minimum	O
of	O
245	O
participants	O
should	O
be	O
recruited	O
.	O

suggested	O
that	O
more	O
accurate	O
clinical	O
trials	O
are	O
required	O
to	O
reach	O
a	O
conclusion	O
about	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
on	O
depression	O
[	O
31	O
].	O

in	O
2006	O
reported	O
that	O
53	O
%	O
and	O
44	O
%	O
of	O
pregnant	O
women	O
received	O
iron	O
and	O
folate	O
supplementation	O
,	O
respectively	O
,	O
during	O
last	O
pregnancy	O
[	O
54	O
].	O

This	O
fact	O
agrees	O
with	O
the	O
increased	O
body	O
weight	O
and	O
the	O
higher	O
plasma	O
levels	O
of	O
leptin	O
in	O
RC	O
male	O
offspring	O
despite	O
of	O
the	O
absence	O
of	O
hyperphagia	O
or	O
alterations	O
in	O
hypothalamic	O
endocannabinoid	O
machinery	O
.	O

Of	O
note	O
,	O
most	O
of	O
the	O
children	O
in	O
this	O
study	O
were	O
not	O
vitamin	O
D	O
deficient	O
and	O
the	O
vitamin	O
D	O
ranges	O
were	O
relatively	O
narrow	O
.	O

Proteins	O
symbols	O
in	O
red	O
were	O
up	O
-	O
regulated	O
,	O
while	O
green	O
were	O
down	O
-	O
regulated	O
.	O

For	O
continuous	O
outcomes	O
,	O
differences	O
in	O
means	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
linear	O
regression	O
.	O

Environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
an	O
issue	O
that	O
has	O
been	O
highlighted	O
as	O
a	O
current	O
research	O
focus	O
within	O
Public	O
Health	O
England	O
’	O
s	O
(	O
PHE	O
'	O
s	O
)	O
Center	O
for	O
Radiation	O
,	O
Chemical	O
and	O
Environmental	O
Hazards	O
(	O
CRCE	O
),	O
the	O
wider	O
PHE	O
organization	O
as	O
part	O
of	O
the	O
early	O
life	O
priority	O
‘	O
ensuring	O
every	O
child	O
has	O
the	O
best	O
start	O
in	O
life	O
’,	O
and	O
the	O
international	O
research	O
and	O
governmental	O
communities	O
.	O

Eligible	O
women	O
initiated	O
prenatal	O
care	O
before	O
20	O
weeks	O
gestation	O
,	O
were	O
18	O
years	O
of	O
age	O
or	O
older	O
,	O
could	O
speak	O
and	O
read	O
English	O
,	O
and	O
planned	O
to	O
carry	O
the	O
pregnancy	O
to	O
term	O
and	O
to	O
deliver	O
at	O
either	O
hospital	O
.	O

Data	O
were	O
analyzed	O
using	O
the	O
PROC	O
MIXED	O
,	O
including	O
effects	O
of	O
diet	O
,	O
sex	O
,	O
mother	O
,	O
birth	O
weight	O
and	O
interaction	O
between	O
diet	O
and	O
sex	O
(	O
SAS	O
version	O
9	O
.	O
1	O
;	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
).	O

All	O
methods	O
were	O
carried	O
out	O
in	O
accordance	O
with	O
the	O
guidelines	O
.	O

Maternal	O
diet	O
was	O
assessed	O
by	O
self	O
-	O
report	O
between	O
24	O
and	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
it	O
is	O
possible	O
that	O
dietary	O
patterns	O
change	O
near	O
the	O
end	O
of	O
pregnancy	O
or	O
during	O
lactation	O
.	O

Food	O
consumption	O
frequency	O
of	O
food	O
rich	O
in	O
Vitamin	O
D	O
Participants	O
filled	O
dietary	O
records	O
for	O
7	O
–	O
232	O
days	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
7	O
days	O
.	O

Exposure	O
to	O
a	O
high	O
level	O
of	O
testosterone	O
during	O
the	O
earlier	O
part	O
of	O
pregnancy	O
is	O
thought	O
to	O
promote	O
right	O
brain	O
development	O
and	O
influence	O
hand	O
preference	O
,	O
although	O
the	O
evidence	O
in	O
support	O
of	O
a	O
relationship	O
is	O
not	O
conclusive	O
[	O
191	O
].	O

It	O
is	O
important	O
to	O
continue	O
supplementing	O
non	O
-	O
human	O
models	O
with	O
human	O
-	O
derived	O
data	O
,	O
incorporating	O
new	O
technologies	O
to	O
maximize	O
data	O
collection	O
,	O
and	O
updating	O
and	O
re	O
-	O
evaluating	O
current	O
conclusions	B
as	O
novel	O
information	O
becomes	O
available	O
.	O

Thus	B
,	O
the	O
evidence	O
in	O
these	O
cohort	O
studies	O
supports	O
the	O
current	O
recommendations	O
for	O
fish	O
consumption	O
during	O
pregnancy	O
[	O
2	O
,	O
3	O
,	O
4	O
].	O

For	O
1	O
hospital	O
(	O
n	O
=	O
23	O
women	O
)	O
certain	O
questions	O
(	O
mainly	O
nationality	O
,	O
ethnicity	O
,	O
education	O
level	O
)	O
needed	O
to	O
be	O
omitted	O
from	O
the	O
questionnaire	O
upon	O
decision	O
of	O
the	O
ethical	O
committee	O
of	O
this	O
particular	O
hospital	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Geographical	O
distribution	O
of	O
the	O
55	O
hospitals	O
visited	O
in	O
Belgium	O
and	O
the	O
number	O
of	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
investigated	O
by	O
site	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
Belgium	O
2010	O
–	O
2011	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Number	O
of	O
pregnant	O
women	O
by	O
region	O
,	O
trimester	O
and	O
age	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
Belgium	O
,	O
2010	O
–	O
2011	O
).	O
RegionsBrussels	O
**	O
Flanders	O
**	O
WalloniaAge	O
(	O
years	O
)	O
1sttrimester3rdtrimester1sttrimester3rdtrimester1sttrimester3rdtrimester15	O
–	O
20721110211721	O
–	O
2534277751567326	O
–	O
304139108149765831	O
–	O
3534536975494536	O
–	O
4014142319132441	O
–	O
45231332Total132138289307218219	O
6	O
missing	O
data	O
for	O
age	O
.	O

The	O
cycle	O
conditions	O
were	O
50	O
°	O
C	O
for	O
2	O
minutes	O
,	O
95	O
°	O
C	O
for	O
10	O
minutes	O
,	O
40	O
cycles	O
for	O
95	O
°	O
C	O
for	O
15	O
seconds	O
,	O
and	O
60	O
°	O
C	O
for	O
1	O
minute	O
.	O

The	O
same	O
authors	O
reported	O
that	O
exclusion	O
of	O
a	O
vitamin	O
A	O
supplement	O
induced	O
hyperplasia	O
in	O
IMF	O
,	O
but	O
not	O
in	O
the	O
subcutaneous	O
fat	O
depot	O
.	O

PubMed	O
Central	O
:	O

Methods	O
/	O
design	O
The	O
effect	O
of	O
the	O
early	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
neonatal	O
mortality	O
will	O
be	O
examined	O
using	O
a	O
community	O
based	O
,	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
five	O
districts	O
with	O
30	O
,	O
000	O
live	O
births	O
.	O

Acetate	O
or	O
glucose	O
is	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
[	O
85	O
].	O

Pearson	O
Chi	O
-	O
square	O
test	O
,	O
analysis	O
of	O
variance	O
and	O
Kruskal	O
-	O
Wallis	O
were	O
employed	O
.	O

Given	O
the	O
very	O
high	O
levels	O
of	O
sugar	O
consumption	O
currently	O
in	O
the	O
West	O
,	O
where	O
childhood	O
allergy	O
and	O
asthma	O
are	O
so	O
prevalent	O
,	O
confirmation	O
of	O
a	O
causal	O
link	O
would	O
raise	O
exciting	O
prospects	O
for	O
the	O
primary	O
prevention	O
of	O
these	O
disorders	O
.	O

Nine	O
integrated	O
public	O
health	O
centres	O
which	O
accounted	O
for	O
about	O
two	O
thirds	O
of	O
the	O
total	O
study	O
population	O
were	O
selected	O
as	O
study	O
sites	O
.	O

Methods	O
Serum	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
was	O
measured	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
in	O
2800	O
women	O
from	O
Adelaide	O
and	O
Auckland	O
who	O
participated	O
in	O
the	O
multi	O
-	O
centre	O
,	O
prospective	O
cohort	O
SCreening	O
fOr	O
Pregnancy	O
Endpoints	O
(	O
SCOPE	O
)	O
study	O
.	O

However	O
,	O
some	O
studies	O
have	O
revealed	O
that	O
mild	O
temperature	O
stress	O
can	O
increase	O
body	O
fat	O
deposition	O
and	O
marbling	O
for	O
insulation	O
and	O
other	O
purposes	O
[	O
74	O
,	O
82	O
],	O
as	O
described	O
above	O
.	O

The	O
results	O
for	O
omega	O
-	O
3	O
fatty	O
acid	O
and	O
marine	O
fatty	O
acids	O
(	O
EPA	O
,	O
DHA	O
)	O
had	O
a	O
similar	O
pattern	O
,	O
indicating	O
a	O
reduced	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
among	O
women	O
with	O
intermediate	O
levels	O
of	O
intake	O
.	O

Thus	B
,	O
while	O
it	O
is	O
important	O
to	O
fully	O
characterize	O
the	O
hazard	O
,	O
further	O
studies	O
at	O
doses	O
and	O
routes	O
of	O
administration	O
similar	O
to	O
those	O
found	O
in	O
humans	O
are	O
necessary	O
for	O
determining	O
relevance	O
to	O
public	O
health	O
.	O

Mechanisms	O
leading	O
to	O
aortic	O
dissection	O
involve	O
a	O
weakening	O
of	O
the	O
layers	O
of	O
the	O
aorta	O
allowing	O
blood	O
to	O
enter	O
the	O
media	O
and	O
separate	O
the	O
intimal	O
and	O
adventitial	O
layers	O
creating	O
a	O
false	O
lumen	O
.	O

However	O
,	O
most	O
of	O
the	O
evidence	O
is	O
from	O
observational	O
epidemiological	O
studies	O
except	O
for	O
a	O
very	O
few	O
randomised	O
controlled	O
trials	O
.	O

These	O
findings	O
suggest	O
that	O
pathways	O
involved	O
in	O
calcium	O
binding	O
and	O
mitochondrial	O
function	O
may	O
underpin	O
the	O
behavioural	O
features	O
associated	O
with	O
this	O
particular	O
animal	O
model	O
of	O
schizophrenia	O
.	O

Fetuses	O
originated	O
from	O
litters	O
of	O
at	O
least	O
11	O
viable	O
piglets	O
.	O

No	O
increase	O
in	O
pregnancy	O
complications	O
have	O
been	O
found	O
in	O
observational	O
studies	O
where	O
lispro	O
was	O
used	O
,	O
in	O
either	O
women	O
with	O
GDM38	O
,	O
43or	O
pre	O
-	O
existing	O
diabetes	O
.	O
38	O
–	O
43There	O
are	O
few	O
reports	O
regarding	O
the	O
use	O
of	O
aspart	O
in	O
pregnancy	O
.	O

Vitamin	O
C	O
or	O
L	O
-	O
ascorbic	O
acid	O
has	O
several	O
roles	O
including	O
in	O
oxidation	O
–	O
reduction	O
reactions	O
and	O
collagen	O
synthesis	O
[	O
147	O
].	O

Additionally	O
,	O
the	O
lack	O
of	O
correlation	O
may	O
suggest	O
that	O
circulating	O
cathelicidin	O
concentration	O
is	O
not	O
reflective	O
of	O
what	O
is	O
happening	O
at	O
the	O
cellular	O
level	O
,	O
and	O
in	O
this	O
regard	O
,	O
cathelicidin	O
mRNA	O
expression	O
by	O
immune	O
cells	O
or	O
target	O
tissue	O
may	O
be	O
a	O
better	O
indicator	O
of	O
vitamin	O
D	O
’	O
s	O
long	O
-	O
term	O
effect	O
on	O
the	O
cathelicidin	O
system	O
.	O

Our	O
objectives	O
were	O
to	O
study	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
,	O
as	O
well	O
as	O
change	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
with	O
neonatal	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

In	O
addition	O
,	O
we	O
have	O
identified	O
particular	O
regions	O
of	O
the	O
genome	O
susceptible	O
to	O
alterations	O
by	O
the	O
intrauterine	O
environment	O
.	O

The	O
data	O
the	O
team	O
amassed	O
over	O
the	O
last	O
13	O
years	O
suggests	O
that	O
health	O
problems	O
from	O
these	O
mines	O
in	O
fact	O
aren	O
’	O
t	O
limited	O
to	O
the	O
miners	O
who	O
worked	O
in	O
them	O
but	O
also	O
extend	O
to	O
those	O
exposed	O
through	O
drinking	O
water	O
or	O
simply	O
living	O
near	O
a	O
mine	O
.	O

The	O
activity	O
of	O
glycerol	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
,	O
a	O
biomarker	O
for	O
adipogenesis	O
,	O
decreases	O
in	O
bovine	O
preadipocytes	O
cultured	O
with	O
retinol	O
[	O
129	O
].	O

One	O
mechanism	O
the	O
infant	O
gut	O
microbiome	O
may	O
be	O
affected	O
by	O
maternal	O
diet	O
is	O
via	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
at	O
delivery	O
.	O

Pearson	O
'	O
s	O
product	O
moment	O
correlations	O
were	O
conducted	O
to	O
examine	O
unadjusted	O
associations	O
between	O
WFA	O
z	O
-	O
scores	O
and	O
maternal	O
variables	O
.	O

Thus	O
,	O
for	O
practical	O
purposes	O
,	O
the	O
early	O
pregnancy	O
window	O
was	O
set	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
.	O

In	O
a	O
recently	O
published	O
meta	O
-	O
analysis	O
,[	O
12	O
]	O
6	O
cohort	O
studies	O
evaluating	O
the	O
relationship	O
between	O
first	O
trimester	O
maternal	O
use	O
of	O
oral	O
corticosteroids	O
and	O
congenital	O
malformations	O
did	O
not	O
show	O
an	O
increased	O
risk	O
of	O
congenital	O
malformations	O
(	O
summary	O
odds	O
ratio	O
,	O
1	O
.	O
45	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
08	O
-	O
2	O
.	O
60	O
).	O

A	O
meta	O
-	O
analysis	O
of	O
starch	O
digestion	O
in	O
dairy	O
cows	O
revealed	O
that	O
the	O
ruminal	O
digestibility	O
of	O
corn	O
was	O
57	O
.	O
4	O
%	O
[	O
112	O
],	O
demonstrating	O
that	O
a	O
substantial	O
portion	O
of	O
corn	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
.	O

The	O
HV	O
pup	O
diet	O
brought	O
BDNF	O
expression	O
to	O
control	O
levels	O
but	O
the	O
HFol	O
pup	O
diet	O
only	O
attenuated	O
the	O
decrease	O
in	O
expression	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
(	O
Figure	O
5a	O
).	O

Attempts	O
at	O
stimulating	O
BAT	O
function	O
in	O
humans	O
With	O
regard	O
to	O
the	O
relationship	O
between	O
BAT	O
and	O
body	O
weight	O
in	O
humans	O
,	O
an	O
inverse	O
correlation	O
between	O
BMI	O
and	O
the	O
amount	O
of	O
BAT	O
was	O
described	O
,	O
already	O
5	O
years	O
ago	O
(	O
Cypess	O
et	O
al	O
.,	O
2009	O
;	O
van	O
Marken	O
Lichtenbelt	O
et	O
al	O
.,	O
2009	O
).	O

Translation	O
of	O
a	O
gestational	O
diabetes	O
nutrition	O
model	O
of	O
care	O
into	O
practice	O
:	O
results	O
from	O
an	O
implementation	O
project	O
Background	O
Reduced	O
need	O
for	O
insulin	O
therapy	O
in	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
)	O
has	O
been	O
documented	O
in	O
a	O
study	O
validating	O
American	O
Nutrition	O
Practice	O
Guidelines	O
,	O
which	O
recommend	O
at	B
least	I
3	O
dietitian	O
visits	O
.	O

However	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
in	O
Japan	O
,	O
higher	O
dietary	O
vitamin	O
D	O
intake	O
was	O
independently	O
associated	O
with	O
a	O
lower	O
prevalence	O
of	O
depressive	O
symptoms	O
during	O
pregnancy	O
[	O
66	O
].	O

SIRT	O
Nampt	O
expression	O
increased	O
in	O
both	O
cell	O
models	O
in	O
the	O
course	O
of	O
bone	O
tissue	O
differentiation	O
from	O
multipotent	O
fibroblast	O
and	O
monopotent	O
pre	O
-	O
osteoblast	O
in	O
rats	O
.	O

Lower	O
expression	O
of	O
the	O
anorexigenic	O
genes	O
in	O
the	O
offspring	O
of	O
dams	O
fed	O
the	O
multivamins	O
during	O
pregnancy	O
is	O
consistent	O
with	O
the	O
observed	O
increased	O
food	O
intake	O
.	O

Mothers	O
are	O
instructed	O
on	O
how	O
to	O
complete	O
the	O
calendar	O
and	O
to	O
return	O
completed	O
calendars	O
at	O
each	O
visit	O
.	O

For	O
41	O
.	O
7	O
%	O
of	O
the	O
women	O
this	O
was	O
their	O
first	O
pregnancy	O
(	O
unknown	O
for	O
0	O
.	O
4	O
%	O
of	O
the	O
women	O
),	O
while	O
for	O
45	O
.	O
6	O
%	O
of	O
the	O
women	O
this	O
would	O
be	O
their	O
first	O
child	O
(	O
status	O
not	O
known	O
for	O
1	O
.	O
4	O
%	O
of	O
the	O
women	O
).	O

After	O
all	O
,	O
we	O
know	O
that	O
insulin	O
therapy	O
is	O
safe	O
and	O
usually	O
effective	O
.	O

Currently	O
,	O
maternal	O
undernutrition	O
is	O
a	O
problem	O
not	O
exclusive	O
of	O
developing	O
countries	O
.	O

We	O
stored	O
the	O
serum	O
samples	O
at	O
−	O
20	O
°	O
C	O
and	O
analysed	O
them	O
at	O
the	O
end	O
of	O
our	O
study	O
with	O
IDS	O
-	O
iSYS	O
Multi	O
-	O
Discipline	O
Automated	O
Chemiluminescent	O
assay	O
(	O
Immunodiagnostic	O
Systems	O
Ltd	O
,	O
Tyne	O
and	O
Wear	O
,	O
UK	O
)	O
at	O
the	O
Manchester	O
Royal	O
Infirmary	O
,	O
Manchester	O
,	O
UK	O
(	O
Supra	O
-	O
Regional	O
Vitamin	O
D	O
Reference	O
Laboratories	O
accredited	O
to	O
ISO9001	O
:	O
2000	O
and	O
ISO13485	O
:	O
2003	O
and	O
participating	O
in	O
the	O
Vitamin	O
D	O
Quality	O
Assurance	O
Scheme	O
).	O

Because	O
subjects	O
were	O
selected	O
based	O
on	O
SGA	O
status	O
and	O
matched	O
to	O
non	O
-	O
SGA	O
infants	O
on	O
sex	O
,	O
gestational	O
age	O
,	O
and	O
maternal	O
age	O
,	O
we	O
observed	O
no	O
significant	O
differences	O
in	O
those	O
characteristics	O
among	O
birth	O
weight	O
groups	O
(	O
SGA	O
,	O
AGA	O
,	O
LGA	O
).	O

Given	O
that	O
73	O
%	O
of	O
children	O
had	O
vitamin	O
D	O
deficiency	O
in	O
the	O
study	O
region	O
in	O
2005	O
,	O
12and	O
that	O
the	O
incidence	O
of	O
pneumonia	O
was	O
ten	O
-	O
times	O
higher	O
in	O
vitamin	O
D	O
deficient	O
children	O
than	O
in	O
children	O
without	O
a	O
deficiency	O
in	O
case	O
-	O
control	O
studies1	O
,	O
2we	O
postulated	O
that	O
there	O
would	O
be	O
at	B
least	I
a	O
35	O
%	O
reduction	O
in	O
pneumonia	O
incidence	O
in	O
the	O
vitamin	O
D	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

We	O
adjusted	O
p	O
values	O
for	O
multiple	O
comparisons	O
using	O
the	O
Benjamini	O
and	O
Hochberg	O
method	O
to	O
control	O
the	O
false	O
discovery	O
rate	O
[	O
49	O
].	O

At	O
188	O
dpn	O
the	O
body	O
weight	O
was	O
slightly	O
but	O
significantly	O
reduced	O
in	O
LP	O
compared	O
to	O
AP	O
(	O
LP	O
:	O
123	O
.	O
19	O
±	O
9	O
.	O
15	O
kg	O
,	O
AP	O
:	O
131	O
.	O
55	O
±	O
15	O
.	O
11	O
kg	O
,	O
P	O
-	O
0	O
.	O
03	O
;	O
n	O
-	O
32	O
).	O

[	O
13	O
]	O
and	O
Kruavit	O
et	O
al	O
.	O

Iron	O
-	O
deficiency	O
anaemia	O
,	O
the	O
late	O
manifestation	O
of	O
chronic	O
iron	O
deficiency	O
,	O
is	O
thought	O
to	O
be	O
the	O
most	O
common	O
nutrient	O
deficiency	O
among	O
pregnant	O
women	O
[	O
10	O
].	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

They	O
were	O
originally	O
thought	O
to	O
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

Participants	O
with	O
an	O
energy	O
intake	O
outside	O
the	O
first	O
(	O
2261	O
kJ	O
/	O
d	O
)	O
and	O
99th	O
(	O
12	O
335	O
kJ	O
/	O
d	O
)	O
percentiles	O
were	O
excluded	O
from	O
the	O
analysis	O
(	O
n	O
=	O
687	O
).	O

Radioimmunoassay	O
and	O
ELISA	O
were	O
performed	O
to	O
analyze	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
,	O
respectively	O
.	O

Fieldworkers	O
allocated	O
children	O
to	O
randomisation	O
groups	O
during	O
recruitment	O
and	O
gave	O
vitamin	O
D	O
or	O
placebo	O
.	O

Overall	O
satisfaction	O
Most	O
of	O
the	O
women	O
were	O
satisfied	O
with	O
the	O
care	O
rendered	O
them	O
at	O
the	O
different	O
health	O
centres	O
with	O
96	O
.	O
9	O
%	O
being	O
“	O
very	O
satisfied	O
”.	O

Data	O
were	O
collected	O
before	O
the	O
2009	O
IOM	O
guidelines	O
were	O
released	O
.	O

Thus	B
,	O
'	O
mTOR	O
signaling	O
'	O
is	O
involved	O
in	O
regulating	O
individual	O
cell	O
growth	O
,	O
growth	O
performance	O
,	O
and	O
developmental	O
processes	O
[	O
33	O
,	O
34	O
].	O

Images	O
PubMed	O
Central	O
:	O

Of	O
the	O
SGA	O
deliveries	O
,	O
37	O
were	O
SGA	O
by	O
weight	O
and	O
56	O
by	O
length	O
.	O

This	O
may	O
have	O
been	O
especially	O
relevant	O
in	O
our	O
measurement	O
of	O
maternal	O
tobacco	O
,	O
alcohol	O
,	O
and	O
prenatal	O
vitamin	O
use	O
and	O
could	O
have	O
potentially	O
introduced	O
a	O
bias	O
toward	O
the	O
null	O
.	O

These	O
effects	O
extended	O
to	O
lipid	O
and	O
cholesterol	O
metabolic	O
pathways	O
,	O
suggesting	O
the	O
existence	O
of	O
a	O
complex	O
pattern	O
alterations	O
derived	O
of	O
adaptation	O
to	O
maternal	O
malnutrition	O
.	O

Here	O
,	O
we	O
also	O
review	O
these	O
factors	O
affecting	O
IMF	O
deposition	O
in	O
cattle	O
.	O

We	O
also	O
noted	O
that	O
associations	O
between	O
short	O
sleep	O
duration	O
and	O
GDM	O
risk	O
were	O
particularly	O
pronounced	O
among	O
overweight	O
women	O
(	O
far	O
right	O
column	O
of	O
Table2	O
).	O

(	O
2012b	O
)*	O
Li	O
et	O
al	O
.	O

Similarly	O
,	O
a	O
growth	O
stage	O
-	O
specific	O
feeding	O
system	O
has	O
generally	B
been	O
applied	O
to	O
Korean	O
cattle	O
to	O
produce	O
highly	O
marbled	O
beef	O
.	O

The	O
newly	O
synthesized	O
cytokines	O
and	O
chemokines	O
lead	O
to	O
the	O
late	O
-	O
phase	O
reaction	O
associated	O
with	O
tissue	O
edema	O
by	O
recruitment	O
and	O
activation	O
of	O
additional	O
inflammatory	O
cells	O
,	O
including	O
basophils	O
,	O
eosinophils	O
,	O
and	O
T	O
helper	O
type	O
2	O
(	O
Th2	O
)	O
lymphocytes	O
[	O
6	O
].	O

Essentially	O
,	O
women	O
at	O
risk	O
of	O
type	O
2	O
diabetes	O
are	O
at	O
risk	O
of	O
GDM	O
.	O

As	O
with	O
any	O
longitudinal	O
study	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
exclusion	O
of	O
mother	O
–	O
child	O
pairs	O
without	O
complete	O
information	O
might	O
have	O
biased	O
our	O
findings	O
.	O

Several	O
of	O
the	O
components	O
of	O
the	O
network	O
converge	O
on	O
MAPK1	O
,	O
a	O
MAP	O
kinase	O
that	O
serves	O
to	O
integrate	O
multiple	O
biochemical	O
signals	O
(	O
previously	O
known	O
as	O
ERK2	O
),	O
that	O
was	O
found	O
to	O
be	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
proteomics	O
study	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Network	O
analysis	O
of	O
the	O
proteins	O
assembled	O
by	O
Ingenuity	O
Pathway	O
Analysis	O
.	O

Objective	O
To	O
identify	O
the	O
presence	O
of	O
GDM	O
risk	O
factors	O
during	O
pregnancy	O
at	O
the	O
time	O
of	O
diagnosis	O
of	O
this	O
pathology	O
.	O

In	O
children	O
,	O
high	O
birth	O
weight	O
has	O
been	O
associated	O
with	O
increased	O
risk	O
for	O
astrocytoma	O
and	O
medulloblastoma	O
/	O
primitive	O
neuroectodermal	O
tumors	O
(	O
PNET	O
)	O
[	O
173	O
].	O

Studies	O
found	O
that	O
about	O
70	O
%	O
of	O
pregnant	O
women	O
are	O
affected	O
by	O
these	O
symptoms	O
during	O
their	O
last	O
trimenon	O
,[	O
85	O
]	O
and	O
50	O
%	O
of	O
them	O
are	O
likely	B
to	O
take	O
acid	O
-	O
suppressing	O
medication	O
.	O

They	O
opined	O
that	O
sufficient	O
attention	O
should	O
be	O
paid	O
to	O
adolescent	O
girls	O
and	O
women	O
of	O
reproductive	O
age	O
long	O
before	O
pregnancy	O
and	O
suggested	O
intermittent	O
low	O
-	O
dose	O
iron	O
supplements	O
and	O
in	O
some	O
cases	O
,	O
combined	O
with	O
necessary	O
micronutrients	O
[	O
36	O
,	O
37	O
].	O

The	O
association	O
between	O
diet	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risks	O
(	O
RR	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
and	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
.	O

Associated	O
symptoms	O
include	O
nausea	O
,	O
vomiting	O
,	O
diaphoresis	O
,	O
and	O
light	O
-	O
headedness	O
.	O

Asibey	O
-	O
Berko	O
et	O
al	O
.	O

A	O
BRAC	O
PO	O
area	O
approximately	O
comprises	O
of	O
40	O
to	O
50	O
villages	O
with	O
an	O
average	O
population	O
of	O
13	O
,	O
000	O
people	O
.	O

Due	O
to	O
the	O
high	O
iron	O
requirements	O
for	O
pregnancy	O
,	O
it	O
is	O
highly	O
prevalent	O
and	O
severe	O
in	O
pregnant	O
women	O
.	O

Methods	O
Participants	O
Between	O
Nov	O
4	O
and	O
Dec	O
4	O
,	O
2008	O
,	O
we	O
did	O
a	O
community	O
based	O
randomised	O
placebo	O
-	O
controlled	O
superiority	O
trial	O
in	O
Kabul	O
,	O
Afghanistan	O
,	O
within	O
the	O
catchment	O
area	O
of	O
the	O
Maiwand	O
Teaching	O
Hospital	O
,	O
which	O
serves	O
an	O
inner	O
-	O
city	O
population	O
.	O

In	O
a	O
study	O
by	O
Hovsepian	O
et	O
al	O
.,	O
in	O
men	O
and	O
women	O
with	O
average	O
age	O
of	O
41	O
.	O
4	O
years	O
in	O
Isfahan	O
,	O
45	O
%	O
of	O
men	O
and	O
52	O
.	O
4	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
concentrations	O
lower	O
than	O
20	O
ng	O
/	O
mL	O
([	O
52	O
]).	O

It	O
should	O
also	O
be	O
noted	O
that	O
,	O
despite	O
ongoing	O
research	O
efforts	O
,	O
relatively	O
little	O
has	O
yet	O
been	O
divulged	O
regarding	O
delivery	O
-	O
room	O
attributes	O
that	O
may	O
be	O
directly	O
or	O
indirectly	O
associated	O
with	O
the	O
incidence	O
of	O
autism	O
.	O

The	O
production	O
of	O
highly	O
marbled	O
beef	O
in	O
Korea	O
is	O
essential	O
to	O
compete	O
with	O
cheap	O
imported	O
beef	O
that	O
has	O
a	O
relatively	O
low	O
marbling	O
score	O
(	O
MS	O
).	O

We	O
will	O
present	O
the	O
intermediate	O
and	O
immediate	O
results	O
,	O
which	O
support	O
the	O
hypotheses	O
generated	O
from	O
the	O
trial	O
,	O
at	O
national	O
and	O
international	O
conferences	O
and	O
publish	O
them	O
in	O
conference	O
proceedings	O
.	O

For	O
patients	O
with	O
local	O
recurrent	O
disease	O
,	O
ultrasound	O
controls	O
by	O
skilled	O
hands	O
is	O
of	O
outmost	O
importance	O
,	O
both	O
to	O
help	O
surgeons	O
in	O
selecting	O
tissues	O
for	O
excision	O
and	O
to	O
perform	O
local	O
therapy	O
,	O
such	O
as	O
alcoholization	O
of	O
small	O
lesions	O
.	O

2	O
.	O
4	O
.	O

However	O
,	O
it	O
is	O
argued	O
that	O
cost	O
benefit	O
of	O
intravenous	O
iron	O
prophylaxis	O
may	O
be	O
large	O
taking	O
into	O
consideration	O
the	O
opportunity	O
costs	O
of	O
erythropoiesis	O
-	O
stimulating	O
agents	O
,	O
blood	O
transfusions	O
,	O
and	O
hospitalization	O
[	O
25	O
].	O

Bindon	O
[	O
115	O
]	O
suggested	O
that	O
maize	O
produces	O
increased	O
glucose	O
from	O
digestion	O
in	O
the	O
small	O
intestine	O
and	O
that	O
steam	O
flaking	O
increases	O
digestion	O
in	O
both	O
the	O
rumen	O
and	O
small	O
intestine	O
.	O

However	O
,	O
we	O
were	O
not	O
able	O
take	O
environmental	O
factors	O
and	O
geographic	O
area	O
into	O
account	O
,	O
because	O
the	O
study	O
questionnaire	O
did	O
not	O
assess	O
the	O
origin	O
of	O
fish	O
,	O
such	O
as	O
the	O
Baltic	O
Sea	O
or	O
the	O
Atlantic	O
Ocean	O
.	O

Interestingly	O
,	O
BAT	O
glucose	O
uptake	O
is	O
close	O
to	O
the	O
values	O
observed	O
for	O
metastasis	O
in	O
cancer	O
in	O
humans	O
(	O
Aukema	O
et	O
al	O
.,	O
2010	O
).	O

All	O
eight	O
studies	O
included	O
in	O
the	O
final	O
review	O
were	O
observational	O
in	O
design	O
.	O

Our	O
laboratory	O
has	O
studied	O
IMF	O
deposition	O
for	O
more	O
than	O
a	O
decade	O
to	O
understand	O
the	O
mechanisms	O
responsible	O
for	O
IMF	O
deposition	O
in	O
beef	O
cattle	O
[	O
6	O
–	O
12	O
],	O
and	O
we	O
have	O
reviewed	O
molecular	O
mechanisms	O
responsible	O
for	O
IMF	O
deposition	O
in	O
cattle	O
[	O
13	O
].	O

PubMed	O
Central	O
:	O

All	O
analyses	O
were	O
analogously	O
performed	O
in	O
the	O
Cesarean	O
section	O
group	O
to	O
assess	O
if	O
an	O
effect	O
of	O
maternal	O
diet	O
on	O
the	O
infant	O
gut	O
microbiome	O
exists	O
in	O
the	O
case	O
of	O
surgical	O
delivery	O
.	O

Records	O
included	O
ethnicity	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
socioeconomic	O
index	O
(	O
SEI	O
)	O
and	O
multivitamin	O
use	O
[	O
29	O
].	O

Thus	B
,	O
although	O
the	O
current	O
literature	O
remains	O
incomplete	O
regarding	O
specific	O
mechanisms	O
of	O
epigenetically	O
mediated	O
environmentally	O
induced	O
toxicity	O
in	O
humans	O
at	O
doses	O
relevant	O
to	O
human	O
exposures	O
,	O
there	O
is	O
sufficient	O
information	O
to	O
perform	O
retrospective	O
epigenetic	O
analysis	O
of	O
existing	O
regulatory	O
studies	O
and	O
identify	O
future	O
research	O
needs	O
.	O

Behaviourally	O
,	O
adult	O
DVD	O
-	O
deficient	O
rats	O
were	O
more	O
active	O
than	O
controls	O
(	O
i	O
.	O
e	O
.	O

Table	O
1	O
shows	O
the	O
demographics	O
and	O
clinical	O
characteristics	O
of	O
the	O
133	O
children	O
participants	O
in	O
this	O
study	O
with	O
measurement	O
of	O
circulating	O
cathelicidin	O
.	O

Conclusion	O
In	O
this	O
study	O
39	O
%	O
of	O
women	O
reported	O
using	O
herbs	O
during	O
pregnancy	O
,	O
a	O
higher	O
frequency	O
than	O
reported	O
in	O
other	O
studies	O
.	O

Smoking	O
has	O
been	O
found	O
to	O
be	O
an	O
environmental	O
hazard	O
.	O

Therefore	B
all	O
women	O
with	O
GDM	O
should	O
receive	O
counseling	O
from	O
a	O
specialist	O
dietitian	O
.	O

BDNF	O
was	O
corrected	O
to	O
similar	O
levels	O
by	O
the	O
HV	O
diet	O
,	O
and	O
only	O
partially	O
by	O
the	O
HFol	O
pup	O
diet	O
.	O

Risk	O
factors	O
for	O
the	O
development	O
of	O
GDM	O
include	O
obesity	O
,	O
older	O
age	O
,	O
family	O
history	O
,	O
previous	O
history	O
of	O
GDM	O
or	O
poor	O
obstetric	O
outcomes	O
,	O
ethnicity	O
,	O
polycystic	O
ovary	O
syndrome	O
and	O
as	O
more	O
recently	O
noted	O
,	O
hypertension	O
.	O
4	O
,	O
5	O
The	O
major	O
significance	O
of	O
GDM	O
is	O
that	O
it	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
.	O

To	O
account	O
for	O
variation	O
in	O
RNA	O
input	O
and	O
efficiency	O
of	O
reverse	O
transcription	O
the	O
calculated	O
mRNA	O
copy	O
numbers	O
were	O
normalized	O
by	O
dividing	O
with	O
a	O
normalization	O
factor	O
derived	O
from	O
the	O
expression	O
of	O
the	O
reference	O
gene	O
.	O

It	O
also	O
supports	O
the	O
premise	O
that	O
cathelicidin	O
increases	O
with	O
increasing	O
age	O
,	O
particularly	O
in	O
males	O
.	O

In	O
our	O
study	O
,	O
the	O
level	O
of	O
nutritional	O
knowledge	O
was	O
an	O
independent	O
determinant	O
for	O
the	O
use	O
of	O
folic	O
acid	O
during	O
pregnancy	O
.	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
extent	O
and	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
but	O
not	O
between	O
LINE	O
-	O
1	O
methylation	O
and	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
.	O

Briefly	O
,	O
at	O
insemination	O
German	O
Landrace	O
primiparous	O
sows	O
(	O
n	O
=	O
42	O
)	O
were	O
randomly	O
assigned	O
to	O
either	O
a	O
low	O
protein	O
diet	O
(	O
LP	O
)	O
with	O
6	O
%	O
(	O
w	O
/	O
w	O
)	O
crude	O
protein	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
)	O
containing	O
12	O
%	O
crude	O
protein	O
.	O

However	O
,	O
in	O
that	O
study	O
neurodevelopment	O
was	O
assessed	O
when	O
the	O
infant	O
was	O
only	O
three	O
days	O
old	O
.	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
and	O
RPMM	O
class	O
methylation	O
(	O
p	O
=	O
0	O
.	O
01	O
);	O
no	O
association	O
was	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
RPMM	O
class	O
methylation	O
.	O

A	O
separate	O
study	O
from	O
Western	O
Australia	O
concluded	O
that	O
autistic	O
children	O
generally	B
had	O
parents	O
who	O
were	O
older	O
and	O
had	O
greater	O
frequencies	O
of	O
threatened	O
abortions	O
,	O
epidural	O
anesthesia	O
,	O
labor	O
induction	O
,	O
and	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
.	O

Atopic	O
Eczema	O
(	O
Dermatitis	O
)	O
Gestational	O
itchy	O
dermatoses	O
are	O
relatively	O
common	O
,	O
with	O
eczema	O
being	O
diagnosed	O
in	O
30	O
%	O
to	O
50	O
%	O
of	O
all	O
cases	O
[	O
41	O
].	O

We	O
computed	O
the	O
relative	O
abundance	O
for	O
each	O
OTU	O
by	O
dividing	O
the	O
read	O
count	O
in	O
each	O
cell	O
by	O
the	O
total	O
number	O
of	O
reads	O
in	O
the	O
sample	O
and	O
filtered	O
out	O
OTUs	O
with	O
zero	O
or	O
near	O
-	O
zero	O
variance	O
using	O
the	O
caret	O
package	O
in	O
R	O
.	O
This	O
results	O
in	O
624	O
OTUs	O
.	O

A	O
lack	O
of	O
vitamins	O
and	O
minerals	O
can	O
adversely	O
influence	O
the	O
newborn	O
’	O
s	O
weight	O
,	O
even	O
if	O
the	O
dietary	O
intake	O
of	O
proteins	O
and	O
energy	O
is	O
adequate	O
[	O
5	O
,	O
6	O
].	O

Midstream	O
spot	O
urine	O
samples	O
(	O
5	O
ml	O
)	O
are	O
collected	O
from	O
the	O
participating	O
women	O
at	O
phases	O
1	O
,	O
2	O
and	O
3	O
during	O
pregnancy	O
and	O
at	O
phase	O
6	O
postnatally	O
into	O
a	O
urine	O
collection	O
cup	O
.	O

For	O
the	O
microarray	O
analyses	O
,	O
8	O
sib	O
pairs	O
(	O
light	O
and	O
heavy	O
piglet	O
from	O
one	O
litter	O
)	O
which	O
were	O
balanced	O
for	O
sex	O
(	O
all	O
stages	O
)	O
and	O
discordant	O
for	O
weight	O
(	O
light	O
and	O
heavy	O
piglet	O
;	O
stages	O
94	O
dpc	O
and	O
1	O
dpn	O
only	O
)	O
were	O
chosen	O
per	O
stage	O
and	O
diet	O
.	O

The	O
infant	O
reported	O
here	O
was	O
managed	O
as	O
a	O
case	O
of	O
acute	O
laryngotracheobronchitis	O
initially	O
as	O
there	O
was	O
no	O
evidence	O
of	O
rickets	O
and	O
the	O
diagnosis	O
of	O
hypocalcemia	O
was	O
made	O
only	O
after	O
he	O
had	O
convulsions	O
.	O

All	O
TGs	O
cited	O
are	O
publically	O
available	O
from	O
the	O
OECD	O
website	O
(	O
http	O
://	O
www	O
.	O
oecd	O
-	O
ilibrary	O
.	O
org	O
/	O
environment	O
/	O
oecd	O
-	O
guidelines	O
-	O
for	O
-	O
the	O
-	O
testing	O
-	O
of	O
-	O
chemicals	O
-	O
section	O
-	O
4	O
-	O
health	O
-	O
effects_20745788	O
).	O

However	O
,	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
was	O
lower	O
.	O

If	O
there	O
are	O
more	O
than	O
5	O
%	O
errors	O
,	O
respective	O
data	O
are	O
re	O
-	O
captured	O
.	O

[	O
21	O
]	O
reported	O
differences	O
in	O
outcomes	O
associated	O
with	O
oily	O
fish	O
intake	O
and	O
total	O
fish	O
intake	O
in	O
early	O
compared	O
to	O
late	O
pregnancy	O
.	O

If	O
an	O
association	O
exists	O
the	O
effect	O
probably	B
represents	O
the	O
interplay	O
between	O
various	O
environmental	O
,	O
genetic	O
,	O
lifestyle	O
,	O
and	O
socioeconomic	O
factors	O
,	O
operating	O
on	O
mother	O
and	O
child	O
within	O
a	O
precise	O
window	O
of	O
vulnerability	O
.	O

A	O
high	O
index	O
of	O
suspicion	O
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	O
for	O
a	O
successful	O
outcome	O
.	O

Treatment	O
to	O
post	O
-	O
prandial	O
targets	O
results	O
in	O
superior	O
pregnancy	O
outcomes	O
compared	O
to	O
pre	O
-	O
prandial	O
targets	O
.	O
25The	O
recommended	O
treatment	O
targets	O
vary	O
from	O
country	O
to	O
country	O
(	O
Table	O
2	O
).	O

The	O
fact	O
that	O
anaemia	O
frequently	O
does	O
occur	O
in	O
pregnancy	O
among	O
women	O
in	O
developing	O
countries	O
is	O
an	O
indication	O
that	O
preexisting	O
iron	O
stores	O
are	O
often	B
inadequate	O
and	O
physiological	O
adaptations	O
to	O
pregnancy	O
are	O
insufficient	O
to	O
meet	O
the	O
increased	O
requirements	O
[	O
4	O
].	O

Data	O
on	O
education	O
level	O
(≤	O
primary	O
level	O
,	O
secondary	O
level	O
or	O
university	O
level	O
)	O
and	O
origin	O
(	O
continent	O
of	O
birth	O
:	O
Northern	O
Europe	O
,	O
Continental	O
Europe	O
,	O
America	O
,	O
Asia	O
,	O
Africa	O
)	O
were	O
collected	O
from	O
study	O
questionnaires	O
.	O

Our	O
recent	O
study	O
indicated	O
that	O
a	O
lower	O
ambient	O
temperature	O
decreased	O
growth	O
and	O
feed	O
efficiency	O
in	O
Korean	O
cattle	O
steers	O
[	O
78	O
].	O

We	O
selected	O
infants	O
from	O
inner	O
-	O
city	O
Kabul	O
because	O
we	O
knew	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency12and	O
incidence	O
of	O
pneumonia3	O
,	O
15were	O
high	O
.	O

The	O
independent	O
and	O
paired	O
t	O
-	O
test	O
were	O
used	O
for	O
normally	O
distributed	O
quantitative	O
variables	O
,	O
the	O
chi	O
-	O
square	O
test	O
was	O
used	O
for	O
qualitative	O
variables	O
,	O
and	O
the	O
Mann	O
-	O
Whitney	O
U	O
and	O
Wilcoxon	O
Signed	O
-	O
Rank	O
tests	O
were	O
used	O
for	O
non	O
-	O
normally	O
distributed	O
variables	O
.	O

From	O
this	O
information	O
,	O
we	O
categorized	O
participants	O
as	O
snoring	O
if	O
their	O
reported	O
snoring	O
most	O
or	O
all	O
of	O
the	O
time	O
;	O
all	O
other	O
women	O
were	O
classified	O
as	O
non	O
-	O
snorers	O
.	O

Vitamin	O
C	O
,	O
which	O
is	O
mostly	O
found	O
in	O
seasonal	O
fruits	O
and	O
vegetables	O
,	O
can	O
react	O
with	O
and	O
then	O
inhibit	O
nitrite	O
formation	O
of	O
nitrosamines	O
[	O
163	O
].	O

Although	O
SSRIs	O
are	O
not	O
contraindicated	O
for	O
use	O
during	O
pregnancy	O
,	O
the	O
effects	O
should	O
be	O
examined	O
more	O
carefully	O
[	O
66	O
].	O

A	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
association	O
between	O
autism	O
and	O
developmental	O
abnormalities	O
in	O
children	O
with	O
perinatal	O
cocaine	O
exposure	O
.	O

Maternal	O
and	O
offspring	O
health	O
is	O
followed	O
-	O
up	O
at	O
6	O
weeks	O
,	O
as	O
well	O
as	O
at	O
6	O
,	O
≈	O
7	O
.	O
5	O
and	O
12	O
months	O
after	O
birth	O
.	O

Bonferroni	O
analysis	O
indicated	O
that	O
the	O
RC	O
males	O
showed	O
a	O
significant	O
increase	O
in	O
the	O
plasma	O
levels	O
of	O
leptin	O
,	O
triglycerides	O
,	O
VLDL	O
,	O
and	O
bilirubin	O
compared	O
to	O
the	O
plasma	O
of	O
CC	O
males	O
.	O

Accordingly	O
,	O
population	O
studies	O
,	O
which	O
have	O
been	O
conducted	O
by	O
the	O
United	O
States	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
have	O
reported	O
a	O
prevalence	O
of	O
ASDs	O
of	O
1	O
of	O
68	O
children	O
at	O
risk	O
.	O

Cross	O
-	O
sectional	O
,	O
observational	O
,	O
and	O
randomized	O
control	O
trials	O
'	O
literature	O
on	O
the	O
subject	O
published	O
between	O
2000	O
and	O
2011	O
served	O
as	O
the	O
main	O
sources	O
of	O
information	O
.	O

When	O
dealing	O
with	O
MTC	O
,	O
we	O
should	O
always	O
bear	O
in	O
mind	O
that	O
these	O
patients	O
may	O
be	O
the	O
index	O
-	O
case	O
for	O
one	O
of	O
the	O
familial	O
forms	O
of	O
the	O
disease	O
:	O
presymptomatic	O
screening	O
of	O
relatives	O
of	O
MTC	O
patients	O
enables	O
early	O
diagnosis	O
of	O
this	O
malignancy	O
.	O

The	O
main	O
positive	O
findings	O
of	O
our	O
study	O
are	O
summarised	O
infigure	O
1	O
.	O

The	O
between	O
groups	O
comparisons	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
presented	O
in	O
Table	O
3	O
.	O

The	O
liver	O
of	O
RC	O
females	O
also	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
the	O
de	O
novo	O
lipogenic	O
enzyme	O
Acaca	O
and	O
Fasn	O
,	O
which	O
constitute	O
rate	O
-	O
limit	O
steps	O
in	O
the	O
fatty	O
-	O
acid	O
synthesis	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

Children	O
of	O
normal	O
weight	O
mothers	O
who	O
were	O
exposed	O
to	O
excessive	O
GWG	O
(	O
n	O
=	O
71	O
)	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
(	O
0	O
.	O
42	O
±	O
0	O
.	O
75	O
versus	O
0	O
.	O
03	O
±	O
0	O
.	O
73	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
GWG	O
,	O
but	O
no	O
significant	O
effects	O
were	O
seen	O
on	O
odds	O
of	O
macrosomia	O
or	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
.	O

PubMed	O
Central	O
:	O

(	O
2015	O
)	O
and	O
Leseva	O
et	O
al	O
.	O

It	O
is	O
,	O
therefore	B
,	O
important	O
to	O
assess	O
if	O
the	O
model	O
system	O
being	O
used	O
accurately	O
replicates	O
the	O
in	O
vivo	O
human	O
metabolic	O
environment	O
,	O
and	O
if	O
not	O
to	O
conduct	O
further	O
studies	O
using	O
any	O
additional	O
appropriate	O
metabolites	O
.	O

Other	O
putative	O
candidates	O
include	O
harmonic	O
variation	O
in	O
population	O
mixing	O
,	O
diet	O
,	O
temperature	O
,	O
humidity	O
,	O
sunlight	O
/	O
photoperiod	O
,	O
levels	O
of	O
vitamin	O
D3	O
,	O
and	O
endogenous	O
hormones	O
[	O
6	O
,	O
7	O
].	O

These	O
cells	O
,	O
which	O
will	O
be	O
discussed	O
below	O
,	O
present	O
a	O
phenotype	O
with	O
metabolic	O
properties	O
that	O
are	O
closest	O
to	O
brown	O
than	O
to	O
white	O
adipocytes	O
.	O

However	O
,	O
as	O
the	O
effect	O
doesn	O
'	O
t	O
vary	O
by	O
cats	O
versus	O
dogs	O
,	O
differences	O
by	O
race	O
in	O
factors	O
correlated	O
with	O
pet	O
ownership	O
or	O
variations	O
in	O
pet	O
keeping	O
styles	O
may	O
be	O
more	O
important	O
.	O

Supplementary	O
materialERJ	O
-	O
00073	O
-	O
2017_Supplement	O
Disclosures10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp2	O
A	O
.	O
BédardERJ	O
-	O
00073	O
-	O
2017_Bedard	O
A	O
.	O
J	O
.	O

3	O
.	O
3	O
.	O
2	O
.	O

In	O
humans	O
,	O
the	O
only	O
physiological	O
recovery	O
of	O
insulin	O
sensitivity	O
after	O
a	O
period	O
of	O
insulin	O
resistance	O
,	O
partially	O
due	O
to	O
an	O
increase	O
in	O
food	O
intake	O
and	O
lipogenesis	O
,	O
is	O
observed	O
in	O
women	O
after	O
pregnancy	O
(	O
Barbour	O
et	O
al	O
.,	O
2007	O
).	O

Intervention	O
in	O
the	O
supplement	O
consumer	O
(	O
vitamin	O
D	O
)	O
group	O
:	O
In	O
2007	O
and	O
2010	O
,	O
the	O
Canadian	O
Pediatric	O
Association	O
recommended	O
a	O
daily	O
amount	O
of	O
2000	O
IU	O
of	O
vitamin	O
D	O
for	O
pregnant	O
and	O
breast	O
-	O
feeding	O
women	O
[	O
47	O
,	O
46	O
].	O

In	O
response	O
,	O
the	O
Chinese	O
government	O
invested	O
US	O
$	O
100	O
million	O
in	O
2007	O
to	O
launch	O
the	O
collection	O
of	O
data	O
from	O
industrial	O
,	O
agricultural	O
,	O
and	O
residential	O
sources	O
at	O
sites	O
throughout	O
China	O
,	O
beginning	O
in	O
February	O
2008	O
.	O

Between	O
15thNovember	O
2011	O
and	O
15thJuly	O
2012	O
,	O
a	O
total	O
of	O
385	O
women	O
were	O
recruited	O
into	O
the	O
study	O
based	O
on	O
the	O
calculated	O
sample	O
size	O
using	O
the	O
Eng	O
'	O
s	O
formula	O
[	O
10	O
]	O
assuming	O
that	O
50	O
%	O
of	O
the	O
women	O
were	O
satisfied	O
with	O
ANC	O
offered	O
them	O
.	O

Among	O
pregnant	O
women	O
,	O
IDA	O
has	O
been	O
associated	O
with	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
[	O
11	O
].	O

This	O
intervention	O
is	O
consistent	O
with	O
the	O
Bangladesh	O
Ministry	O
of	O
Health	O
guidelines	O
.	O

With	O
this	O
,	O
there	O
was	O
a	O
1	O
%	O
incidence	O
of	O
serious	O
perinatal	O
outcomes	O
(	O
death	O
,	O
shoulder	O
dystocia	O
,	O
fracture	O
,	O
and	O
nerve	O
palsy	O
)	O
compared	O
to	O
4	O
%	O
amongst	O
women	O
provided	O
with	O
standard	O
pregnancy	O
care	O
only	O
(	O
adjusted	O
risk	O
reduction	O
0	O
.	O
33	O
,	O
p	O
=	O
0	O
.	O
01	O
).	O

Anaphylaxis	O
associated	O
with	O
folic	O
acid	O
:	O
domestic	O
case	O
review	O
Background	O
Synthetic	O
folic	O
acid	O
has	O
been	O
shown	O
to	O
cause	O
serious	O
,	O
potentially	O
life	O
-	O
threatening	O
IgE	O
mediated	O
anaphylaxis	O
[	O
1	O
-	O
3	O
].	O

Weak	O
Infrastructure	O
and	O
Political	O
Commitment	O
The	O
efforts	O
of	O
World	O
Food	O
Programme	O
(	O
WFP	O
)	O
in	O
overcoming	O
micronutrient	O
deficiencies	O
in	O
nutritionally	O
-	O
vulnerable	O
groups	O
and	O
low	O
-	O
income	O
food	O
-	O
deficit	O
countries	O
continue	O
to	O
be	O
thwarted	O
by	O
challenges	O
such	O
as	O
technical	O
and	O
managerial	O
capacity	O
constraints	O
,	O
the	O
need	O
for	O
systematic	O
compliance	O
with	O
procurement	O
specifications	O
and	O
quality	O
control	O
,	O
clearer	O
policies	O
on	O
micronutrient	O
content	O
labeling	O
,	O
and	O
the	O
need	O
for	O
cash	O
resources	O
to	O
support	O
many	O
aspects	O
associated	O
with	O
local	O
processing	O
and	O
fortification	O
activities	O
[	O
57	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Primer	O
used	O
to	O
verify	O
microarray	O
experiments	O
in	O
liver	O
tissue	O
by	O
qRT	O
-	O
PCRGene	O
nameProbe	O
-	O
set	O
IDSequence	O
5	O
'	O
-	O
3	O
'	O
T	O
(°	O
C	O
)	O
Size	O
(	O
bp	O
)	O
CCND2Ssc	O
.	O
15749	O
.	O
1	O
.	O
S1_atFor	O
AGGAGCAGATTGAGGTCGTG86185Rev	O
CAACCAGAGAGAAGGAAGGAGANCAPGSsc	O
.	O
28512	O
.	O
1	O
.	O
S1_atFor	O
CTTGTAGATTTGACGAGACCA60156Rev	O
GGCTTTAGTATAGACCCGAACMGMTSsc	O
.	O
19639	O
.	O
1	O
.	O
A1_atFor	O
GCAACTACTCGGGAGGAATG88171Rev	O
CTGCGAACGCTCAGTCTTGGADD45BSsc	O
.	O
14764	O
.	O
1	O
.	O
A1_atFor	O
GGACTTAGACTTTGGGACTTG60140Rev	O
GTAAGCCTCCCATCTCTCTTSDHBSsc	O
.	O
8939	O
.	O
1	O
.	O
S1_atFor	O
GCAGGACCCGTTCTCTCTGT60170Rev	O
GGTTACAGTCACGTTAGGTTGGPPARGC1ASsc	O
.	O
16864	O
.	O
1	O
.	O
S1_atFor	O
GTAAATCTGCGGGATGATGG60208Rev	O
TGGTGGAAGCAGGATCAAAGPRKAA1Ssc	O
.	O
8107	O
.	O
1	O
.	O
A1_atFor	O
TTGTTAATTTCATAAACTTTGCTTC60193Rev	O
GTGCAGCCTTGACATACTCPRKAA2Ssc	O
.	O
16257	O
.	O
1	O
.	O
S1_atFor	O
TCTGTAATTCTGTTTTGCCTACGA60168Rev	O
AGCAAGAAGGTGATGCCAAGRPL10	O
*	O
Ssc	O
.	O
9130	O
.	O
1	O
.	O
A1_atFor	O
CTGTGTTCGTCTTTTCTTCC60199Rev	O
TCATCCACTTTTGCCTTCT	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
;	O
RPL10	O
-	O
Ribosomal	O
protein	O
10	O
;	O
*	O
house	O
keeping	O
gene	O
.	O

The	O
RNA	O
from	O
the	O
homogenized	O
samples	O
was	O
isolated	O
using	O
Trizol	O
reagent	O
and	O
chloroform	O
extraction	O
by	O
the	O
manufacturer	O
’	O
s	O
protocol	O
(	O
Invitrogen	O
,	O
Grand	O
Island	O
,	O
NY	O
,	O
USA	O
)	O
and	O
quantified	O
by	O
Nanodrop	O
1000	O
.	O

The	O
binding	O
of	O
this	O
to	O
vitamin	O
D	O
receptors	O
in	O
turn	O
results	O
in	O
increased	O
intracellular	O
formation	O
of	O
antimicrobial	O
compounds	O
,	O
such	O
as	O
cathelicidins	O
.	O
5The	O
generation	O
of	O
intracellular	O
antimicrobial	O
compounds	O
is	O
impaired	O
in	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
(	O
ie	O
,	O
low	O
serum	O
concentrations	O
of	O
calcifediol	O
).	O

For	O
obese	O
women	O
,	O
a	O
30	O
%–	O
33	O
%	O
calorie	O
restriction	O
to	O
approximately	O
25	O
kcal	O
/	O
kg	O
actual	O
weight	O
per	O
day	O
is	O
recommended	O
.	O

Asthma	O
Certain	O
physiological	O
changes	O
occur	O
normally	O
during	O
pregnancy	O
(	O
Table2	O
)	O
[	O
17	O
].	O

Women	O
presenting	O
for	O
other	O
services	O
than	O
ANC	O
visits	O
were	O
excluded	O
on	O
the	O
grounds	O
that	O
they	O
did	O
not	O
have	O
any	O
experience	O
of	O
a	O
particular	O
health	O
centre	O
and	O
so	O
could	O
not	O
give	O
an	O
opinion	O
on	O
the	O
ANC	O
services	O
.	O

Nevertheless	O
there	O
is	O
a	O
consensus	B
to	O
consider	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
below	O
20	O
ng	O
/	O
ml	O
as	O
inadequately	O
low	O
[	O
25	O
],	O
and	O
some	O
evidence	O
suggests	O
that	O
values	O
higher	O
than	O
30	O
ng	O
/	O
ml	O
may	O
be	O
associated	O
with	O
better	O
health	O
outcomes	O
in	O
the	O
adult	O
population	O
.[	O
26	O
],[	O
27	O
].	O

Maternal	O
short	O
stature	O
is	O
,	O
in	O
turn	O
,	O
a	O
risk	O
factor	O
for	O
birth	O
complications	O
[	O
24	O
]	O
–	O
illustrating	O
the	O
intergenerational	O
effect	O
of	O
poor	O
nutrition	O
.	O

However	O
,	O
Burgaz	O
et	O
al	O
.	O

Based	O
on	O
the	O
results	O
from	O
these	O
observational	O
studies	O
the	O
current	O
recommendation	O
of	O
two	O
to	O
three	O
servings	O
per	O
week	O
appears	O
appropriate	O
.	O

Expression	O
of	O
hepatic	O
miRNAs	O
targeting	O
porcine	O
glucocorticoid	O
receptor	O
(	O
GR	O
)	O
3	O
′	O
UTR	O
in	O
the	O
neonatal	O
piglets	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
Abstract	O
Glucocorticoid	O
receptor	O
(	O
GR	O
)	O
has	O
been	O
previously	O
demonstrated	O
an	O
important	O
transcriptional	O
factor	O
of	O
hepatic	O
metabolic	O
genes	O
in	O
the	O
neonates	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
(“	O
Gestational	O
dietary	O
betaine	O
supplementation	O
suppresses	O
hepatic	O
expression	O
of	O
lipogenic	O
genes	O
in	O
neonatal	O
piglets	O
through	O
epigenetic	O
and	O
glucocorticoid	O
receptor	O
-	O
dependent	O
mechanisms	O
”	O
Cai	O
et	O
al	O
.,	O
2015	O
[	O
1	O
]).	O

Alternatively	O
,	O
an	O
equally	O
effective	O
,	O
safe	O
,	O
and	O
affordable	O
iron	O
compound	O
with	O
little	O
or	O
no	O
side	O
effect	O
can	O
be	O
developed	O
for	O
use	O
especially	O
in	O
public	O
health	O
antenatal	O
supplementation	O
programmes	O
.	O

Database	O
searching	O
and	O
secondary	O
analyses	O
Data	O
generated	O
from	O
peptide	O
mass	O
mapping	O
(	O
PMM	O
)	O
of	O
each	O
spot	O
were	O
used	O
to	O
perform	O
searches	O
of	O
the	O
SWISS	O
-	O
PROT	O
,	O
NCBI	O
and	O
TrEMBL	O
databases	O
using	O
the	O
programs	O
Aldente	O
(	O
www	O
.	O
expasy	O
.	O
ch	O
)	O
and	O
MASCOT	O
(	O
www	O
.	O
matrixscience	O
.	O
com	O
).	O

The	O
main	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
association	O
between	O
the	O
dietary	O
intake	O
of	O
different	O
fish	O
species	O
,	O
the	O
dietary	O
intake	O
of	O
PUFAs	O
(	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
)	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
population	O
-	O
based	O
study	O
among	O
Swedish	O
women	O
.	O

Decreases	O
in	O
perceived	O
stress	O
during	O
pregnancy	O
were	O
also	O
independently	O
related	O
to	O
higher	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
OR	O
=	O
1	O
.	O
5	O
(	O
1	O
.	O
1	O
,	O
2	O
.	O
0	O
);	O
P	O
=	O
.	O
01	O
)	O
but	O
did	O
not	O
independently	O
predict	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
.	O

The	O
calendar	O
and	O
symptoms	O
are	O
explained	O
to	O
the	O
mother	O
at	O
birth	O
and	O
each	O
postnatal	O
visit	O
up	O
to	O
phase	O
7	O
,	O
whereby	O
each	O
new	O
section	O
of	O
the	O
calendar	O
is	O
handed	O
to	O
the	O
mother	O
for	O
return	O
at	O
the	O
next	O
visit	O
.	O

Acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
is	O
the	O
most	O
common	O
childhood	O
cancer	O
(	O
with	O
2	O
,	O
400	O
cases	O
diagnosed	O
each	O
year	O
in	O
those	O
under	O
age	O
20	O
)	O
and	O
the	O
second	O
most	O
common	O
cause	O
of	O
mortality	O
in	O
children	O
aged	O
1	O
–	O
14	O
.	O

These	O
findings	O
suggest	O
that	O
cellular	O
energics	O
may	O
be	O
altered	O
in	O
this	O
brain	O
region	O
in	O
the	O
DVD	O
-	O
deficient	O
rat	O
.	O

Surely	O
,	O
it	O
is	O
better	O
for	O
both	O
society	O
and	O
public	O
health	O
to	O
fully	O
assess	O
the	O
potential	O
epigenetic	O
effects	O
of	O
environmental	O
exposures	O
and	O
introduce	O
regulations	O
and	O
TGs	O
based	O
on	O
relevant	O
data	O
and	O
proven	O
mechanisms	O
of	O
toxicity	O
.	O

A	O
control	O
group	O
of	O
offspring	O
from	O
dams	O
fed	O
the	O
RV	O
diet	O
was	O
weaned	O
to	O
the	O
RV	O
pup	O
diet	O
for	O
29	O
weeks	O
.	O

PubMed	O
Central	O
:	O

Protein	O
spots	O
that	O
were	O
significantly	O
altered	O
were	O
excised	O
for	O
identification	O
by	O
mass	O
spectrometry	O
.	O

Based	O
on	O
the	O
information	O
available	O
(	O
Table1	O
),	O
loratadine	O
or	O
cetirizine	O
may	O
be	O
considered	O
the	O
second	O
-	O
generation	O
antihistamines	O
of	O
choice	O
.	O

Statistical	O
analyses	O
Statistical	O
analyses	O
were	O
performed	O
in	O
R	O
(	O
v3	O
.	O
1	O
.	O
1	O
)	O
[	O
33	O
].	O

Chocolate	O
and	O
total	O
caloric	O
intakes	O
relative	O
to	O
body	O
weight	O
(	O
kcal	O
/	O
kg	O
)	O
were	O
calculated	O
for	O
4	O
h	O
.	O
We	O
generated	O
the	O
following	O
eight	O
experimental	O
offspring	O
groups	O
:	O
Vehicle	O
in	O
CC	O
male	O
(	O
n	O
=	O
7	O
);	O
AM251	O
in	O
CC	O
male	O
(	O
n	O
=	O
8	O
);	O
Vehicle	O
in	O
RC	O
male	O
(	O
n	O
=	O
9	O
);	O
AM251	O
in	O
RC	O
male	O
(	O
n	O
=	O
10	O
);	O
Vehicle	O
in	O
CC	O
female	O
(	O
n	O
=	O
6	O
);	O
AM251	O
in	O
CC	O
female	O
(	O
n	O
=	O
7	O
);	O
Vehicle	O
in	O
RC	O
female	O
(	O
n	O
=	O
11	O
);	O
and	O
AM251	O
in	O
RC	O
female	O
(	O
n	O
=	O
11	O
).	O

The	O
effect	O
was	O
most	O
pronounced	O
for	O
omega	O
-	O
6	O
PUFAs	O
.	O

It	O
is	O
quite	O
possible	O
that	O
the	O
adverse	O
findings	O
in	O
this	O
study	O
are	O
due	O
to	O
more	O
women	O
in	O
the	O
metformin	O
group	O
having	O
a	O
greater	O
severity	O
of	O
hyperglycemia	O
early	O
in	O
the	O
pregnancy	O
.	O

In	O
conclusion	O
,	O
vitamin	O
D	O
deficiency	O
is	O
highly	O
prevalent	O
among	O
pregnant	O
women	O
in	O
Belgium	O
and	O
this	O
raises	O
concerns	O
about	O
the	O
health	O
consequences	O
for	O
the	O
mother	O
and	O
the	O
offspring	O
.	O

Among	O
the	O
four	O
seasons	O
,	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
is	O
highest	O
in	O
Summer	O
,	O
lowest	O
in	O
the	O
Winter	O
,	O
which	O
is	O
significantly	O
lower	O
than	O
summer	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
spring	O
(	O
p	O
=	O
0	O
.	O
003	O
).	O

These	O
concerns	O
had	O
been	O
attributed	O
to	O
inadequate	O
infrastructure	O
and	O
poor	O
compliance	O
with	O
preventive	O
treatment	O
,	O
among	O
others	O
[	O
34	O
].	O

Additional	O
studies	O
are	O
warranted	O
to	O
produce	O
beef	O
with	O
appropriate	O
levels	O
of	O
IMF	O
deposition	O
to	O
satisfy	O
beef	O
quality	O
and	O
taste	O
,	O
support	O
human	O
health	O
,	O
and	O
sustain	O
the	O
animal	O
industry	O
,	O
depending	O
on	O
the	O
situation	O
of	O
each	O
country	O
.	O

Several	O
studies	O
have	O
reported	O
higher	O
IMF	O
content	O
in	O
high	O
concentrate	O
diets	O
compared	O
with	O
low	O
concentrate	O
diets	O
(	O
reviewed	O
in	O
Wood	O
et	O
al	O
[	O
116	O
]).	O

linear	O
mixed	O
effects	O
models	O
),	O
adjusting	O
for	O
potential	O
time	O
-	O
dependent	O
and	O
static	O
covariates	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
research	O
council	O
(	O
research	O
project	O
number	O
:	O
193053	O
)	O
and	O
ethics	O
committee	O
(	O
research	O
ethics	O
number	O
:	O
IR	O
.	O
MUI	O
.	O
REC193053	O
).	O

Red	O
circles	O
indicate	O
increased	O
spots	O
,	O
blue	O
circles	O
indicate	O
spots	O
reduced	O
in	O
the	O
average	O
gel	O
in	O
DVD	O
animals	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Summary	O
of	O
differentially	O
expressed	O
protein	O
spots	O
in	O
nucleus	O
accumbens	O
tissue	O
from	O
adult	O
DVD	O
-	O
deficient	O
and	O
control	O
ratsFold	O
changep	O
valueProteinUniprot	O
Accession	O
NumberMowse	O
scoreMolecular	O
weightpH	O
Calcium	O
Binding	O
Proteins	O
1	O
.	O
140	O
.	O
031Calreticulin	O
CALRP18418114479664	O
.	O
33	O
-	O
1	O
.	O
250	O
.	O
050Calbindin	O
(	O
calretinin	O
)	O
CALB2P47728156313844	O
.	O
94	O
-	O
1	O
.	O
180	O
.	O
045Calbindin	O
CALB1P0717169299754	O
.	O
711	O
.	O
170	O
.	O
032Hippocalcin	O
HPCAP8407679224134	O
.	O
87	O
General	O
cellular	O
metabolism	O
proteins	O
1	O
.	O
470	O
.	O
026L	O
-	O
lactate	O
dehydrogenase	O
B	O
chain	O
LDHBP42123119365895	O
.	O
701	O
.	O
230	O
.	O
004Aldose	O
reductase	O
ALDRP07943154357746	O
.	O
26	O
-	O
1	O
.	O
110	O
.	O
014crystallin	O
,	O
mu	O
CRYMQ9QYU496335335	O
.	O
34	O
-	O
1	O
.	O
090	O
.	O
030Malate	O
dehydrogenase	O
,	O
cytoplasmic	O
MDHCO8898969364606	O
.	O
16	O
-	O
1	O
.	O
350	O
.	O
030Glycerol	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
[	O
NAD	O
+],	O
cytoplasmic	O
GPDAO35077141374286	O
.	O
16	O
-	O
1	O
.	O
170	O
.	O
043Glutathione	O
S	O
-	O
transferase	O
P	O
GSTP1P0490678234246	O
.	O
89	O
Mitochondria	O
Proteins	O
-	O
1	O
.	O
540	O
.	O
041Hexokinase	O
1	O
HXK1P05708761023426	O
.	O
29	O
-	O
1	O
.	O
350	O
.	O
048Dynamin	O
1	O
-	O
like	O
protein	O
DNM1LO35303106838566	O
.	O
64	O
-	O
1	O
.	O
120	O
.	O
046Ubiquinol	O
-	O
cytochrome	O
-	O
c	O
reductase	O
complex	O
core	O
protein	O
1	O
,	O
UQCR1Q68FY0145528155	O
.	O
57	O
-	O
1	O
.	O
140	O
.	O
033Isocitrate	O
dehydrogenase	O
(	O
NAD	O
)	O
subunit	O
alpha	O
,	O
mitochondrial	O
IDH3AQ99NA5113395886	O
.	O
471	O
.	O
160	O
.	O
037IDH3AQ99NA5117	O
..-	O
1	O
.	O
370	O
.	O
011NADH	O
dehydrogenase	O
1	O
alpha	O
subcomplex	O
subunit	O
10	O
,	O
NDUAAQ561S0219404687	O
.	O
64	O
-	O
1	O
.	O
100	O
.	O
039Pyruvate	O
dehydrogenase	O
E1	O
component	O
subunit	O
beta	O
,	O
ODPBP4943295389576	O
.	O
20	O
-	O
1	O
.	O
180	O
.	O
033Voltage	O
-	O
dependent	O
anion	O
-	O
selective	O
channel	O
protein	O
2	O
VDAC2P8115559317267	O
.	O
44	O
Signal	O
transduction	O
and	O
MAP	O
-	O
related	O
proteins	O
-	O
1	O
.	O
280	O
.	O
007Mitogen	O
-	O
activated	O
protein	O
kinase	O
1	O
(	O
ERK	O
-	O
2	O
;	O
MAPK	O
2	O
)	O
MK01P6308657412496	O
.	O
50	O
-	O
1	O
.	O
240	O
.	O
009Serine	O
/	O
threonine	O
-	O
protein	O
phosphatase	O
2A	O
catalytic	O
subunit	O
beta	O
isoform	O
PP2ABP62716107355525	O
.	O
211	O
.	O
230	O
.	O
036Guanine	O
nucleotide	O
-	O
binding	O
protein	O
G	O
(	O
I	O
)/	O
G	O
(	O
S	O
)/	O
G	O
(	O
T	O
)	O
subunit	O
beta	O
1	O
GBB1P5431164373535	O
.	O
60	O
-	O
1	O
.	O
150	O
.	O
031Guanine	O
nucleotide	O
-	O
binding	O
protein	O
G	O
(	O
I	O
)/	O
G	O
(	O
S	O
)/	O
G	O
(	O
T	O
)	O
subunit	O
beta	O
2	O
GBB2P5431374373075	O
.	O
60	O
-	O
1	O
.	O
240	O
.	O
029Dynamin	O
1	O
DYN1P21575152958676	O
.	O
32	O
-	O
1	O
.	O
670	O
.	O
047Thimet	O
oligopeptidase	O
MEPDP24155112782645	O
.	O
54	O
-	O
1	O
.	O
220	O
.	O
006Dihydropyrimidinase	O
-	O
related	O
protein	O
2	O
(	O
DRP	O
-	O
2	O
;	O
CRMP	O
-	O
2	O
)	O
DPYL2P47942101622395	O
.	O
951	O
.	O
170	O
.	O
038DPYL2P4794253	O
..	O
1	O
.	O
240	O
.	O
007DPYL2P4794285	O
..-	O
1	O
.	O
210	O
.	O
024Syntaxin	O
-	O
binding	O
protein	O
1	O
STXB1P6176591675266	O
.	O
49	O
-	O
1	O
.	O
250	O
.	O
036Adenosylhomocysteinase	O
SAHHP1076093475076	O
.	O
071	O
.	O
310	O
.	O
013Ras	O
-	O
related	O
protein	O
Rab	O
-	O
3C	O
RAB3CP6282464258565	O
.	O
101	O
.	O
140	O
.	O
003Beta	O
-	O
synuclein	O
SYUBQ6375456144954	O
.	O
481	O
.	O
170	O
.	O
013Myosin	O
light	O
polypeptide	O
6	O
MYL6Q6411954169644	O
.	O
46	O
Proteins	O
not	O
otherwise	O
classified	O
1	O
.	O
480	O
.	O
011Eukaryotic	O
initiation	O
factor	O
4A	O
-	O
II	O
IF4A2Q5RKI190463735	O
.	O
331	O
.	O
190	O
.	O
001Glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
G3PP0479778358058	O
.	O
14	O
-	O
1	O
.	O
150	O
.	O
047ADP	O
-	O
ribosylation	O
factor	O
1	O
ARF1P84079128206846	O
.	O
32	O
Ingenuity	O
Pathway	O
Analysis	O
identified	O
two	O
major	O
networks	O
;	O
(	O
a	O
)	O
Cellular	O
Movement	O
,	O
cellular	O
assembly	O
and	O
organization	O
,	O
cell	O
signaling	O
;	O
and	O
(	O
b	O
)	O
Protein	O
synthsis	O
,	O
RNA	O
Post	O
-	O
transcriptional	O
Modification	O
,	O
Cancer	O
.	O

High	O
vitamin	O
D	O
status	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
was	O
associated	O
with	O
lower	O
odds	O
of	O
SGA	O
and	O
LBW	O
.	O

Ethics	O
Approval	O
was	O
granted	O
by	O
the	O
Women	O
’	O
s	O
and	O
Children	O
’	O
s	O
Local	O
Health	O
Network	O
Human	O
Research	O
and	O
Ethics	O
Committee	O
at	O
the	O
Women	O
’	O
s	O
and	O
Children	O
’	O
s	O
Hospital	O
,	O
the	O
Central	O
Northern	O
Adelaide	O
Health	O
Service	O
Ethics	O
of	O
Human	O
Research	O
Committee	O
(	O
Lyell	O
McEwin	O
Hospital	O
)	O
and	O
the	O
Flinders	O
Clinical	O
Research	O
Ethics	O
Committee	O
(	O
Flinders	O
Medical	O
Centre	O
).	O

The	O
study	O
controlled	O
for	O
environmental	O
factors	O
such	O
as	O
socioeconomic	O
status	O
,	O
maternal	O
health	O
,	O
pregnancy	O
-	O
related	O
events	O
and	O
conditions	O
,	O
and	O
birth	O
year	O
.	O

The	O
fact	O
that	O
we	O
did	O
not	O
observe	O
differences	O
in	O
other	O
subtypes	O
of	O
SeroR	O
may	O
indicate	O
that	O
SeroR2A	O
is	O
more	O
sensitive	O
to	O
BDNF	O
-	O
induced	O
changes	O
by	O
the	O
vitamin	O
diets	O
.	O

Although	O
the	O
importance	O
of	O
IFA	O
supplements	O
to	O
prevent	O
maternal	O
anaemia	O
and	O
mortality	O
is	O
widely	O
accepted	O
,	O
most	O
antenatal	O
IFA	O
supplements	O
distribution	O
programs	O
are	O
of	O
low	O
priority	O
.	O

PubMed	O
Central	O
:	O

BAT	O
,	O
the	O
principal	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
i	O
.	O
e	O
.,	O
heat	O
production	O
that	O
does	O
not	O
involve	O
skeletal	O
muscle	O
contraction	O
),	O
is	O
present	O
in	O
most	O
mammals	O
and	O
its	O
maturation	O
in	O
the	O
perinatal	O
period	O
varies	O
between	O
species	O
,	O
according	O
to	O
their	O
developmental	O
status	O
at	O
birth	O
(	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

PubMed	O
Central	O
:	O

Transfer	O
Mechanisms	O
of	O
Allergy	O
(	O
Immunopathogenesis	O
of	O
Atopy	O
)	O
The	O
allergic	O
status	O
of	O
the	O
mother	O
can	O
potentially	O
affect	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
through	O
numerous	O
factors	O
that	O
are	O
transferable	O
via	O
the	O
placenta	O
or	O
breast	O
milk	O
.	O

The	O
authors	O
stress	O
that	O
dietary	O
factors	O
work	O
together	O
,	O
and	O
no	O
one	O
food	O
should	O
be	O
singled	O
out	O
in	O
attributing	O
risk	O
or	O
benefit	O
.	O

Postnatal	O
assessments	O
focus	O
mainly	O
on	O
offspring	O
health	O
and	O
development	O
at	O
6	O
weeks	O
,	O
6	O
months	O
,	O
7	O
.	O
5	O
months	O
(	O
6	O
months	O
+	O
6	O
weeks	O
)	O
and	O
12	O
months	O
’	O
postnatal	O
age	O
.	O

Effect	O
of	O
weaning	O
age	O
has	O
been	O
studied	O
in	O
Shorthorn	O
calves	O
[	O
52	O
].	O

cups	O
,	O
bowls	O
and	O
glasses	O
)	O
as	O
well	O
as	O
two	O
-	O
and	O
three	O
-	O
dimensional	O
food	O
models	O
are	O
being	O
used	O
to	O
assist	O
in	O
quantifying	O
portion	O
sizes	O
.	O

The	O
fact	O
that	O
several	O
risk	O
factors	O
during	O
the	O
prenatal	O
and	O
labor	O
periods	O
are	O
implicated	O
in	O
autism	O
should	O
prompt	O
the	O
medical	O
community	O
to	O
focus	O
on	O
the	O
pregnancy	O
and	O
labor	O
periods	O
as	O
preventive	O
measures	O
to	O
curb	O
the	O
incidence	O
of	O
autism	O
.	O

In	O
Iran	O
,	O
iron	O
and	O
folic	O
acid	O
supplements	O
are	O
routinely	O
given	O
to	O
all	O
pregnant	O
mothers	O
and	O
some	O
mothers	O
based	O
on	O
doctors	O
’	O
order	O
may	O
consume	O
multivitamins	O
or	O
calcium	O
.	O

Assessment	O
of	O
Dietary	O
Intake	O
Pregnant	O
women	O
in	O
these	O
analyses	O
completed	O
validated	O
117	O
-	O
item	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
in	O
the	O
first	O
visit	O
,	O
at	O
8	O
–	O
16	O
weeks	O
.	O

Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
:	O
A	O
Review	O
of	O
Their	O
Effectiveness	O
and	O
Implications	O
for	O
Health	O
System	O
Strengthening	O
Abstract	O
Objectives	O
.	O

In	O
the	O
entire	O
country	O
,	O
by	O
the	O
end	O
of	O
June	O
2013	O
,	O
1373349	O
AWCs	O
/	O
mini	O
-	O
AWCs	O
have	O
been	O
sanctioned	O
,	O
of	O
which	O
around	O
1339410	O
(	O
97	O
.	O
5	O
%)	O
are	O
operational	O
.	O

On	O
the	O
other	O
hand	O
,	O
liver	O
dysfunction	O
in	O
patients	O
with	O
HELLP	O
syndrome	O
decreases	O
the	O
degradation	O
of	O
the	O
vasopressinase	O
as	O
described	O
by	O
Ellidokuz	O
et	O
al	O
.	O

The	O
estimated	O
associations	O
given	O
by	O
a	O
multinomial	O
logistic	O
regression	O
are	O
relative	O
risk	O
ratios	O
(	O
RRR	O
).	O

Importantly	O
,	O
as	B
Alvarez	O
–	O
Rodriguez	O
and	O
colleagues	O
have	O
found	O
a	O
negative	O
correlation	O
between	O
age	O
and	O
immune	O
function	O
in	O
healthy	O
adult	O
subjects	O
,	O
especially	O
those	O
over	O
the	O
age	O
of	O
60	O
[	O
15	O
],	O
perhaps	O
innate	O
immune	O
function	O
,	O
in	O
particular	O
cytokine	O
function	O
,	O
increases	O
with	O
age	O
for	O
a	O
period	O
of	O
time	O
,	O
reaches	O
a	O
threshold	O
and	O
then	O
decreases	O
later	O
in	O
life	O
.	O

Pregnancy	O
loss	O
was	O
defined	O
as	O
both	O
spontaneous	O
abortions	O
from	O
gestational	O
week	O
4	O
and	O
intrauterine	O
fetal	O
death	O
(	O
IUFD	O
).	O

Varying	O
observations	O
,	O
however	O
,	O
have	O
been	O
made	O
when	O
determining	O
whether	O
a	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
concentrations	O
exists	O
.	O

The	O
sum	O
of	O
the	O
total	O
deposits	O
of	O
perirenal	O
and	O
perigonadal	O
fat	O
determines	O
the	O
amount	O
of	O
abdominal	O
fat	O
.	O

The	O
decreased	O
flake	O
thickness	O
of	O
steam	O
-	O
flaked	O
sorghum	O
increased	O
starch	O
digestion	O
and	O
liver	O
gluconeogenesis	O
[	O
114	O
].	O

Dams	O
were	O
sacrificed	O
.	O

There	O
is	O
limited	O
evidence	O
about	O
the	O
optimal	O
timing	O
of	O
IFA	O
supplementation	O
in	O
pregnancy	O
.	O

Pregnancy	O
termination	O
was	O
mostly	O
due	O
to	O
fetal	O
malformations	O
.	O

To	O
detect	O
a	O
30	O
%	O
reduction	O
in	O
preterm	O
delivery	O
from	O
15	O
%	O
in	O
control	O
compared	O
to	O
10	O
.	O
5	O
%	O
in	O
the	O
intervention	O
arm	O
,	O
assuming	O
80	O
%	O
power	O
,	O
5	O
%	O
level	O
of	O
significance	O
,	O
intracluster	O
correlation	O
of	O
0	O
.	O
012	O
for	O
small	O
birth	O
size	O
(	O
Bangladesh	O
DHS	O
data	O
),	O
would	O
require	O
a	O
sample	O
size	O
of	O
1300	O
/	O
arm	O
or	O
40	O
pregnant	O
women	O
from	O
64	O
clusters	O
.	O

Neonatal	O
and	O
gestational	O
data	O
were	O
obtained	O
from	O
antenatal	O
and	O
obstetrics	O
medical	O
records	O
.	O

DNA	O
is	O
methylated	O
by	O
a	O
family	O
of	O
DNA	O
methyltransferases	O
(	O
DNMTs	O
)	O
(	O
Bestor	O
&	O
Ingram1983	O
;	O
Li	O
et	O
al	O
.	O
1992	O
,	O
1996	O
;	O
Okano	O
et	O
al	O
.	O
1998	O
,	O
1999	O
;	O
Aapola	O
et	O
al	O
.	O
2000	O
;	O
Gowher	O
et	O
al	O
.	O
2005	O
).	O

Data	O
regarding	O
the	O
long	O
-	O
acting	O
insulin	O
analogs	O
are	O
less	O
clear	O
than	O
for	O
rapid	O
-	O
acting	O
analogs	O
.	O

The	O
expression	O
level	O
of	O
NCAPG	O
(	O
non	O
-	O
structural	O
maintenance	O
of	O
chromosomes	O
(	O
SMC	O
)	O
condensin	O
I	O
complex	O
subunit	O
G	O
)	O
was	O
highlighted	O
as	O
strongly	O
associated	O
with	O
fetal	O
growth	O
retardation	O
[	O
28	O
,	O
29	O
].	O

This	O
raises	O
the	O
possibility	O
that	O
,	O
in	O
contrast	O
to	O
its	O
beneficial	O
effects	O
on	O
peripheral	O
metabolism	O
,	O
FGF21	O
may	O
exert	O
deleterious	O
effects	O
by	O
acting	O
centrally	O
.	O

The	O
most	O
common	O
causes	O
of	O
nasal	O
symptoms	O
necessitating	O
treatment	O
during	O
pregnancy	O
are	O
AR	O
,	O
rhinitis	O
medicamentosa	O
,	O
sinusitis	O
,	O
and	O
(	O
non	O
-	O
AR	O
)	O
vasomotor	O
[	O
24	O
].	O

There	O
has	O
been	O
considerable	O
research	O
interest	O
in	O
the	O
provision	O
of	O
antenatal	O
dietary	O
interventions	O
during	O
pregnancy	O
to	O
limit	O
weight	O
gain	O
and	O
improve	O
pregnancy	O
and	O
birth	O
outcomes	O
for	O
women	O
and	O
their	O
infants	O
.	O

All	O
procedures	O
were	O
approved	O
by	O
the	O
appropriate	O
institutional	O
review	O
boards	O
at	O
Women	O
and	O
Infants	O
Hospital	O
and	O
at	O
Brown	O
University	O
,	O
and	O
participants	O
were	O
exempted	O
from	O
informed	O
consent	O
requirements	O
.	O

Global	O
Methylation	O
Status	O
Neither	O
the	O
gestational	O
nor	O
post	O
-	O
weaning	O
diet	O
had	O
any	O
effect	O
on	O
the	O
global	O
methylation	O
status	O
in	O
the	O
offspring	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
(	O
Figure	O
6c	O
).	O

However	O
,	O
there	O
were	O
elements	O
of	O
dissatisfaction	O
with	O
health	O
centre	O
services	O
,	O
poor	O
sitting	O
facilities	O
,	O
amenities	O
,	O
few	O
health	O
education	O
talks	O
and	O
poor	O
nursing	O
skills	O
.	O

Moreover	O
,	O
umbilical	O
cord	O
serum	O
visfatin	O
concentrations	O
were	O
found	O
to	O
have	O
a	O
positive	O
relationship	O
with	O
insulin	O
levels	O
(	O
13	O
).	O

Effective	O
interventions	O
directed	O
specifically	O
at	O
preventing	O
neonatal	O
deaths	O
are	O
required	O
to	O
improve	O
overall	O
child	O
survival	O
.	O

Description	O
of	O
covariates	O
At	O
the	O
time	O
of	O
enrollment	O
in	O
the	O
study	O
,	O
a	O
45	O
to	O
60	O
-	O
minute	O
structured	O
questionnaire	O
was	O
administered	O
by	O
a	O
trained	O
interviewer	O
.	O

In	O
the	O
same	O
study	O
,	O
LM	O
area	O
also	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
.	O

Immunotherapy	O
may	O
be	O
continued	O
as	O
maintenance	O
treatment	O
but	O
should	O
not	O
be	O
initiated	O
during	O
pregnancy	O
.	O

Vitamin	O
D	O
deficiency	O
has	O
previously	O
been	O
associated	O
with	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
given	O
its	O
role	O
in	O
supporting	O
insulin	O
secretion	O
and	O
pancreatic	O
β	O
-	O
cell	O
function	O
[	O
42	O
].	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

The	O
normality	O
of	O
the	O
data	O
was	O
evaluated	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
a	O
slightly	O
negative	O
trend	O
of	O
increased	O
cathelicidin	O
correlated	O
with	O
a	O
decreased	O
frequency	O
of	O
diagnosed	O
infections	O
within	O
the	O
last	O
year	O
(	O
ρ	O
=	O
-	O
0	O
.	O
147	O
,	O
p	O
=	O
0	O
.	O
092	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Cathelicidin	O
Concentration	O
by	O
Age	O
.	O

Different	O
approaches	O
were	O
used	O
to	O
delineate	O
the	O
impact	O
of	O
UCP1	O
on	O
insulin	O
sensitivity	O
.	O

Accordingly	O
,	O
in	O
human	O
blood	O
samples	O
,	O
Th2	O
cytokines	O
responsible	O
for	O
a	O
predisposition	O
toward	O
allergy	O
were	O
elevated	O
in	O
the	O
neonates	O
only	O
of	O
mothers	O
who	O
had	O
smoked	O
during	O
pregnancy	O
[	O
71	O
].	O

The	O
observation	O
that	O
early	O
registration	O
with	O
a	O
physician	O
in	O
pregnancy	O
was	O
associated	O
with	O
folic	O
acid	O
intake	O
could	O
indicate	O
the	O
recognised	B
importance	O
of	O
early	O
prenatal	O
care	O
.	O

After	O
delivery	O
,	O
study	O
personnel	O
abstracted	O
data	O
from	O
participants	O
'	O
hospital	O
labor	O
and	O
delivery	O
medical	O
records	O
and	O
clinic	O
records	O
.	O

There	O
is	O
evidence	O
that	O
lifestyle	O
modification	O
,	O
aiming	O
for	O
a	O
5	O
%–	O
7	O
%	O
reduction	O
in	O
body	O
weight	O
,	O
is	O
effective	O
in	O
preventing	O
or	O
delaying	O
the	O
development	O
of	O
diabetes	O
in	O
people	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

The	O
incidence	O
of	O
first	O
episodes	O
of	O
simple	O
,	O
severe	O
or	O
very	O
severe	O
pneumonias	O
confirmed	O
with	O
chest	O
radiography	O
also	O
did	O
not	O
differ	O
(	O
table	O
1	O
,	O
appendix	O
).	O

Epigenetic	O
programing	O
via	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNAs	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

However	O
,	O
thyroid	O
cancer	O
detected	O
during	O
pregnancy	O
may	O
cause	O
anxiety	O
about	O
the	O
optimal	O
timing	O
of	O
recommended	O
treatments	O
and	O
about	O
both	O
maternal	O
and	O
neonatal	O
morbidity	O
,	O
as	O
weel	O
as	O
pregnancy	O
following	O
a	O
diagnosis	O
of	O
thyroid	O
cancer	O
obviously	O
needs	O
both	O
maternal	O
and	O
foetal	O
management	O
.	O

Although	O
maternal	O
obesity	O
and	O
excessive	O
GWG	O
are	O
both	O
the	O
result	O
of	O
energy	O
intake	O
exceeding	O
energy	O
expenditure	O
,	O
few	O
studies	O
have	O
examined	O
the	O
specific	O
influences	O
of	O
maternal	O
dietary	O
and	O
exercise	O
behaviors	O
during	O
pregnancy	O
on	O
offspring	O
obesity	O
risk	O
.	O

Studies	O
in	O
which	O
participants	O
were	O
chosen	O
at	O
convenience	O
were	O
not	O
considered	O
in	O
this	O
review	O
.	O

Fatty	O
acid	O
metabolism	O
,	O
Biosynthesis	O
of	O
steroids	O
,	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
,	O
FA	O
elongation	O
in	O
mitochondria	O
,	O
Bile	O
acid	O
synthesis	O
)	O
and	O
cell	O
cycle	O
regulation	O
(	O
e	O
.	O
g	O
.	O

The	O
composition	O
(	O
in	O
g	O
/	O
kg	O
)	O
of	O
the	O
RV	O
AIN	O
-	O
93G	O
diet	O
is	O
529	O
.	O
5	O
cornstarch	O
,	O
200	O
casein	O
,	O
100	O
sucrose	O
,	O
70	O
soybean	O
oil	O
,	O
50	O
cellulose	O
,	O
10	O
vitamin	O
mixture	O
,	O
35	O
mineral	O
mixture	O
,	O
3	O
L	O
-	O
cystine	O
,	O
2	O
.	O
5	O
choline	O
bitartarate	O
and	O
0	O
.	O
014	O
tert	O
-	O
butyl	O
hydroquinone	O
.	O

In	O
Australia	O
and	O
New	O
Zealand	O
,	O
the	O
deficiency	O
cut	O
-	O
offs	O
are	O
based	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
bone	O
health	O
where	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
at	O
the	O
end	O
of	O
winter	O
is	O
required	O
for	O
optimal	O
musculoskeletal	O
health	O
[	O
1	O
].	O

Clinically	O
-	O
relevant	O
trends	O
were	O
seen	O
in	O
changes	O
in	O
medication	O
requirements	O
;	O
the	O
percentage	O
of	O
women	O
requiring	O
pharmacologic	O
treatment	O
decreased	O
from	O
31	O
.	O
1	O
%	O
to	O
26	O
.	O
9	O
%.	O

At	O
the	O
completion	O
of	O
the	O
amplification	O
protocol	O
,	O
all	O
samples	O
were	O
subjected	O
to	O
melting	O
curve	O
analyses	O
and	O
gel	O
electrophoresis	O
to	O
verify	O
the	O
absence	O
of	O
any	O
non	O
-	O
specific	O
product	O
.	O

The	O
first	O
section	O
comprises	O
10	O
chapters	O
on	O
various	O
aspects	O
of	O
nutrition	O
such	O
as	O
nutrition	O
adequacy	O
to	O
dietary	O
supplements	O
.	O

2010	O
;	O
Lin	O
et	O
al	O
.	O

These	O
features	O
were	O
also	O
linked	O
to	O
an	O
impairment	O
of	O
the	O
browning	O
process	O
of	O
the	O
white	O
adipose	O
tissue	O
(	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

In	O
a	O
study	O
by	O
Mozafari	O
-	O
Khosravi	O
et	O
al	O
.,	O
300	O
,	O
000	O
and	O
150	O
,	O
000	O
IU	O
vitamin	O
D	O
were	O
administered	O
by	O
injection	O
to	O
the	O
two	O
groups	O
who	O
suffered	O
depression	O
and	O
the	O
third	O
group	O
did	O
not	O
receive	O
vitamin	O
D	O
.	O
High	O
doses	O
of	O
vitamin	O
D	O
were	O
effective	O
in	O
decreasing	O
depression	O
levels	O
after	O
3	O
months	O
[	O
30	O
].	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

While	O
,	O
the	O
mean	O
depression	O
scores	O
were	O
significantly	O
lower	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
one	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
>	O
0	O
.	O
001	O
)	O
(	O
Table	O
3	O
).	O

Cost	O
-	O
effectiveness	O
analysis	O
The	O
economic	O
evaluation	O
will	O
take	O
a	O
societal	O
perspective	O
.	O

Furthermore	O
,	O
the	O
divergence	O
of	O
results	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
reported	O
throughout	O
this	O
work	O
suggests	O
that	O
these	O
repetitive	O
element	O
methylation	O
markers	O
are	O
distinct	O
measures	O
and	O
may	O
not	O
represent	O
true	O
,	O
and	O
potentially	O
interchangeable	O
,	O
surrogates	O
of	O
“	O
global	O
”	O
methylation	O
.	O

The	O
primary	O
follow	O
-	O
up	O
study	O
endpoint	O
was	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infant	O
sex	O
and	O
age	O
.	O

The	O
exam	O
of	O
her	O
extremities	O
showed	O
1	O
+	O
right	O
radial	O
pulse	O
and	O
2	O
+	O
left	O
radial	O
pulse	O
.	O

Any	O
drug	O
may	O
carry	O
a	O
small	O
risk	O
that	O
must	O
be	O
balanced	O
against	O
the	O
benefits	O
of	O
keeping	O
the	O
mother	O
and	O
baby	O
healthy	O
.	O

Pregnancy	O
status	O
requires	O
much	O
more	O
accuracy	O
in	O
assessing	O
levothyroxine	O
dosage	O
to	O
protect	O
the	O
foetus	O
from	O
maternal	O
hypothyroidism	O
because	O
,	O
as	O
mentioned	O
above	O
,	O
the	O
mother	O
is	O
the	O
only	O
source	O
of	O
thyroid	O
hormones	O
for	O
the	O
embryo	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

These	O
models	O
were	O
adjusted	O
for	O
BMI	O
,	O
season	O
of	O
conception	O
,	O
education	O
level	O
,	O
origin	O
and	O
gestational	O
age	O
at	O
registration	O
to	O
antenatal	O
care	O
(	O
based	O
on	O
last	O
menstrual	O
period	O
).	O

Women	O
who	O
had	O
attended	O
antenatal	O
visits	O
in	O
their	O
previous	O
pregnancy	O
thought	O
that	O
it	O
was	O
beneficial	O
to	O
start	O
ANC	O
early	O
in	O
pregnancy	O
unlike	O
those	O
who	O
did	O
not	O
have	O
this	O
experience	O
and	O
who	O
opted	O
for	O
third	O
trimester	O
enrollment	O
.	O

Median	O
initial	O
calcium	O
was	O
3	O
.	O
00mmol	O
/	O
L	O
(	O
range	O
2	O
.	O
84	O
-	O
4	O
.	O
03	O
)	O
and	O
phosphate	O
2	O
.	O
04mmol	O
/	O
L	O
(	O
1	O
.	O
1	O
-	O
3	O
.	O
33	O
).	O

These	O
changes	O
include	O
increased	O
total	O
circulatory	O
volume	O
,	O
increased	O
systemic	O
blood	O
pressure	O
,	O
and	O
structural	O
changes	O
in	O
the	O
aortic	O
wall	O
secondary	O
to	O
the	O
hormonal	O
effects	O
of	O
estrogen	O
and	O
progesterone	O
[	O
4	O
].	O

Conclusions	O
Iron	O
deficiency	O
remains	O
the	O
most	O
important	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

The	O
difference	O
may	O
be	O
due	O
to	O
genetic	O
factors	O
,	O
management	O
,	O
or	O
feed	O
.	O

Maternal	O
serum	O
T1	O
and	O
T3	O
samples	O
were	O
analysed	O
in	O
sequence	O
.	O

The	O
Projahnmo	O
trial	O
demonstrated	O
improved	O
IFA	O
supplements	O
as	O
84	O
%	O
of	O
pregnant	O
women	O
in	O
the	O
home	O
-	O
care	O
treatment	O
arm	O
reported	O
IFA	O
supplements	O
use	O
in	O
pregnancy	O
[	O
18	O
].	O

Stata	O
Statistical	O
Software	O
:	O
Release	O
14	O
.	O

In	O
addition	O
,	O
follow	O
-	O
up	O
studies	O
have	O
shown	O
no	O
significant	O
increase	O
in	O
risk	O
.	O

In	O
another	O
study	O
conducted	O
in	O
rural	O
pocket	O
of	O
Varanasi	O
to	O
evaluate	O
the	O
impact	O
of	O
ICDS	O
on	O
maternal	O
nutrition	O
and	O
birth	O
weight	O
,	O
it	O
was	O
concluded	O
that	O
undernourished	O
antenatal	O
women	O
are	O
definitely	O
benefitted	O
by	O
late	O
pregnancy	O
nutrition	O
supplement	O
(	O
7	O
).	O

The	O
results	O
showed	O
that	O
in	O
both	O
subgroups	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
statistically	O
significant	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
at	O
childbirth	O
and	O
lower	O
depression	O
score	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
than	O
the	O
control	O
group	O
(	O
Table	O
4	O
).	O

The	O
pellet	O
was	O
air	O
dried	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Buffer	O
2	O
(	O
7M	O
urea	O
,	O
2M	O
thiourea	O
,	O
1	O
%	O
C7bZO	O
).	O

Duration	O
of	O
gestation	O
We	O
will	O
measure	O
the	O
duration	O
of	O
gestation	O
will	O
be	O
measured	O
using	O
the	O
date	O
of	O
last	O
menstrual	O
period	O
with	O
the	O
pregnancy	O
confirmed	O
by	O
urine	O
test	O
in	O
the	O
field	O
.	O

The	O
third	O
section	O
has	O
14	O
chapters	O
and	O
covers	O
various	O
diseases	O
from	O
cardiovascular	O
diseases	O
to	O
HIV	O
/	O
AIDS	O
,	O
osteoporosis	O
,	O
liver	O
diseases	O
and	O
neurological	O
disorders	O
.	O

In	O
our	O
study	O
setting	O
,	O
according	O
to	O
the	O
recommendations	O
from	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
[	O
25	O
],	O
all	O
pregnant	O
women	O
were	O
screened	O
at	O
24	O
-	O
28	O
weeks	O
gestation	O
using	O
a	O
50	O
gram	O
1	O
-	O
hour	O
oral	O
glucose	O
challenge	O
test	O
.	O

2008	O
).	O

A	O
longer	O
follow	O
up	O
of	O
the	O
ALSPAC	O
cohort	O
demonstrated	O
a	O
reduction	O
in	O
the	O
percentage	O
of	O
children	O
with	O
suboptimal	O
IQ	O
at	O
eight	O
years	O
of	O
age	O
amongst	O
mothers	O
with	O
a	O
high	O
seafood	O
intake	O
(	O
greater	O
than	O
340	O
g	O
)	O
during	O
pregnancy	O
[	O
20	O
].	O

An	O
important	O
limitation	O
of	O
this	O
study	O
is	O
that	O
we	O
measured	O
dietary	O
intake	O
only	O
once	O
,	O
involving	O
misclassification	O
among	O
those	O
who	O
changed	O
their	O
dietary	O
pattern	O
during	O
follow	O
-	O
up	O
.	O

Future	O
studies	O
examining	O
the	O
relationship	O
between	O
maternal	O
diet	O
and	O
components	O
of	O
breast	O
milk	O
including	O
microbial	O
and	O
nutritional	O
profiles	O
,	O
as	O
well	O
as	O
the	O
potential	O
influence	O
of	O
maternal	O
diet	O
on	O
the	O
fetal	O
microbiome	O
,	O
may	O
offer	O
insight	O
into	O
the	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
influences	O
the	O
infant	O
gut	O
microbiome	O
.	O

The	O
vast	O
majority	O
of	O
the	O
mammalian	O
genome	O
is	O
composed	O
of	O
so	O
-	O
called	O
non	O
-	O
coding	O
DNA	O
(	O
ncDNA	O
),	O
with	O
only	O
1	O
–	O
5	O
%	O
coding	O
for	O
proteins	O
.	O

The	O
medical	O
management	O
of	O
gestational	O
diabetes	O
is	O
still	O
evolving	O
,	O
and	O
recent	O
randomized	O
controlled	O
trials	O
have	O
added	O
considerably	O
to	O
our	O
knowledge	O
in	O
this	O
area	O
.	O

Accumulation	O
of	O
Vitamin	O
D2	O
in	O
food	O
chain	O
,	O
such	O
as	O
from	O
poultry	O
fed	O
with	O
Vitamin	O
D2	O
fortified	O
feeds	O
and	O
their	O
eggs	O
,	O
also	O
contribute	O
to	O
elevated	O
Vitamin	O
D2	O
levels	O
in	O
human	O
bodies	O
.	O

The	O
BPA	O
,	O
TCDD	O
,	O
alcohol	O
and	O
smoking	O
-	O
related	O
evidence	O
is	O
particularly	O
compelling	O
as	B
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	B
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

Glioma	O
patients	O
are	O
known	O
to	O
suffer	O
from	O
an	O
impaired	O
immune	O
system	O
[	O
99	O
],	O
and	O
the	O
reduced	O
association	O
with	O
allergies	O
alternatively	O
could	O
be	O
due	O
to	O
immunosuppression	O
induced	O
by	O
the	O
tumor	O
(	O
i	O
.	O
e	O
.,	O
reverse	O
causality	O
)	O
[	O
84	O
].	O

in	O
a	O
study	O
with	O
a	O
small	O
sample	O
size	O
(	O
97	O
participants	O
),	O
observed	O
an	O
association	O
between	O
maternal	O
low	O
serum	O
concentrations	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
and	O
high	O
depression	O
scores	O
within	O
several	O
post	O
-	O
partum	O
visits	O
[	O
32	O
].	O

In	O
Romania	O
,	O
almost	O
all	O
women	O
are	O
hospitalised	O
for	O
at	O
least	O
3	O
days	O
post	O
-	O
partum	O
during	O
which	O
time	O
the	O
newborn	O
is	O
immunised	O
against	O
tuberculosis	O
and	O
hepatitis	O
B	O
;	O
it	O
is	O
very	O
uncommon	O
to	O
leave	O
the	O
hospital	O
earlier	O
.	O

Hypervitaminosis	O
D	O
is	O
thought	O
to	O
be	O
associated	O
with	O
a	O
rare	O
infant	O
disease	O
with	O
supravalvular	O
aortic	O
stenosis	O
,	O
elfin	O
facies	O
and	O
mental	O
retardation	O
.	O

Besides	O
the	O
role	O
of	O
genetic	O
predisposition	O
,	O
some	O
factors	O
have	O
been	O
identified	O
that	O
may	O
either	O
contribute	O
to	O
sensitization	O
of	O
the	O
mother	O
and	O
to	O
the	O
subsequent	O
transfer	O
of	O
a	O
predisposition	O
for	O
allergy	O
to	O
the	O
offspring	O
,	O
or	O
that	O
directly	O
induce	O
sensitization	O
in	O
offspring	O
that	O
manifests	O
shortly	O
after	O
birth	O
or	O
at	O
a	O
young	O
age	O
.	O

Future	O
research	O
is	O
needed	O
to	O
determine	O
whether	O
differences	O
in	O
postnatal	O
feeding	O
behaviors	O
might	O
explain	O
differential	O
growth	O
rates	O
in	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

A	O
targeted	O
screening	O
strategy	O
to	O
detect	O
and	O
treat	O
women	O
at	O
high	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
is	O
clearly	O
needed	O
in	O
Belgium	O
and	O
in	O
other	O
European	O
countries	O
.	O

This	O
trial	O
of	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
supplementation	O
along	O
with	O
antibiotic	O
treatment	O
of	O
children	O
younger	O
than	O
3	O
years	O
with	O
clinically	O
diagnosed	O
pneumonia	O
in	O
Kabul	O
showed	O
no	O
difference	O
in	O
the	O
time	O
to	O
recovery	O
between	O
the	O
groups	O
.	O

They	O
examined	O
milk	O
and	O
venous	O
blood	O
samples	O
of	O
24	O
healthy	O
breastfeeding	O
women	O
with	O
complication	O
-	O
free	O
physiologic	O
pregnancies	O
and	O
neonates	O
with	O
appropriate	O
weight	O
for	O
gestational	O
age	O
at	O
birth	O
and	O
180	O
days	O
after	O
birth	O
.	O

Some	O
researchers	O
defined	B
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
lower	O
than	O
50	O
nmol	O
/	O
L	O
as	B
diagnostic	O
criteria	O
for	O
Vitamin	O
D	O
deficiency	O
,	O
50	O
–	O
75	O
nmol	O
/	O
L	O
as	B
inadequate	O
,	O
and	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
as	B
adequate	O
[	O
4	O
,	O
6	O
,	O
7	O
].	O

“	O
We	O
didn	O
’	O
t	O
know	O
what	O
it	O
is	O
.	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	O
interest	O
in	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

Altogether	O
,	O
these	O
observations	O
suggest	O
that	O
FGF21	O
may	O
be	O
a	O
key	O
factor	O
linking	O
UCP1	O
expression	O
to	O
improved	O
glucose	O
metabolism	O
.	O

This	O
enzyme	O
counteracts	O
the	O
action	O
of	O
phosphatidylinositol	O
-	O
4	O
,	O
5	O
-	O
bisphosphate	O
3	O
-	O
kinase	O
(	O
PI3K	O
),	O
resulting	O
in	O
inhibition	O
of	O
the	O
AKT	O
signaling	O
pathway	O
involved	O
in	O
multiple	O
biological	O
processes	O
,	O
including	O
insulin	O
action	O
.	O

These	O
two	O
enzymes	O
are	O
induced	O
in	O
adipose	O
tissues	O
of	O
ruminants	O
by	O
increasing	O
energy	O
intake	O
[	O
89	O
].	O

The	O
overall	O
response	O
rate	O
was	O
72	O
%,	O
and	O
34	O
415	O
answered	O
the	O
follow	O
-	O
up	O
questionnaire	O
and	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
was	O
measured	O
(	O
outcome	O
under	O
study	O
).	O

PubMed	O
Central	O
:	O

However	O
,	O
studies	O
in	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
are	O
less	O
consistent	O
.	O

These	O
analyses	O
were	O
also	O
repeated	O
but	O
using	O
the	O
current	O
definitions	O
of	O
vitamin	O
D	O
deficiency	O
:	O
<	O
25	O
,	O
25	O
–	O
50	O
,	O
50	O
–	O
75	O
and	O
>	O
75	O
nmol	O
/	O
L	O
in	O
the	O
non	O
-	O
standardised	O
data	O
[	O
7	O
].	O

Thus	B
,	O
during	O
the	O
late	O
fattening	O
stage	O
of	O
beef	O
cattle	O
,	O
marbling	O
adipocytes	O
may	O
grow	O
continuously	O
even	O
though	O
development	O
of	O
abdominal	O
,	O
intermuscular	O
,	O
and	O
subcutaneous	O
fat	O
may	O
slow	O
or	O
cease	O
.	O

Furthermore	O
,	O
we	O
did	O
not	O
record	O
when	O
during	O
the	O
pregnancy	O
the	O
supplements	O
were	O
taken	O
,	O
which	O
is	O
of	O
particular	O
importance	O
for	O
folic	O
acid	O
.	O

The	O
selection	O
of	O
covariates	O
included	O
in	O
the	O
final	O
multivariate	O
models	O
was	O
based	O
on	O
proportional	O
(≥	O
10	O
%)	O
change	O
in	O
β	O
-	O
coefficients	O
and	O
previous	O
subject	O
matter	O
knowledge	O
.	O

Thus	O
,	O
it	O
is	O
very	O
necessary	O
to	O
promote	O
the	O
pregnant	O
women	O
to	O
take	O
proper	O
diet	O
i	O
.	O
e	O
.	O

Women	O
with	O
a	O
≥	O
30	O
nmol	O
/	O
L	O
increment	O
in	O
25OHD	O
from	O
T1	O
to	O
T3	O
had	O
the	O
lowest	O
odds	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Body	O
circumference	O
and	O
skin	O
-	O
fold	O
thickness	O
measures	O
also	O
did	O
not	O
differ	O
significantly	O
between	O
infants	O
born	O
to	O
women	O
who	O
received	O
the	O
antenatal	O
intervention	O
,	O
and	O
those	O
who	O
received	O
standard	O
care	O
.	O

As	O
part	O
of	O
the	O
FFQ	O
,	O
the	O
participants	O
reported	O
how	O
often	O
,	O
on	O
average	O
,	O
they	O
ate	O
salmon	O
-	O
type	O
fish	O
(	O
Baltic	O
herring	O
,	O
herring	O
,	O
or	O
mackerel	O
),	O
white	O
fish	O
(	O
cod	O
,	O
saithe	O
,	O
or	O
pike	O
),	O
caviar	O
,	O
or	O
shellfish	O
(	O
e	O
.	O
g	O
.,	O
shrimp	O
):	O
never	O
-	O
seldom	O
,	O
1	O
-	O
3	O
times	O
/	O
month	O
,	O
1	O
time	O
/	O
week	O
,	O
2	O
times	O
/	O
week	O
,	O
3	O
-	O
4	O
times	O
/	O
week	O
,	O
5	O
-	O
6	O
times	O
/	O
week	O
,	O
1	O
time	O
/	O
day	O
,	O
2	O
times	O
/	O
day	O
or	O
3	O
times	O
/	O
day	O
.	O

This	O
is	O
worrisome	O
as	O
suboptimal	O
childhood	O
development	O
is	O
associated	O
with	O
poorer	O
adult	O
health	O
,	O
well	O
-	O
being	O
and	O
productivity	O
–	O
leading	O
to	O
an	O
intergenerational	O
cycle	O
of	O
poverty	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Experimental	O
design	O
.	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
30	O
ng	O
/	O
ml	O
),	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Implications	O
for	O
research	O
and	O
practice	O
are	O
also	O
discussed	O
.	O

Western	O
dietary	O
pattern	O
as	O
an	O
unhealthy	O
food	O
choice	O
is	O
unable	O
to	O
fulfill	O
the	O
increased	O
key	O
micronutrients	O
requirements	O
for	O
normal	O
fetal	O
growth	O
during	O
pregnancy	O
and	O
results	O
in	O
such	O
adverse	O
effects	O
on	O
the	O
fetus	O
[	O
23	O
].	O

Herb	O
users	O
were	O
more	O
likely	O
to	O
be	O
high	O
school	O
graduates	O
,	O
identify	O
as	O
black	O
,	O
and	O
have	O
an	O
obstetrical	O
condition	O
.	O

However	O
,	O
due	O
to	O
a	O
wide	O
range	O
of	O
nutrient	O
interactions	O
,	O
maternal	O
dietary	O
patterns	O
should	O
be	O
explored	O
to	O
achieve	O
the	O
association	O
between	O
maternal	O
nutrition	O
and	O
fetal	O
growth	O
.	O

Data	O
were	O
accepted	O
with	O
a	O
coefficient	O
of	O
variance	O
(	O
CV	O
)	O
of	O
<	O
10	O
%.	O

This	O
could	O
lead	O
to	O
activation	O
of	O
TEs	O
,	O
and	O
abnormal	O
imprinting	O
and	O
gene	O
expression	O
.	O

The	O
MS	O
generally	B
increases	O
with	O
slaughter	O
age	O
in	O
Korean	O
cattle	O
.	O

All	O
the	O
AWCs	O
are	O
manned	O
by	O
members	O
from	O
the	O
ICDS	O
team	O
-	O
consisting	O
of	O
Anganwadi	O
helpers	O
,	O
Anganwadi	O
workers	O
,	O
Supervisors	O
,	O
Child	O
Development	O
Project	O
Officers	O
(	O
CDPOs	O
)	O
and	O
District	O
Program	O
Officers	O
(	O
1	O
,	O
4	O
).	O

Therefore	B
,	O
strategies	O
that	O
up	O
-	O
regulate	O
both	O
hyperplasia	O
and	O
hypertrophy	O
of	O
fat	O
cells	O
are	O
effective	O
ways	O
to	O
improve	O
IMF	O
deposition	O
.	O

Then	O
in	O
2005	O
,	O
Anway	O
et	O
al	O
.	O

Depression	O
scores	O
were	O
determined	O
four	O
times	O
:	O
at	O
26	O
–	O
28	O
weeks	O
of	O
gestation	O
(	O
baseline	O
),	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
and	O
finally	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
.	O

Chailurkit	O
et	O
al	O
.	O

So	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
and	O
neonatal	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
.	O

Therefore	B
,	O
expression	O
profiles	O
at	O
weaning	O
and	O
adult	O
stages	O
point	O
to	O
an	O
alarm	O
alert	O
(	O
activated	O
defence	O
)	O
in	O
LP	O
offspring	O
.	O

Authors	O
'	O
contributions	O
EW	O
was	O
responsible	O
for	O
the	O
recruitment	O
,	O
data	O
collection	O
and	O
funding	O
.	O

Mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
was	O
not	O
significantly	O
associated	O
with	O
the	O
birth	O
weight	O
groups	O
(	O
see	O
Supplemental	O
Material	O
,	O
Table	O
1	O
).	O

Unexpectedly	O
,	O
the	O
intake	O
of	O
fatty	O
fish	O
(	O
salmon	O
,	O
herring	O
and	O
mackerel	O
)	O
or	O
shellfish	O
more	O
than	O
twice	O
a	O
week	O
increased	O
the	O
risk	O
of	O
being	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

The	O
remaining	O
seven	O
deaths	O
were	O
due	O
to	O
accidental	O
or	O
congenital	O
causes	O
.	O

This	O
suggests	O
that	O
baseline	O
DA	O
signaling	O
may	O
be	O
normal	O
in	O
this	O
model	O
and	O
abnormalities	O
only	O
become	O
unmasked	O
in	O
the	O
presence	O
of	O
drugs	O
that	O
alter	O
DA	O
/	O
glutamate	O
balance	O
in	O
the	O
brain	O
.	O

Ursodeoxycholic	O
acid	O
,	O
which	O
is	O
a	O
bile	O
acid	O
,	O
is	O
synthesized	O
chemically	O
from	O
cholic	O
acid	O
.	O

The	O
adequate	O
intake	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
lactation	O
is	O
unknown	O
,	O
although	O
it	O
appears	O
to	O
be	O
greater	O
than	O
the	O
current	O
dietary	O
recommendations	O
of	O
400	O
IU	O
/	O
d	O
or	O
10	O
µg	O
/	O
d	O
[	O
58	O
].	O

There	O
are	O
other	O
more	O
time	O
and	O
financially	O
economical	O
ways	O
in	O
which	O
lifetime	O
,	O
multigenerational	O
and	O
/	O
or	O
transgenerational	O
toxicity	O
could	O
be	O
assessed	O
,	O
for	O
example	O
using	O
zebrafish	O
models	O
,	O
both	O
respecting	O
the	O
3Rs	O
and	O
satisfying	O
sufficient	O
statistical	O
power	O
.	O

considered	O
maternal	O
diet	O
by	O
classifying	O
women	O
as	O
following	O
a	O
“	O
prudent	O
”	O
or	O
“	O
western	O
”	O
dietary	O
pattern	O
[	O
23	O
].	O

Thus	O
the	O
experimental	O
data	O
will	O
complement	O
previous	O
findings	O
from	O
rodent	O
models	O
and	O
epidemiological	O
human	O
data	O
.	O

Overall	O
,	O
AluYb8	O
had	O
higher	O
DNA	O
methylation	O
levels	O
than	O
did	O
LINE	O
-	O
1	O
,	O
which	O
may	O
be	O
due	O
to	O
the	O
lower	O
degree	O
of	O
C	O
-	O
to	O
-	O
T	O
transition	O
mutations	O
owing	O
to	O
the	O
younger	O
age	O
of	O
AluYb8	O
elements	O
(	O
Choi	O
et	O
al	O
.	O

The	O
cut	O
-	O
off	O
points	O
of	O
<	O
9	O
and	O
9	O
–	O
13	O
were	O
used	O
as	B
low	O
and	O
moderate	O
risk	O
for	O
depression	O
.	O

3	O
.	O
2	O
.	O
2	O
.	O

Both	O
intervention	O
and	O
control	O
treatment	O
arms	O
will	O
receive	O
the	O
usual	O
antenatal	O
and	O
postnatal	O
care	O
services	O
by	O
BRAC	O
.	O

The	O
lack	O
of	O
differentiation	O
of	O
underlying	O
complications	O
in	O
pregnancy	O
,	O
which	O
lead	O
to	O
eventual	O
use	O
of	O
induction	O
,	O
could	O
be	O
the	O
cause	O
of	O
these	O
conflicting	O
findings	O
[	O
51	O
].	O

In	O
another	O
study	O
in	O
US	O
,	O
in	O
498	O
pregnant	O
mothers	O
with	O
the	O
mean	O
gestational	O
age	O
of	O
15	O
weeks	O
,	O
generally	B
there	O
was	O
an	O
inverse	O
relationship	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
depression	O
level	O
.	O

A	O
second	O
aim	O
was	O
to	O
determine	O
if	O
the	O
concentration	O
of	O
cathelicidin	O
and	O
vitamin	O
D	O
correlate	O
with	O
the	O
number	O
of	O
infections	O
a	O
child	O
experiences	O
during	O
childhood	O
and	O
as	O
a	O
function	O
of	O
age	O
.	O

BMI	O
between	O
18	O
.	O
5	O
and	O
25	O
kg	O
/	O
m2is	O
considered	O
normal	O
,	O
and	O
≥	O
25	O
kg	O
/	O
m2is	O
abnormal	O
.	O

Primary	O
prevention	O
addresses	O
symptom	O
-	O
free	O
children	O
at	O
risk	O
(	O
ie	O
,	O
without	O
the	O
established	O
disease	O
).	O

folate	O
,	O
vitamin	O
B6	O
and	O
B12	O
)	O
is	O
closely	O
linked	O
.	O
36	O
A	O
significant	O
weakness	O
of	O
the	O
study	O
arises	O
from	O
the	O
lack	O
of	O
measurement	O
of	O
gene	O
expression	O
at	O
different	O
stages	O
of	O
maturity	O
.	O

Recent	O
nationwide	O
shortages	O
of	O
low	O
-	O
calcium	O
formula	O
(	O
LCF	O
)	O
suggest	O
this	O
problem	O
may	O
be	O
widespread	O
.	O

From	O
the	O
infants	O
,	O
a	O
2	O
–	O
5	O
ml	O
urine	O
sample	O
is	O
collected	O
at	O
phases	O
6	O
,	O
7	O
and	O
8	O
using	O
adhesive	O
paediatric	O
urine	O
collection	O
bags	O
.	O

For	O
3	O
women	O
information	O
on	O
the	O
trimester	O
was	O
missing	O
.	O

2015	O
.	O

Conclusion	O
The	O
importance	O
of	O
nutritional	O
counseling	O
before	O
conception	O
and	O
during	O
pregnancy	O
should	O
be	O
emphasized	O
in	O
order	O
to	O
encourage	O
proper	O
PPBMI	O
and	O
avoidance	O
of	O
excessive	O
gestational	O
weight	O
gain	O
,	O
since	O
both	O
are	O
related	O
to	O
risk	O
for	O
GDM	O
.	O

[	O
14	O
]	O
Soontrapa	O
et	O
al	O
.	O

Postoperatively	O
,	O
the	O
mother	O
continued	O
to	O
be	O
hypernatremic	O
despite	O
IV	O
infusion	O
of	O
hypotonic	O
fluids	O
.	O

T1	O
25OHD	O
was	O
also	O
investigated	O
as	O
a	O
continuous	O
variable	O
as	O
there	O
were	O
few	O
cases	O
in	O
some	O
categories	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Primary	O
Prevention	O
of	O
Asthma	O
and	O
Allergies	O
in	O
Early	O
LifePreventive	O
Measures	O
Smoking	O
and	O
exposure	O
to	O
environmental	O
tobacco	O
smoke	O
should	O
be	O
avoided	O
,	O
especially	O
during	O
pregnancy	O
and	O
early	O
childhood	O
Alcohol	O
consumption	O
should	O
be	O
avoided	O
by	O
the	O
mother	O
during	O
pregnancy	O
and	O
lactation	O
Damp	O
housing	O
conditions	O
should	O
be	O
avoided	O
and	O
indoor	O
air	O
pollutants	O
reduced	O
,	O
especially	O
for	O
high	O
-	O
risk	O
children	O
(	O
history	O
of	O
atopy	O
or	O
allergy	O
in	O
a	O
first	O
-	O
degree	O
relative	O
)	O
Breast	O
-	O
feeding	O
should	O
be	O
performed	O
exclusively	O
until	O
6	O
months	O
with	O
no	O
special	O
diet	O
for	O
the	O
lactating	O
mother	O
(	O
except	O
when	O
the	O
mother	O
is	O
already	O
diagnosed	O
with	O
food	O
allergy	O
)	O
Nonprescription	O
drugs	O
should	O
be	O
avoided	O
during	O
pregnancy	O
and	O
lactation	O
unless	O
recommended	O
by	O
a	O
physician	O
Smoking	O
and	O
Alcohol	O
Smoking	O
and	O
passive	O
exposure	O
to	O
cigarette	O
smoke	O
as	O
well	O
as	O
alcohol	O
consumption	O
should	O
be	O
strictly	O
avoided	O
.	O

Although	O
most	O
drugs	O
do	O
not	O
harm	O
the	O
fetus	O
,	O
this	O
knowledge	O
is	O
incomplete	O
.	O

The	O
RR	O
comparing	O
the	O
highest	O
to	O
the	O
lowest	O
quartile	O
of	O
omega	O
-	O
6	O
PUFAs	O
intake	O
was	O
0	O
.	O
78	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
64	O
-	O
0	O
.	O
97	O
).	O

(	O
2015	O
)	O
*	O
Metals	O
:	O
Arsenic	O
(	O
As	O
)	O
LifetimeAdulthoodSkin	O
abnormalitiesDNA	O
methylationPaul	O
et	O
al	O
.	O

Because	B
the	O
negative	O
consequences	O
of	O
the	O
HV	O
gestational	O
diet	O
on	O
food	O
intake	O
,	O
weight	O
gain	O
and	O
glucose	O
control	O
were	O
prevented	O
by	O
feeding	O
either	O
the	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
these	O
observations	O
support	O
the	O
PAR	O
hypothesis	O
that	O
offspring	O
fed	O
diets	O
similar	O
to	O
their	O
mothers	O
lead	O
to	O
a	O
more	O
appropriate	O
adaptation	O
to	O
their	O
postnatal	O
environment	O
compared	O
to	O
those	O
fed	O
an	O
unmatched	O
diet	O
.	O

But	O
the	O
implementation	O
of	O
this	O
recommendation	O
is	O
inadequate	O
.	O

In	O
our	O
study	O
we	O
found	O
that	O
the	O
adjusted	O
relative	O
risk	O
of	O
GDM	O
was	O
highest	O
among	O
overweight	O
mothers	O
who	O
snored	O
during	O
pregnancy	O
(	O
OR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
3	O
)	O
when	O
compared	O
with	O
lean	O
mothers	O
who	O
did	O
not	O
snore	O
.	O

All	O
measurements	O
are	O
done	O
twice	O
and	O
recorded	O
to	O
the	O
nearest	O
0	O
.	O
05	O
kg	O
for	O
weight	O
,	O
0	O
.	O
1	O
cm	O
for	O
MUAC	O
and	O
height	O
.	O

In	O
addition	O
,	O
six	O
mitochondrial	O
proteins	O
were	O
down	O
-	O
regulated	O
in	O
DVD	O
-	O
deficient	O
rats	O
(	O
NDUAA	O
,	O
UQCR1	O
,	O
ODPB	O
,	O
IDH3A	O
,	O
HKK1	O
,	O
VDAC2	O
).	O

A	O
previous	O
study	O
in	O
Romania	O
reported	O
that	O
supplemental	O
iron	O
was	O
taken	O
by	O
53	O
.	O
3	O
%	O
of	O
women	O
during	O
pregancy	O
[	O
14	O
].	O

It	O
was	O
translated	O
to	O
Persian	O
and	O
was	O
used	O
in	O
the	O
study	O
by	O
Mazhari	O
and	O
Nakhaee	O
,	O
with	O
a	O
validity	O
and	O
reliability	O
of	O
0	O
.	O
76	O
and	O
0	O
.	O
83	O
,	O
respectively	O
[	O
42	O
].	O

These	O
lambs	O
were	O
fatter	O
but	O
had	O
higher	O
hypothalamic	O
POMC	O
expression	O
at	O
postnatal	O
day	O
30	O
and	O
relative	O
milk	O
intake	O
of	O
these	O
lambs	O
was	O
not	O
different	O
from	O
those	O
born	O
to	O
control	O
-	O
fed	O
mothers	O
after	O
the	O
third	O
postnatal	O
week	O
.	O
23In	O
contrast	O
,	O
the	O
data	O
from	O
the	O
present	O
study	O
show	O
that	O
higher	O
food	O
intake	O
in	O
adulthood	O
of	O
offspring	O
born	O
to	O
the	O
HV	O
dams	O
and	O
fed	O
the	O
RV	O
diet	O
is	O
consistent	O
with	O
their	O
lower	O
expression	O
of	O
anorexigenic	O
neuropeptides	O
in	O
the	O
hypothalamus	O
.	O

It	O
should	O
be	O
added	O
that	O
the	O
understanding	O
of	O
the	O
role	O
of	O
IL	O
-	O
6	O
is	O
more	O
complex	O
,	O
as	O
this	O
cytokine	O
is	O
known	O
to	O
be	O
secreted	O
by	O
skeletal	O
muscle	O
in	O
response	O
to	O
exercise	O
,	O
exerting	O
insulin	O
sensitizing	O
effects	O
(	O
Kelly	O
et	O
al	O
.,	O
2004	O
;	O
Petersen	O
and	O
Pedersen	O
,	O
2005	O
).	O

The	O
temperature	O
profiles	O
comprised	O
an	O
initial	O
denaturation	O
step	O
at	O
95	O
°	O
C	O
for	O
10	O
min	O
and	O
40	O
cycles	O
consisting	O
of	O
denaturation	O
at	O
95	O
°	O
C	O
for	O
15	O
s	O
,	O
annealing	O
at	O
60	O
°	O
C	O
for	O
10	O
s	O
and	O
extension	O
/	O
fluorescence	O
acquisition	O
at	O
72	O
°	O
C	O
for	O
15	O
s	O
.	O
For	O
all	O
the	O
assays	O
threshold	O
cycles	O
were	O
converted	O
to	O
copy	O
numbers	O
using	O
a	O
standard	O
curve	O
generated	O
by	O
amplifying	O
serial	O
dilutions	O
of	O
an	O
external	O
PCR	O
standard	O
(	O
107	O
-	O
102copies	O
).	O

Introduction	O
Autism	O
is	O
a	O
complex	O
condition	O
that	O
lacks	O
an	O
established	O
method	O
of	O
prevention	O
;	O
thus	B
there	O
is	O
a	O
need	O
for	O
research	O
to	O
identify	O
its	O
possible	O
causative	O
factors	O
.	O

The	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
was	O
shown	O
to	O
be	O
doubled	O
with	O
maternal	O
use	O
of	O
SSRIs	O
in	O
a	O
recent	O
case	O
controlled	O
study	O
of	O
298	O
children	O
,	O
with	O
prenatal	O
exposure	O
reported	O
for	O
20	O
of	O
those	O
children	O
[	O
36	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Levels	O
of	O
adiposity	O
in	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
of	O
rat	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
21	O
–	O
23	O
†	O
.	O
MaleFemaleTwo	O
-	O
way	O
ANOVACC	O
(	O
n	O
=	O
12	O
)	O
RC	O
(	O
n	O
=	O
15	O
)	O
CC	O
(	O
n	O
=	O
11	O
)	O
RC	O
(	O
n	O
=	O
17	O
)	O
InteractionPrenatal	O
dietSex	O
Perirenal	O
fat	O
(	O
g	O
)	O
8	O
.	O
90	O
±	O
0	O
.	O
4112	O
.	O
30	O
±	O
0	O
.	O
64	O
***	O
4	O
.	O
82	O
±	O
0	O
.	O
36	O
***	O
5	O
.	O
73	O
±	O
0	O
.	O
69	O
$$$	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
214	O
,	O
P	O
=	O
0	O
.	O
045	O
F	O
(	O
1	O
,	O
51	O
)=	O
12	O
.	O
542	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
76	O
.	O
281	O
,	O
P	O
<	O
0	O
.	O
001Perirenal	O
fat	O
/	O
BW	O
(%)	O
1	O
.	O
97	O
±	O
0	O
.	O
082	O
.	O
47	O
±	O
0	O
.	O
12	O
*	O
1	O
.	O
80	O
±	O
0	O
.	O
122	O
.	O
06	O
±	O
0	O
.	O
19	O
$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
106	O
,	O
P	O
=	O
0	O
.	O
017nsPerigonadal	O
fat	O
(	O
g	O
)	O
9	O
.	O
32	O
±	O
0	O
.	O
6111	O
.	O
32	O
±	O
0	O
.	O
70	O
*	O
6	O
.	O
14	O
±	O
0	O
.	O
67	O
**	O
7	O
.	O
2	O
±	O
0	O
.	O
49	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
059	O
,	O
P	O
=	O
0	O
.	O
049	O
F	O
(	O
1	O
,	O
51	O
)=	O
34	O
.	O
261	O
,	O
P	O
<	O
0	O
.	O
001Perigonadal	O
fat	O
/	O
BW	O
(%)	O
2	O
.	O
06	O
±	O
0	O
.	O
122	O
.	O
27	O
±	O
0	O
.	O
132	O
.	O
29	O
±	O
0	O
.	O
212	O
.	O
66	O
±	O
0	O
.	O
14nsNs	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
111	O
,	O
P	O
=	O
0	O
.	O
048Abdominal	O
fat	O
(	O
g	O
)	O
18	O
.	O
22	O
±	O
0	O
.	O
9423	O
.	O
63	O
±	O
1	O
.	O
14	O
**	O
10	O
.	O
96	O
±	O
0	O
.	O
96	O
***	O
12	O
.	O
95	O
±	O
1	O
.	O
11	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
11	O
.	O
302	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
66	O
.	O
545	O
,	O
P	O
<	O
0	O
.	O
001Abdominal	O
fat	O
/	O
BW	O
(%)	O
4	O
.	O
03	O
±	O
0	O
.	O
184	O
.	O
74	O
±	O
0	O
.	O
204	O
.	O
15	O
±	O
0	O
.	O
284	O
.	O
72	O
±	O
0	O
.	O
30ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
163	O
,	O
P	O
=	O
0	O
.	O
016ns	O
CC	O
,	O
offspring	O
from	O
control	O
-	O
fed	O
dams	O
;	O
RC	O
,	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
.	O

Biochemical	O
screening	O
of	O
familial	O
disease	O
consists	O
of	O
serum	O
calcitonin	O
evaluation	O
,	O
and	O
genetic	O
screening	O
of	O
individuals	O
with	O
a	O
RET	O
mutation	O
may	O
also	O
be	O
performed	O
.	O

This	O
increase	O
in	O
C	O
-	O
reactive	O
protein	O
has	O
been	O
found	O
to	O
have	O
a	O
correlation	O
with	O
a	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
29	O
].	O

Thus	B
,	O
animals	O
with	O
low	O
genetic	O
potential	O
for	O
QG	O
are	O
not	O
recommended	O
for	O
a	O
long	O
fattening	O
stage	O
,	O
which	O
would	O
result	O
in	O
low	O
feed	O
efficiency	O
.	O

Many	O
hundreds	O
of	O
studies	O
have	O
investigated	O
such	O
toxicity	O
,	O
yet	O
relatively	O
few	O
have	O
demonstrated	O
a	O
mechanistic	O
association	O
among	O
specific	O
environmental	O
exposures	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
health	O
outcomes	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
/	O
or	O
rodent	O
models	O
.	O

Vitamin	O
D	O
is	O
to	O
a	O
large	O
extent	O
metabolized	O
in	O
the	O
body	O
through	O
sun	O
exposure	O
,	O
and	O
people	O
with	O
dark	O
skin	O
need	O
more	O
sun	O
exposure	O
to	O
maintain	O
adequate	O
blood	O
levels	O
.	O

Methods	O
:	O
Placental	O
tissues	O
and	O
associated	O
demographic	O
and	O
clinical	O
data	O
were	O
obtained	O
from	O
subjects	O
delivering	O
at	O
Women	O
and	O
Infants	O
Hospital	O
in	O
Providence	O
,	O
Rhode	O
Island	O
(	O
USA	O
).	O

We	O
have	O
previously	O
shown	O
that	O
a	O
comprehensive	O
dietary	O
and	O
lifestyle	O
intervention	O
during	O
pregnancy	O
,	O
in	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
,	O
significantly	O
improves	O
both	O
maternal	O
diet	O
and	O
physical	O
activity	O
[	O
21	O
],	O
is	O
associated	O
with	O
an	O
18	O
and	O
41	O
%	O
relative	O
reduction	O
in	O
the	O
risk	O
of	O
high	O
infant	O
birth	O
weight	O
above	O
4	O
and	O
4	O
.	O
5	O
kg	O
[	O
22	O
,	O
23	O
],	O
and	O
was	O
a	O
cost	O
neutral	O
intervention	O
[	O
24	O
].	O

Role	O
of	O
epigenetics	O
in	O
the	O
mammalian	O
life	O
cycle	O
Normal	O
mammalian	O
development	O
is	O
a	O
cyclical	O
series	O
of	O
events	O
that	O
enable	O
the	O
continued	O
production	O
of	O
multiple	O
generations	O
(	O
described	O
in	O
Gilbert2014	O
).	O

Pearson	O
Chi	O
-	O
square	O
test	O
,	O
analysis	O
of	O
variance	O
,	O
Kruskal	O
-	O
Wallis	O
and	O
Bland	O
-	O
Altman	O
tests	O
were	O
employed	O
.	O

Whether	O
women	O
treated	O
for	O
thyroid	O
cancer	O
should	O
become	O
pregnant	O
was	O
once	O
a	O
matter	O
of	O
concern	O
,	O
but	O
current	O
evidence	O
suggests	O
that	O
DTC	O
should	O
not	O
discourage	O
intended	O
pregnancy	O
,	O
with	O
the	O
usual	O
recommendation	O
to	O
postpone	O
it	O
to	O
at	B
least	I
6	O
months	O
after	O
radioiodine	O
therapy	O
.	O

The	O
comparisons	O
of	O
the	O
relative	O
mRNA	O
abundances	O
depending	O
on	O
dietary	O
group	O
and	O
ontogenetic	O
stages	O
provide	O
an	O
overall	O
view	O
of	O
the	O
developmental	O
plasticity	O
of	O
the	O
liver	O
.	O

The	O
iron	O
status	O
indices	O
,	O
ferritin	O
and	O
transferrin	O
receptor	O
,	O
as	O
well	O
as	O
the	O
vitamin	O
A	O
status	O
indicator	O
retinol	O
binding	O
protein	O
will	O
be	O
determined	O
using	O
the	O
Q	O
-	O
Plex	O
™	O
Human	O
Micronutrient	O
Array	O
(	O
7	O
-	O
plex	O
,	O
Quansys	O
Bioscience	O
,	O
Logan	O
,	O
UT	O
,	O
USA	O
)	O
[	O
69	O
].	O

Eligibility	O
criteria	O
for	O
inclusion	O
of	O
cluster	O
We	O
will	O
exclude	O
any	O
potential	O
BRAC	O
PO	O
area	O
(	O
cluster	O
)	O
if	O
there	O
are	O
any	O
other	O
maternal	O
and	O
or	O
neonatal	O
interventions	O
either	O
by	O
the	O
government	O
or	O
non	O
-	O
government	O
organisations	O
in	O
the	O
area	O
.	O

Conclusions	O
Our	O
data	O
indicate	O
that	O
maternal	O
diet	O
influences	O
the	O
infant	O
gut	O
microbiome	O
and	O
that	O
these	O
effects	O
differ	O
by	O
delivery	O
mode	O
.	O

Labs	O
revealed	O
an	O
unremarkable	O
BMP	O
,	O
coagulation	O
study	O
,	O
and	O
CBC	O
with	O
a	O
hemoglobin	O
of	O
10	O
.	O
8	O
and	O
hematocrit	O
of	O
32	O
.	O
2	O
.	O

This	O
prevents	O
the	O
conclusion	O
of	O
a	O
definitive	O
relationship	O
without	O
further	O
research	O
,	O
preferably	B
clinical	O
randomised	O
controlled	O
trials	O
,	O
and	O
a	O
proper	O
meta	O
-	O
analysis	O
.	O

The	O
women	O
with	O
high	O
level	O
of	O
education	O
and	O
women	O
attending	O
for	O
their	O
first	O
pregnancies	O
were	O
not	O
satisfied	O
with	O
the	O
competence	O
of	O
the	O
staff	O
.	O

Similarly	O
,	O
the	O
activation	O
of	O
TEs	O
would	O
be	O
deleterious	O
for	O
the	O
embryonic	O
genome	O
and	O
so	O
the	O
continued	O
silencing	O
of	O
such	O
loci	O
through	O
early	O
embryogenesis	O
is	O
essential	O
for	O
genome	O
stability	O
and	O
subsequent	O
normal	O
development	O
.	O

In	O
7	O
/	O
10	O
infants	O
with	O
data	O
available	O
,	O
treated	O
with	O
LCF	O
for	O
median	O
95	O
days	O
(	O
range	O
25	O
-	O
310	O
),	O
median	O
PTH	O
rose	O
to	O
17	O
.	O
1pmol	O
/	O
L	O
([	O
8	O
.	O
2	O
-	O
49	O
.	O
3	O
],	O
P	O
=	O
0	O
.	O
02	O
)	O
with	O
a	O
trend	O
to	O
lower	O
25OHVit	O
D	O
(	O
median	O
23nmol	O
/	O
L	O
[<	O
10	O
-	O
108	O
],	O
P	O
=	O
0	O
.	O
09	O
)	O
despite	O
continued	O
high	O
-	O
normal	O
calcium	O
levels	O
(	O
median	O
2	O
.	O
66mmol	O
/	O
L	O
[	O
2	O
.	O
11	O
-	O
2	O
.	O
75	O
]).	O

This	O
study	O
was	O
conducted	O
according	O
to	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
all	O
procedures	O
were	O
approved	O
by	O
the	O
Regional	O
Ethics	O
Committee	O
in	O
Gothenburg	O
,	O
Sweden	O
.	O

Furthermore	O
,	O
better	O
overall	O
diet	O
quality	O
has	O
been	O
associated	O
with	O
a	O
lower	O
risk	O
for	O
maternal	O
perinatal	O
depression	O
and	O
gestational	O
weight	O
gain	O
,	O
which	O
in	O
turn	O
are	O
risk	O
factors	O
for	O
suboptimal	O
offspring	O
development	O
[	O
14	O
–	O
16	O
].	O

At	O
baseline	O
,	O
using	O
Pearson	O
’	O
s	O
correlation	O
coefficient	O
,	O
no	O
relations	O
were	O
observed	O
between	O
the	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
and	O
depression	O
scores	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

Measurement	O
of	O
adiposity	O
Adiposity	O
was	O
estimated	O
by	O
calculating	O
the	O
percentage	O
of	O
abdominal	O
fat	O
weight	O
over	O
total	O
body	O
weight	O
.	O

The	O
cohort	O
has	O
been	O
followed	O
since	O
birth	O
with	O
annual	O
questionnaires	O
and	O
,	O
since	O
age	O
7	O
years	O
,	O
with	O
objective	O
measures	O
in	O
annual	O
research	O
clinics	O
.	O

Respiratory	O
rate	O
and	O
anthropomorphic	O
data	O
were	O
collected	O
twice	O
and	O
we	O
used	O
the	O
mean	O
values	O
in	O
our	O
analysis	O
.	O

Stata	O
V	O
.	O
14	O
(	O
StataCorp	O
.	O

Notably	O
,	O
in	O
the	O
aforementioned	O
study	O
examining	O
localized	O
cathelicidin	O
concentrations	O
in	O
saliva	O
,	O
the	O
female	O
gender	O
was	O
found	O
to	O
positively	O
correlate	O
with	O
cathelicidin	O
[	O
30	O
].	O

Follow	O
-	O
up	O
assessments	O
of	O
the	O
offspring	O
include	O
feeding	O
practices	O
,	O
nutrient	O
status	O
,	O
measures	O
of	O
growth	O
,	O
psychomotor	O
,	O
socio	O
-	O
emotional	O
and	O
immune	O
development	O
,	O
morbidity	O
,	O
allergy	O
,	O
as	O
well	O
as	O
analysis	O
of	O
the	O
gut	O
microbiome	O
and	O
the	O
epigenome	O
.	O

Hyperplasia	O
of	O
fat	O
cells	O
mainly	O
occurs	O
from	O
conception	O
until	O
birth	O
,	O
and	O
hypertrophy	O
is	O
a	O
greater	O
contributor	O
to	O
IMF	O
deposition	O
than	O
is	O
hyperplasia	O
from	O
250	O
d	O
of	O
age	O
to	O
slaughter	O
[	O
16	O
,	O
17	O
].	O

For	O
simplicity	O
of	O
language	O
we	O
abbreviated	O
'	O
relative	O
risk	O
ratio	O
'	O
to	O
'	O
relative	O
risk	O
'	O
(	O
RR	O
).	O

RC	O
male	O
offspring	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Cpt1b	O
,	O
Acox1	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
(	O
Figures5C	O
,	O
D	O
).	O

However	O
,	O
this	O
review	O
did	O
not	O
include	O
antenatal	O
iron	O
and	O
folic	O
acid	O
(	O
IFA	O
)	O
supplementation	O
for	O
pregnant	O
women	O
.	O

A	O
subgroup	O
of	O
infants	O
from	O
the	O
MIG	O
Study	O
are	O
currently	O
being	O
followed	O
up	O
.	O
72It	O
may	O
be	O
circumspect	O
to	O
await	O
the	O
findings	O
from	O
this	O
follow	O
-	O
up	O
study	O
before	O
metformin	O
can	O
be	O
considered	O
safe	O
for	O
the	O
routine	O
treatment	O
of	O
GDM	O
.	O

Parents	O
and	O
other	O
individuals	O
track	O
dust	O
and	O
dirt	O
into	O
the	O
home	O
,	O
on	O
shoes	O
and	O
clothes	O
,	O
after	O
working	O
on	O
the	O
farm	O
.	O

Regarding	O
male	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
that	O
there	O
was	O
not	O
prenatal	O
diet	O
effect	O
on	O
chocolate	O
intake	O
and	O
total	O
caloric	O
intake	O
in	O
a	O
treatment	O
-	O
independent	O
manner	O
.	O

It	O
was	O
interesting	O
to	O
investigate	O
trend	O
of	O
vitamin	O
D	O
effectiveness	O
in	O
the	O
two	O
primiparous	O
and	O
multiparous	O
subgroups	O
.	O

For	O
all	O
genes	O
exemplarily	O
analysed	O
,	O
qRT	O
-	O
PCR	O
confirmed	O
the	O
direction	O
of	O
differential	O
regulation	O
as	O
obtained	O
by	O
microarray	O
analysis	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
plasma	O
levels	O
of	O
leptin	O
,	O
metabolites	O
,	O
alkaline	O
phosphatase	O
,	O
and	O
hepatic	O
transaminases	O
in	O
adult	O
offspring	O
Two	O
-	O
way	O
ANOVA	O
showed	O
an	O
effect	O
of	O
prenatal	O
diet	O
on	O
the	O
plasma	O
levels	O
of	O
glucose	O
,	O
the	O
lipid	O
profile	O
(	O
triglycerides	O
,	O
HDL	O
,	O
LDL	O
,	O
and	O
VLDL	O
)	O
and	O
urea	O
(	O
Table1	O
).	O

Between	O
fetal	O
and	O
perinatal	O
stages	O
(	O
period	O
I	O
),	O
there	O
were	O
1	O
,	O
034	O
(	O
503	O
1	O
dpn	O
≻	O
94	O
dpc	O
)	O
probe	O
-	O
sets	O
showing	O
levels	O
and	O
directions	O
of	O
regulation	O
in	O
the	O
AP	O
group	O
that	O
were	O
different	O
from	O
the	O
LP	O
group	O
.	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

In	O
the	O
strata	O
,	O
each	O
eligible	O
pregnant	O
woman	O
was	O
assigned	O
in	O
the	O
control	O
or	O
the	O
vitamin	O
D	O
groups	O
using	O
block	O
randomization	O
strategy	O
.	O

5	O
.	O

Also	O
at	O
increased	O
risk	O
for	O
vitamin	O
D	O
insufficiency	O
are	O
young	O
Thai	O
people	O
living	O
in	O
urban	O
areas	O
in	O
Thailand	O
who	O
have	O
less	O
leisure	O
time	O
and	O
spend	O
less	O
time	O
in	O
the	O
sunlight	O
.	O

So	O
the	O
proteins	O
become	O
incapacitated	O
,”	O
Hudson	O
says	O
.	O

Some	O
effects	O
of	O
maternal	O
diet	O
were	O
more	O
apparent	O
in	O
exclusively	O
breastfed	O
infants	O
;	O
however	O
,	O
we	O
were	O
unable	O
to	O
compare	O
to	O
exclusively	O
formula	O
-	O
fed	O
infants	O
since	O
most	O
infants	O
received	O
some	O
breast	O
milk	O
.	O

In	O
this	O
case	O
,	O
the	O
optimum	O
slaughter	O
age	O
for	O
the	O
highest	O
profit	O
was	O
28	O
months	O
.	O

We	O
aimed	O
to	O
compare	O
vitamin	O
D	O
status	O
in	O
two	O
distinct	O
populations	O
of	O
pregnant	O
women	O
in	O
Australia	O
and	O
New	O
Zealand	O
and	O
to	O
investigate	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
.	O

In	O
the	O
ventromedial	O
hypothalamic	O
nucleus	O
,	O
dopamine	O
release	O
is	O
required	O
to	O
initiate	O
a	O
meal	O
,	O
and	O
is	O
positively	O
associated	O
with	O
meal	O
number	O
and	O
duration	O
.	O
27	O
,	O
28By	O
possibly	O
reducing	O
dopamine	O
signaling	O
,	O
the	O
HV	O
pup	O
diet	O
may	O
have	O
provided	O
some	O
protection	O
against	O
excess	O
food	O
intake	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
.	O

In	O
the	O
literature	O
,	O
recent	O
studies	O
across	O
a	O
wide	O
range	O
of	O
populations	O
have	O
demonstrated	O
a	O
positive	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
[	O
8	O
–	O
11	O
,	O
15	O
,	O
16	O
,	O
18	O
,	O
19	O
].	O

Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
the	O
search	O
terms	O
:	O
pregnant	O
,	O
neurodevelopment	O
,	O
cognition	O
,	O
fish	O
and	O
seafood	O
.	O

Criteria	O
for	O
admission	O
and	O
hospital	O
management	O
of	O
the	O
pregnant	O
woman	O
with	O
acute	O
asthma	O
should	O
be	O
more	O
lenient	O
than	O
for	O
nonpregnant	O
patients	O
.	O

This	O
has	O
been	O
elegantly	O
demonstrated	O
by	O
the	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
offspring	O
of	O
Pima	O
Indian	O
mothers	O
.	O
16	O
,	O
17Offspring	O
who	O
were	O
born	O
to	O
mothers	O
who	O
were	O
already	O
diabetic	O
when	O
pregnant	O
had	O
a	O
45	O
%	O
likelihood	B
of	O
type	O
2	O
diabetes	O
by	O
the	O
age	O
of	O
20	O
–	O
24	O
,	O
whereas	O
it	O
was	O
8	O
.	O
6	O
%	O
amongst	O
those	O
with	O
mothers	O
who	O
only	O
developed	O
diabetes	O
after	O
pregnancy	O
(	O
ie	O
,	O
were	O
prediabetic	O
).	O

We	O
provided	O
each	O
child	O
with	O
an	O
identification	O
card	O
,	O
which	O
included	O
a	O
photograph	O
of	O
the	O
child	O
,	O
to	O
enable	O
easy	O
access	O
to	O
outpatient	O
and	O
out	O
-	O
of	O
-	O
hours	O
paediatric	O
services	O
at	O
the	O
study	O
hospital	O
.	O

One	O
case	O
of	O
anaphylaxis	O
and	O
3	O
cases	O
of	O
serious	O
allergic	O
reaction	O
involved	O
women	O
taking	O
prenatal	O
supplements	O
,	O
two	O
of	O
which	O
reported	O
spontaneous	O
abortion	O
.	O

New	O
drugs	O
with	O
anti	O
-	O
angiogenetic	O
,	O
anti	O
-	O
tyrosine	O
kinase	O
and	O
anti	O
-	O
VEGF	O
effects	O
are	O
currently	O
under	O
observation	O
.	O

Investigations	O
revealed	O
normal	O
hemoglobin	O
,	O
total	O
and	O
differential	O
counts	O
and	O
normal	O
c	O
-	O
reactive	O
protein	O
.	O

At	O
6	O
months	O
,	O
no	O
significant	O
differences	O
in	O
WFA	O
z	O
-	O
scores	O
were	O
observed	O
between	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

In	O
intervention	O
clusters	O
trained	O
BRAC	O
village	O
volunteers	O
will	O
identify	O
pregnant	O
women	O
&	O
provide	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

As	O
described	O
previously	O
[	O
24	O
],	O
16S	O
rDNA	O
V4	O
-	O
V5	O
amplicons	O
were	O
generated	O
from	O
purified	O
genomic	O
DNA	O
samples	O
using	O
fusion	O
primers	O
.	O

Upon	O
reviewing	O
the	O
CT	O
,	O
we	O
immediately	O
notified	O
the	O
obstetric	O
and	O
vascular	O
teams	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
an	O
emergent	O
cesarean	O
section	O
and	O
repair	O
of	O
her	O
aortic	O
dissection	O
.	O

The	O
focus	O
of	O
this	O
review	O
is	O
set	O
on	O
asthma	O
and	O
type	O
I	O
allergy	O
associated	O
with	O
pregnancy	O
.	O

Missing	O
data	O
were	O
imputed	O
for	O
all	O
randomised	O
participants	O
except	O
those	O
who	O
had	O
no	O
live	O
birth	O
,	O
who	O
had	O
an	O
infant	O
death	O
,	O
or	O
who	O
withdrew	O
from	O
the	O
study	O
and	O
also	O
withdrew	O
permission	O
to	O
use	O
data	O
.	O

demonstrated	O
that	O
in	O
utero	O
exposure	O
to	O
the	O
environmental	O
chemical	O
vinclozolin	O
(	O
a	O
fungicide	O
used	O
in	O
the	O
wine	O
industry	O
)	O
reduced	O
sperm	O
quantity	O
,	O
quality	O
and	O
thus	B
male	O
fertility	O
with	O
a	O
>	O
90	O
%	O
penetrance	O
through	O
multiple	O
generations	O
(	O
to	O
at	B
least	I
the	O
F4generation	O
).	O

Methods	O
Study	O
population	O
.	O

Expression	O
of	O
psychotic	O
symptoms	O
in	O
populations	O
is	O
continuous	O
and	O
characterized	O
by	O
differing	O
levels	O
of	O
severity	O
and	O
persistence	O
[	O
7	O
].	O

Because	B
POMC	O
was	O
not	O
brought	O
to	O
control	O
levels	O
,	O
vitamins	O
other	O
than	O
folate	O
may	O
play	O
a	O
role	O
in	O
correcting	O
POMC	O
.	O

The	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O
Visfatin	O
has	O
extensive	O
effects	O
on	O
pregnancy	O
physiology	O
and	O
pathology	O
,	O
maternal	O
and	O
especially	O
neonatal	O
outcomes	O
,	O
and	O
its	O
effect	O
is	O
different	O
in	O
normal	O
weight	O
and	O
overweight	O
women	O
.	O

There	O
were	O
nine	O
cases	O
of	O
IUFD	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

PubMed	O
Central	O
:	O

Values	O
for	O
binary	O
outcomes	O
(*)	O
are	O
number	O
and	O
percentage	O
and	O
treatment	O
effects	O
are	O
relative	O
risks	O
.	O

Data	O
analysis	O
Overall	O
,	O
data	O
processing	O
and	O
statistical	O
analysis	O
are	O
performed	O
using	O
the	O
SAS	O
statistical	O
package	O
(	O
SAS	O
,	O
Cary	O
,	O
NC	O
,	O
USA	O
).	O

Bonferroni	O
analysis	O
indicated	O
that	O
while	O
RC	O
female	O
offspring	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
(	O
Figure6A	O
),	O
RC	O
males	O
only	O
presented	O
a	O
significant	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Pparg	O
in	O
PAT	O
(	O
Figure6B	O
),	O
compared	O
to	O
CC	O
ones	O
.	O

The	O
validity	O
of	O
the	O
fat	O
estimates	O
from	O
the	O
FFQ	O
assessed	O
using	O
Pearson	O
correlation	O
coefficients	O
between	O
FFQ	O
data	O
and	O
estimates	O
derived	O
from	O
weighed	O
food	O
records	O
varied	O
between	O
r	O
=	O
0	O
.	O
4	O
and	O
r	O
=	O
0	O
.	O
5	O
.	O

Portion	O
sizes	O
of	O
consumed	O
foods	O
were	O
converted	O
to	O
grams	O
from	O
household	O
measures	O
.	O

Of	O
total	O
,	O
89	O
%	O
achieved	O
vitamin	O
D	O
concentration	O
of	O
higher	O
than	O
20	O
ng	O
/	O
mL	O
and	O
56	O
%	O
achieved	O
vitamin	O
D	O
concentration	O
of	O
higher	O
than	O
32	O
ng	O
/	O
mL	O
[	O
57	O
].	O

Identified	O
Major	O
Dietary	O
Patterns	O
Three	O
major	O
dietary	O
patterns	O
were	O
identified	O
according	O
to	O
the	O
results	O
obtained	O
from	O
the	O
factor	O
loading	O
matrix	O
(	O
Table	O
2	O
):	O
(	O
i	O
)	O
“	O
western	O
dietary	O
pattern	O
”	O
which	O
was	O
greatly	O
loaded	O
by	O
processed	O
meats	O
,	O
fruit	O
,	O
fruit	O
juice	O
,	O
citrus	O
,	O
nuts	O
,	O
fish	O
,	O
desserts	O
and	O
sweets	O
,	O
sugar	O
,	O
saturated	O
fat	O
,	O
sweat	O
fruit	O
,	O
potato	O
,	O
legumes	O
,	O
coffee	O
,	O
egg	O
,	O
pizza	O
,	O
high	O
fat	O
dairy	O
,	O
whole	O
grain	O
,	O
and	O
soft	O
drink	O
;	O
(	O
ii	O
)	O
“	O
traditional	O
dietary	O
pattern	O
”	O
which	O
was	O
high	O
in	O
refined	O
grains	O
,	O
colored	O
vegetables	O
,	O
olive	O
,	O
sugar	O
,	O
salt	O
,	O
spices	O
,	O
unsaturated	O
fat	O
,	O
garlic	O
,	O
onion	O
,	O
and	O
tea	O
;	O
(	O
iii	O
)	O
“	O
healthy	O
dietary	O
pattern	O
”	O
which	O
was	O
high	O
in	O
green	O
vegetables	O
,	O
leafy	O
vegetable	O
,	O
colored	O
vegetables	O
,	O
fruit	O
,	O
low	O
-	O
fat	O
dairy	O
,	O
poultry	O
,	O
bulky	O
vegetables	O
,	O
red	O
meat	O
,	O
citrus	O
,	O
nuts	O
,	O
fish	O
,	O
evil	O
,	O
marinades	O
,	O
sweat	O
fruit	O
,	O
egg	O
,	O
and	O
unsaturated	O
fat	O
.	O

Many	O
of	O
the	O
dopaminergic	O
cells	O
in	O
this	O
region	O
also	O
express	O
neuropeptides	O
such	O
as	O
bradykinan	O
,	O
neurotensin	O
and	O
substance	O
P	O
.	O
The	O
protein	O
with	O
the	O
greatest	O
fold	O
change	O
in	O
this	O
study	O
was	O
thimet	O
oligopeptidase	O
(	O
down	O
-	O
regulated	O
1	O
.	O
67	O
),	O
which	O
is	O
involved	O
in	O
the	O
degradation	O
of	O
these	O
small	O
proteins	O
[	O
37	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
6	O
month	O
infant	O
weight	O
and	O
anthropometric	O
outcomes	O
by	O
treatment	O
groupOutcomeLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
Care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueBMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
*	O
233	O
(	O
21	O
.	O
71	O
)	O
233	O
(	O
21	O
.	O
90	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
19	O
)	O
0	O
.	O
9270	O
.	O
99	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
18	O
)	O
0	O
.	O
882BMI	O
z	O
-	O
score	O
≥	O
85th	O
centile	O
*	O
299	O
(	O
27	O
.	O
88	O
)	O
303	O
(	O
28	O
.	O
48	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
84	O
,	O
1	O
.	O
14	O
)	O
0	O
.	O
7830	O
.	O
97	O
(	O
0	O
.	O
84	O
,	O
1	O
.	O
13	O
)	O
0	O
.	O
713BMI17	O
.	O
68	O
(	O
1	O
.	O
82	O
)	O
17	O
.	O
70	O
(	O
1	O
.	O
79	O
)−	O
0	O
.	O
01	O
(−	O
0	O
.	O
18	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
873	O
−	O
0	O
.	O
02	O
(−	O
0	O
.	O
19	O
,	O
0	O
.	O
15	O
)	O
0	O
.	O
824BMI	O
z	O
-	O
score0	O
.	O
37	O
(	O
1	O
.	O
17	O
)	O
0	O
.	O
38	O
(	O
1	O
.	O
16	O
)−	O
0	O
.	O
01	O
(−	O
0	O
.	O
12	O
,	O
0	O
.	O
10	O
)	O
0	O
.	O
860	O
−	O
0	O
.	O
01	O
(−	O
0	O
.	O
12	O
,	O
0	O
.	O
09	O
)	O
0	O
.	O
792Weight	O
(	O
kg	O
)	O
8	O
.	O
26	O
(	O
1	O
.	O
33	O
)	O
8	O
.	O
29	O
(	O
1	O
.	O
33	O
)−	O
0	O
.	O
03	O
(−	O
0	O
.	O
15	O
,	O
0	O
.	O
09	O
)	O
0	O
.	O
619	O
−	O
0	O
.	O
05	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
376Weight	O
z	O
-	O
score0	O
.	O
30	O
(	O
1	O
.	O
13	O
)	O
0	O
.	O
34	O
(	O
1	O
.	O
11	O
)−	O
0	O
.	O
04	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
453	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
426Length	O
(	O
cm	O
)	O
68	O
.	O
24	O
(	O
3	O
.	O
76	O
)	O
68	O
.	O
28	O
(	O
4	O
.	O
13	O
)−	O
0	O
.	O
05	O
(−	O
0	O
.	O
41	O
,	O
0	O
.	O
31	O
)	O
0	O
.	O
793	O
−	O
0	O
.	O
12	O
(−	O
0	O
.	O
41	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
407Length	O
z	O
-	O
score0	O
.	O
06	O
(	O
1	O
.	O
22	O
)	O
0	O
.	O
11	O
(	O
1	O
.	O
28	O
)−	O
0	O
.	O
05	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
444	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
463Weight	O
-	O
Length	O
Ratio0	O
.	O
12	O
(	O
0	O
.	O
01	O
)	O
0	O
.	O
12	O
(	O
0	O
.	O
01	O
)−	O
0	O
.	O
00	O
(−	O
0	O
.	O
00	O
,	O
0	O
.	O
00	O
)	O
0	O
.	O
881	O
−	O
0	O
.	O
00	O
(−	O
0	O
.	O
00	O
,	O
0	O
.	O
00	O
)	O
0	O
.	O
718Weight	O
-	O
Length	O
Ratio	O
z	O
-	O
score0	O
.	O
44	O
(	O
1	O
.	O
18	O
)	O
0	O
.	O
48	O
(	O
1	O
.	O
14	O
)−	O
0	O
.	O
03	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
525	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
15	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
466Head	O
circumference	O
(	O
cm	O
)	O
43	O
.	O
83	O
(	O
1	O
.	O
77	O
)	O
43	O
.	O
79	O
(	O
1	O
.	O
88	O
)	O
0	O
.	O
04	O
(−	O
0	O
.	O
13	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
6550	O
.	O
03	O
(−	O
0	O
.	O
12	O
,	O
0	O
.	O
18	O
)	O
0	O
.	O
698Head	O
circumference	O
z	O
-	O
score0	O
.	O
45	O
(	O
1	O
.	O
08	O
)	O
0	O
.	O
43	O
(	O
1	O
.	O
13	O
)	O
0	O
.	O
02	O
(−	O
0	O
.	O
08	O
,	O
0	O
.	O
12	O
)	O
0	O
.	O
6840	O
.	O
03	O
(−	O
0	O
.	O
08	O
,	O
0	O
.	O
13	O
)	O
0	O
.	O
602Chest	O
circumference	O
(	O
cm	O
)	O
44	O
.	O
45	O
(	O
2	O
.	O
77	O
)	O
44	O
.	O
51	O
(	O
2	O
.	O
75	O
)−	O
0	O
.	O
06	O
(−	O
0	O
.	O
33	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
677	O
−	O
0	O
.	O
09	O
(−	O
0	O
.	O
35	O
,	O
0	O
.	O
17	O
)	O
0	O
.	O
485Abdominal	O
circumference	O
(	O
cm	O
)	O
44	O
.	O
53	O
(	O
3	O
.	O
79	O
)	O
44	O
.	O
35	O
(	O
3	O
.	O
76	O
)	O
0	O
.	O
18	O
(−	O
0	O
.	O
19	O
,	O
0	O
.	O
55	O
)	O
0	O
.	O
3460	O
.	O
16	O
(−	O
0	O
.	O
20	O
,	O
0	O
.	O
52	O
)	O
0	O
.	O
392Arm	O
circumference	O
(	O
cm	O
)	O
14	O
.	O
97	O
(	O
1	O
.	O
31	O
)	O
14	O
.	O
95	O
(	O
1	O
.	O
34	O
)	O
0	O
.	O
02	O
(−	O
0	O
.	O
11	O
,	O
0	O
.	O
15	O
)	O
0	O
.	O
7760	O
.	O
01	O
(−	O
0	O
.	O
11	O
,	O
0	O
.	O
14	O
)	O
0	O
.	O
841Biceps	O
SFTM	O
(	O
mm	O
)	O
6	O
.	O
47	O
(	O
2	O
.	O
00	O
)	O
6	O
.	O
34	O
(	O
2	O
.	O
00	O
)	O
0	O
.	O
13	O
(−	O
0	O
.	O
09	O
,	O
0	O
.	O
35	O
)	O
0	O
.	O
2570	O
.	O
12	O
(−	O
0	O
.	O
10	O
,	O
0	O
.	O
34	O
)	O
0	O
.	O
275Triceps	O
SFTM	O
(	O
mm	O
)	O
10	O
.	O
03	O
(	O
2	O
.	O
53	O
)	O
10	O
.	O
24	O
(	O
2	O
.	O
52	O
)−	O
0	O
.	O
21	O
(−	O
0	O
.	O
49	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
129	O
−	O
0	O
.	O
22	O
(−	O
0	O
.	O
50	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
120Subscapular	O
SFTM	O
(	O
mm	O
)	O
6	O
.	O
94	O
(	O
1	O
.	O
81	O
)	O
6	O
.	O
93	O
(	O
1	O
.	O
87	O
)	O
0	O
.	O
02	O
(−	O
0	O
.	O
18	O
,	O
0	O
.	O
22	O
)	O
0	O
.	O
8810	O
.	O
01	O
(−	O
0	O
.	O
19	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
936Supra	O
-	O
iliac	O
SFTM	O
(	O
mm	O
)	O
11	O
.	O
50	O
(	O
4	O
.	O
91	O
)	O
11	O
.	O
34	O
(	O
5	O
.	O
13	O
)	O
0	O
.	O
16	O
(−	O
0	O
.	O
37	O
,	O
0	O
.	O
69	O
)	O
0	O
.	O
5470	O
.	O
14	O
(−	O
0	O
.	O
38	O
,	O
0	O
.	O
66	O
)	O
0	O
.	O
600Abdominal	O
SFTM	O
(	O
mm	O
)	O
7	O
.	O
81	O
(	O
2	O
.	O
39	O
)	O
7	O
.	O
89	O
(	O
2	O
.	O
39	O
)−	O
0	O
.	O
08	O
(−	O
0	O
.	O
33	O
,	O
0	O
.	O
17	O
)	O
0	O
.	O
543	O
−	O
0	O
.	O
09	O
(−	O
0	O
.	O
33	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
492Thigh	O
SFTM	O
(	O
mm	O
)	O
18	O
.	O
43	O
(	O
4	O
.	O
58	O
)	O
18	O
.	O
32	O
(	O
4	O
.	O
17	O
)	O
0	O
.	O
11	O
(−	O
0	O
.	O
37	O
,	O
0	O
.	O
59	O
)	O
0	O
.	O
6420	O
.	O
08	O
(−	O
0	O
.	O
39	O
,	O
0	O
.	O
56	O
)	O
0	O
.	O
725Sum	O
of	O
SFTM	O
(	O
mm	O
)	O
60	O
.	O
79	O
(	O
12	O
.	O
61	O
)	O
60	O
.	O
50	O
(	O
12	O
.	O
68	O
)	O
0	O
.	O
30	O
(−	O
0	O
.	O
96	O
,	O
1	O
.	O
56	O
)	O
0	O
.	O
6440	O
.	O
25	O
(−	O
1	O
.	O
01	O
,	O
1	O
.	O
50	O
)	O
0	O
.	O
703	O
Values	O
for	O
continuous	O
outcomes	O
are	O
mean	O
and	O
standard	O
deviation	O
and	O
treatment	O
effects	O
are	O
differences	O
in	O
means	O
.	O

A	O
seasonal	O
infectious	O
etiology	O
for	O
disease	O
is	O
complicated	O
by	O
many	O
factors	O
[	O
126	O
].	O

In	O
all	O
fitted	O
models	O
,	O
the	O
low	O
level	O
of	O
each	O
dietary	O
pattern	O
(	O
quartile	O
1	O
)	O
was	O
defined	O
as	O
the	O
reference	O
category	O
.	O

Latitude	O
is	O
an	O
important	O
determinant	O
of	O
vitamin	O
D	O
status	O
since	O
the	O
amount	O
of	O
UVB	O
that	O
penetrates	O
the	O
earth	O
'	O
s	O
surface	O
decreases	O
markedly	O
with	O
increasing	O
latitude	O
[	O
8	O
].	O

Bacterial	O
urinary	O
tract	O
infections	O
have	O
been	O
shown	O
to	O
follow	O
a	O
well	O
defined	O
seasonal	O
pattern	O
with	O
a	O
peak	O
in	O
August	O
[	O
127	O
].	O

Introduction	O
Aortic	O
dissection	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
with	O
significant	O
morbidity	O
and	O
mortality	O
for	O
both	O
the	O
mother	O
and	O
infant	O
.	O

This	O
was	O
the	O
first	O
use	O
of	O
a	O
newly	O
developed	O
questionnaire	O
,	O
which	O
we	O
administered	O
2	O
–	O
3	O
days	O
after	O
delivery	O
,	O
to	O
include	O
women	O
who	O
may	O
not	O
have	O
engaged	O
with	O
prenatal	O
care	O
.	O

Interestingly	O
,	O
the	O
decreased	O
gene	O
expression	O
of	O
Ppar	O
γ	O
has	O
been	O
linked	O
to	O
inflammatory	O
processes	O
associated	O
with	O
obesity	O
and	O
insulin	O
resistance	O
(	O
Odegaard	O
et	O
al	O
.,	O
2007	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
),	O
an	O
issue	O
that	O
enhances	O
the	O
importance	O
of	O
the	O
inflammatory	O
responses	O
in	O
the	O
developmental	O
programming	O
.	O

Fourteen	O
cases	O
were	O
female	O
(	O
93	O
%).	O

Listed	O
pathways	O
between	O
AP	O
stages	O
(	O
white	O
boxes	O
)	O
indicate	O
the	O
appropriate	O
ontogenetic	O
development	O
,	O
which	O
does	O
not	O
take	O
place	O
in	O
the	O
LP	O
offspring	O
(	O
black	O
boxes	O
)	O
at	O
the	O
corresponding	O
developmental	O
period	O
.	O

It	O
is	O
important	O
to	O
note	O
the	O
number	O
methodological	O
limitations	O
in	O
research	O
on	O
diet	O
and	O
infant	O
neurodevelopment	O
that	O
are	O
present	O
in	O
these	O
studies	O
.	O

Most	O
,	O
but	O
not	O
all	O
,	O
suggest	O
that	O
glyburide	O
is	O
as	O
safe	O
as	O
insulin	O
for	O
the	O
fetus	O
.	O

Thus	B
,	O
the	O
World	O
Health	O
Organization	O
has	O
defined	B
anaemia	O
in	O
pregnancy	O
as	B
a	O
haemoglobin	O
value	O
below	O
11	O
g	O
/	O
dL	O
[	O
1	O
,	O
3	O
].	O

For	O
all	O
animals	O
of	O
the	O
experiment	O
no	O
significant	O
differences	O
in	O
body	O
weight	O
were	O
observed	O
at	O
28	O
and	O
188	O
dpn	O
[	O
15	O
,	O
16	O
].	O

They	O
showed	O
that	O
there	O
was	O
no	O
evidence	O
linking	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
in	O
pregnancy	O
with	O
an	O
increase	O
in	O
autism	O
risk	O
,	O
except	O
exposure	O
to	O
terbutaline	O
during	O
the	O
third	O
trimester	O
for	O
more	O
than	O
two	O
days	O
[	O
26	O
,	O
62	O
].	O

The	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
cohort	O
(	O
overall	O
and	O
by	O
GDM	O
status	O
),	O
are	O
presented	O
in	O
Table1	O
.	O

However	O
,	O
studies	O
show	O
that	O
the	O
majority	O
of	O
South	O
African	O
women	O
only	O
seek	O
or	O
get	O
access	O
to	O
public	O
antenatal	O
care	O
in	O
their	O
second	O
trimester	O
of	O
pregnancy	O
[	O
27	O
–	O
30	O
],	O
which	O
might	O
be	O
too	O
late	O
for	O
the	O
routine	O
supplementation	O
programme	O
or	O
other	O
interventions	O
to	O
be	O
effective	O
.	O

Global	O
methylation	O
status	O
of	O
hypothalamic	O
genomic	O
DNA	O
was	O
determined	O
by	O
the	O
in	O
vitro	O
methyl	O
acceptance	O
assay	O
method	O
as	O
described	O
previously	O
.	O
18	O
,	O
19This	O
assay	O
involves3H	O
-	O
methyl	O
-	O
S	O
-	O
adenosylmethionine	O
(	O
New	O
England	O
Nuclear	O
,	O
Boston	O
,	O
MA	O
,	O
USA	O
)	O
as	O
a	O
methyl	O
donor	O
mediated	O
by	O
Sss1	O
DNA	O
methyltransferase	O
(	O
New	O
England	O
Biolabs	O
,	O
Pickering	O
,	O
ON	O
,	O
Canada	O
).	O

We	O
will	O
ask	O
the	O
participants	O
to	O
record	O
use	O
of	O
health	O
services	O
at	O
each	O
follow	O
-	O
up	O
interview	O
,	O
which	O
will	O
enable	O
assessment	O
of	O
potential	O
cost	O
offsets	O
particularly	O
associated	O
with	O
differences	O
in	O
rates	O
of	O
birth	O
complications	O
and	O
neonatal	O
morbidity	O
.	O

After	O
adjustments	O
(	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
),	O
no	O
significant	O
interactions	O
were	O
observed	O
in	O
normal	O
weight	O
or	O
overweight	O
/	O
obese	O
mothers	O
(	O
data	O
not	O
shown	O
).	O

For	O
these	O
analyses	O
,	O
we	O
classified	O
women	O
by	O
the	O
joint	O
distribution	O
of	O
pre	O
-	O
pregnancy	O
lean	O
or	O
overweight	O
status	O
(<	O
25	O
vs	O
.	O
≥	O
25	O
kg	O
/	O
m2	O
)	O
and	O
snoring	O
during	O
early	O
pregnancy	O
(	O
no	O
vs	O
.	O
yes	O
)	O
thus	O
resulting	O
in	O
the	O
following	O
categories	O
:	O
lean	O
and	O
non	O
-	O
snorer	O
(	O
the	O
reference	O
group	O
);	O
lean	O
and	O
snorer	O
;	O
overweight	O
and	O
non	O
-	O
snorer	O
;	O
and	O
overweight	O
and	O
snorer	O
.	O

Our	O
previous	O
study	O
showed	O
the	O
possible	O
involvement	O
of	O
DNA	O
methylation	O
in	O
regulating	O
tissue	O
-	O
specific	O
expression	O
of	O
PPARG	O
gene	O
in	O
IMF	O
and	O
muscle	O
of	O
beef	O
cattle	O
[	O
6	O
].	O

Dietary	O
information	O
was	O
consistent	O
with	O
current	O
Australian	O
standards	O
[	O
25	O
],	O
while	O
physical	O
activity	O
advice	O
focussed	O
on	O
the	O
benefits	O
of	O
exercise	O
in	O
pregnancy	O
[	O
26	O
].	O

PubMed	O
Central	O
:	O

Iron	O
fortification	O
of	O
foods	O
might	O
be	O
particularly	O
useful	O
and	O
cost	O
effective	O
in	O
settings	O
where	O
the	O
logistics	O
of	O
oral	O
iron	O
supplementation	O
among	O
pregnant	O
women	O
are	O
highly	O
challenging	O
.	O

Whether	O
vitamin	O
D	O
metabolism	O
is	O
altered	O
in	O
placental	O
dysfunction	O
in	O
unclear	O
and	O
warrants	O
further	O
investigation	O
.	O

Portions	O
(	O
100	O
–	O
300	O
mg	O
)	O
of	O
liver	O
and	O
PAT	O
,	O
and	O
the	O
whole	O
hypothalamus	O
were	O
homogenized	O
in	O
ice	O
and	O
RNA	O
was	O
extracted	O
using	O
the	O
Trizol	O
®	O
method	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instruction	O
(	O
Gibco	O
BRL	O
).	O

For	O
each	O
animal	O
,	O
two	O
gels	O
were	O
averaged	O
.	O

adjusted	O
for	O
paternal	O
IQ	O
but	O
not	O
the	O
home	O
environment	O
[	O
22	O
,	O
23	O
].	O

Hence	O
,	O
not	O
surprisingly	O
,	O
31	O
%	O
and	O
13	O
%	O
of	O
South	O
African	O
women	O
of	O
reproductive	O
age	O
are	O
anaemic	O
[	O
22	O
]	O
and	O
vitamin	O
A	O
deficient	O
[	O
18	O
],	O
respectively	O
,	O
while	O
68	O
%	O
of	O
women	O
are	O
overweight	O
or	O
obese	O
,	O
and	O
46	O
%	O
hypertensive	O
[	O
22	O
].	O

Therefore	B
,	O
the	O
observed	O
mRNA	O
expression	O
patterns	O
might	O
contribute	O
to	O
an	O
impaired	O
developmental	O
growth	O
in	O
LP	O
offspring	O
.	O

Pregnancy	O
-	O
associated	O
hormones	O
have	O
direct	O
and	O
indirect	O
effects	O
on	O
nasal	O
blood	O
flow	O
and	O
mucous	O
glands	O
.	O

The	O
services	O
offered	O
were	O
acceptable	O
in	O
contrast	O
with	O
observations	O
from	O
other	O
studies	O
in	O
Sub	O
-	O
Saharan	O
countries	O
such	O
as	O
in	O
Uganda	O
by	O
Cham	O
et	O
al	O
[	O
27	O
]	O
and	O
that	O
by	O
van	O
Eijket	O
al	O
[	O
4	O
]	O
in	O
Kenya	O
where	O
for	O
example	O
,	O
urine	O
and	O
serological	O
tests	O
are	O
not	O
routinely	O
done	O
.	O

Nutritional	O
factors	O
,	O
including	O
fat	O
metabolism	O
,	O
digestion	O
and	O
absorption	O
of	O
feed	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
and	O
vitamin	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
are	O
important	O
for	O
IMF	O
deposition	O
.	O

Statistics	O
Both	O
R	O
(	O
version	O
2	O
.	O
11	O
.	O
1	O
)	O
and	O
SPSS	O
(	O
PASW	O
version	O
18	O
.	O
0	O
.	O
1	O
)	O
statistical	O
packages	O
were	O
used	O
.	O

check	O
-	O
ups	O
<	O
4	O
4	O
-	O
9	O
111111	O
18	O
.	O
9212	O
.	O
065	O
.	O
705	O
.	O
555	O
.	O
344	O
.	O
12	O
≥	O
10	O
(	O
4	O
.	O
41	O
;	O
81	O
.	O
24	O
)*(	O
2	O
.	O
75	O
;	O
52	O
.	O
84	O
)**(	O
2	O
.	O
85	O
;	O
11	O
.	O
38	O
)*(	O
2	O
.	O
70	O
;	O
11	O
.	O
39	O
)**(	O
2	O
.	O
77	O
;	O
10	O
.	O
29	O
)*(	O
2	O
.	O
08	O
;	O
8	O
.	O
15	O
)**	O
83	O
.	O
0335	O
.	O
927	O
.	O
777	O
.	O
1616	O
.	O
449	O
.	O
38	O
(	O
19	O
.	O
5	O
;	O
344	O
.	O
7	O
)*(	O
8	O
.	O
24	O
;	O
156	O
.	O
5	O
)**(	O
4	O
.	O
02	O
;	O
14	O
.	O
67	O
)*(	O
3	O
.	O
42	O
;	O
15	O
.	O
00	O
)**(	O
8	O
.	O
59	O
;	O
31	O
.	O
51	O
)*(	O
4	O
.	O
50	O
;	O
19	O
.	O
48	O
)**	O
Low	O
score	O
111111	O
Medium	O
score	O
6	O
.	O
674	O
.	O
431	O
.	O
801	O
.	O
793	O
.	O
583	O
.	O
08	O
High	O
score	O
(	O
2	O
.	O
62	O
;	O
17	O
.	O
01	O
)(	O
1	O
.	O
70	O
;	O
11	O
.	O
55	O
)(	O
0	O
.	O
99	O
;	O
3	O
.	O
27	O
)(	O
0	O
.	O
95	O
;	O
3	O
.	O
35	O
)(	O
1	O
.	O
88	O
;	O
6	O
.	O
80	O
)(	O
1	O
.	O
58	O
;	O
6	O
.	O
01	O
)	O
8	O
.	O
304	O
.	O
722	O
.	O
412	O
.	O
583	O
.	O
482	O
.	O
81	O
(	O
2	O
.	O
99	O
;	O
23	O
.	O
40	O
)(	O
1	O
.	O
61	O
;	O
13	O
.	O
84	O
)(	O
1	O
.	O
14	O
;	O
5	O
.	O
14	O
)(	O
1	O
.	O
16	O
;	O
5	O
.	O
74	O
)(	O
1	O
.	O
50	O
;	O
8	O
.	O
10	O
)(	O
1	O
.	O
16	O
;	O
6	O
.	O
84	O
)	O
Breastfeeding	O
advice1	O
.	O
851	O
.	O
501	O
.	O
961	O
.	O
971	O
.	O
261	O
.	O
10	O
(	O
0	O
.	O
96	O
;	O
3	O
.	O
55	O
)(	O
0	O
.	O
76	O
;	O
2	O
.	O
95	O
)(	O
1	O
.	O
12	O
;	O
3	O
.	O
46	O
)(	O
1	O
.	O
11	O
;	O
3	O
.	O
50	O
)(	O
0	O
.	O
68	O
;	O
2	O
.	O
32	O
)(	O
0	O
.	O
59	O
;	O
2	O
.	O
06	O
)	O
Diet	O
advice1	O
.	O
531	O
.	O
39	O
1	O
.	O
56	O
1	O
.	O
53	O
1	O
.	O
71	O
1	O
.	O
59	O
(	O
0	O
.	O
96	O
;	O
2	O
.	O
44	O
)(	O
0	O
.	O
85	O
;	O
2	O
.	O
27	O
)	O
(	O
1	O
.	O
01	O
;	O
2	O
.	O
40	O
)	O
(	O
0	O
.	O
98	O
;	O
2	O
.	O
37	O
)	O
(	O
1	O
.	O
03	O
;	O
2	O
.	O
84	O
)	O
(	O
0	O
.	O
95	O
;	O
2	O
.	O
68	O
)	O
*:	O
crude	O
OR	O
;	O
**:	O
OR	O
adjusted	O
for	O
age	O
,	O
schooling	O
,	O
residence	O
area	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
age	O
,	O
gestational	O
week	O
or	O
pre	O
-	O
pregnancy	O
BMI	O
between	O
participants	O
in	O
intervention	O
group	O
and	O
control	O
group	O
.	O

*:	O
p	O
<	O
0	O
.	O
05	O
compared	O
between	O
the	O
two	O
groups	O
Vitamin	O
D	O
supplement	O
intake	O
situation	O
There	O
were	O
fourteen	O
out	O
of	O
total	O
ninety	O
-	O
eight	O
participants	O
(	O
19	O
.	O
5	O
%)	O
who	O
did	O
not	O
take	O
Vitamin	O
D	O
supplement	O
.	O

We	O
had	O
no	O
information	O
about	O
socioeconomic	O
status	O
,	O
but	O
the	O
adjustment	O
for	O
education	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
socioeconomic	O
status	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

Whilst	O
the	O
latter	O
studies	O
were	O
not	O
specifically	O
performed	O
in	O
women	O
with	O
GDM	O
,	O
they	O
suggest	O
that	O
the	O
concept	O
of	O
GI	O
is	O
valid	O
in	O
pregnancy	O
,	O
and	O
it	O
would	O
be	O
appropriate	O
to	O
recommend	O
low	O
GI	O
carbohydrate	O
to	O
women	O
with	O
GDM	O
.	O

In	O
addition	O
to	O
FAs	O
,	O
a	O
glycerol	O
“	O
backbone	O
”,	O
mainly	O
supplied	O
by	O
glucose	O
,	O
is	O
needed	O
for	O
TG	O
synthesis	O
.	O

If	O
the	O
proportion	O
of	O
non	O
-	O
urbanized	O
participants	O
was	O
high	O
in	O
the	O
study	O
population	O
this	O
could	O
have	O
confounded	O
our	O
results	O
,	O
nevertheless	O
this	O
is	O
not	O
the	O
case	O
in	O
the	O
Swedish	O
population	O
.	O

The	O
newborn	O
in	O
this	O
case	O
also	O
had	O
hypernatremia	O
thereby	O
raising	O
possibilities	O
of	O
vasopressinase	O
crossing	O
the	O
placenta	O
.	O

The	O
plasma	O
levels	O
of	O
HDL	O
were	O
significantly	O
decreased	O
in	O
RC	O
males	O
and	O
females	O
.	O

Information	O
obtained	O
from	O
the	O
Finnish	O
prenatal	O
study	O
of	O
autism	O
and	O
autism	O
spectrum	O
disorders	O
correlated	O
advanced	O
paternal	O
age	O
with	O
an	O
increased	O
risk	O
of	O
ASD	O
[	O
10	O
].	O

Pathways	O
between	O
the	O
LP	O
stages	O
indicate	O
processes	O
and	O
metabolic	O
regulation	O
,	O
which	O
occur	O
in	O
the	O
LP	O
offspring	O
but	O
not	O
in	O
the	O
AP	O
offspring	O
in	O
the	O
corresponding	O
developmental	O
period	O
.	O

The	O
sampling	O
flow	O
chart	O
was	O
presented	O
in	O
Fig	O
.	O

Software	O
.	O
Socio	O
-	O
demographic	O
data	O
was	O
expressed	O
using	O
descriptive	O
statistics	O
and	O
means	O
(±	O
Standard	O
Deviation	O
).	O

Associations	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
and	O
pregnancy	O
loss	O
were	O
also	O
studied	O
.	O

These	O
disorders	O
represent	O
the	O
most	O
common	O
group	O
of	O
medical	O
conditions	O
that	O
complicate	O
pregnancy	O
.	O

These	O
compounds	O
may	O
be	O
present	O
in	O
foods	O
through	O
their	O
use	O
as	O
preservatives	O
or	O
in	O
fertilizers	O
[	O
166	O
].	O

Methods	O
2	O
.	O
1	O
.	O

2009	O
;	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

Those	O
who	O
did	O
not	O
complete	O
the	O
interview	O
were	O
recorded	O
as	O
having	O
refused	O
to	O
participate	O
and	O
were	O
taken	O
into	O
account	O
when	O
calculating	O
the	O
refusal	O
rate	O
,	O
but	O
excluded	O
from	O
the	O
final	O
analysis	O
.	O

RNA	O
was	O
quantified	O
by	O
spectrometry	O
with	O
a	O
NanoDrop	O
ND	O
-	O
1000	O
spectrophotometer	O
(	O
PEQLAB	O
,	O
Erlangen	O
,	O
Germany	O
).	O

The	O
country	O
was	O
divided	O
into	O
two	O
regions	O
.	O

Maternal	O
health	O
and	O
nutrition	O
gained	O
heightened	O
attention	O
three	O
decades	O
ago	O
with	O
the	O
publication	O
of	O
the	O
developmental	O
origins	O
of	O
health	O
and	O
disease	O
(	O
DOHaD	O
)	O
hypothesis	O
.	O

2	O
.	O
9	O
.	O

45	O
.	O
2	O
%	O
of	O
respondents	O
received	O
information	O
on	O
the	O
detection	O
or	O
management	O
of	O
pregnancy	O
danger	O
signs	O
,	O
an	O
observation	O
similar	O
to	O
the	O
42	O
%	O
in	O
Pembe	O
'	O
s	O
study	O
in	O
Tanzania	O
[	O
23	O
].	O

We	O
calculated	O
person	O
-	O
time	O
at	O
risk	O
for	O
each	O
child	O
up	O
to	O
the	O
date	O
a	O
child	O
reached	O
our	O
primary	O
endpoint	O
,	O
was	O
last	O
seen	O
at	O
the	O
end	O
of	O
our	O
study	O
,	O
or	O
when	O
censored	O
because	O
they	O
were	O
lost	O
to	O
follow	O
-	O
up	O
.	O

Additional	O
epigenetic	O
mechanisms	O
are	O
likely	B
to	O
be	O
elucidated	O
as	O
research	O
continues	O
.	O

One	O
third	O
of	O
respondents	O
were	O
single	O
(	O
n	O
=	O
113	O
).	O

These	O
conditions	O
were	O
maintained	O
for	O
six	O
weeks	O
prior	O
to	O
mating	O
and	O
throughout	O
gestation	O
.	O

The	O
risk	O
of	O
GDM	O
was	O
particularly	O
elevated	O
among	O
overweight	O
women	O
who	O
snored	O
.	O

The	O
data	O
show	O
new	O
way	O
to	O
study	O
porcine	O
hepatic	O
function	O
of	O
glucocorticoid	O
receptor	O
.	O

The	O
'	O
mTOR	O
signaling	O
'	O
acts	O
as	O
an	O
important	O
nutrient	O
sensing	O
pathway	O
that	O
controls	O
protein	O
synthesis	O
in	O
mammalian	O
cells	O
at	O
the	O
level	O
of	O
translation	O
[	O
31	O
].	O

After	O
separating	O
the	O
serum	O
from	O
blood	O
sample	O
,	O
the	O
serum	O
was	O
kept	O
under	O
−	O
20	O
°	O
C	O
temperature	O
until	O
the	O
laboratory	O
test	O
was	O
done	O
.	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	O
(	O
1	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
global	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
phenotype	O
(	O
s	O
);	O
(	O
2	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
size	O
and	O
nature	O
of	O
cohort	O
,	O
type	O
of	O
sample	O
analyzed	O
,	O
use	O
of	O
case	O
controls	O
,	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
,	O
validation	O
in	O
independent	O
cohorts	O
);	O
or	O
(	O
3	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
using	O
SPSS	O
20	O
.	O
0	O
for	O
windows	O
(	O
SPSS	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
and	O
GraphPad	O
Prism	O
version	O
6	O
.	O
0	O
(	O
GraphPad	O
Software	O
Inc	O
.,	O
San	O
Diego	O
,	O
CA	O
,	O
USA	O
).	O

DNMT1	O
,	O
the	O
maintenance	O
DNMT	O
,	O
preferentially	O
methylates	O
hemimethylated	O
DNA	O
and	O
thus	O
maintains	O
DNA	O
methylation	O
following	O
DNA	O
replication	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
associations	O
of	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
with	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
versus	O
paternal	O
intake	O
after	O
pregnancyFree	O
sugar	O
intakep	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
n	O
=	O
3063	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
04	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
55	O
)	O
1	O
.	O
33	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
82	O
)	O
1	O
.	O
64	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
37	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
004	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
02	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
36	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
53	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
79	O
)	O
1	O
.	O
61	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
33	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
22	O
)	O
0	O
.	O
005	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
12	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
73	O
)	O
1	O
.	O
36	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
86	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
68	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
22	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
10	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
30	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
76	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
34	O
Atopic	O
asthma	O
n	O
=	O
2830	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
11	O
(	O
1	O
.	O
26	O
–	O
3	O
.	O
52	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
66	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
82	O
(	O
1	O
.	O
60	O
–	O
4	O
.	O
96	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
01	O
–	O
4	O
.	O
00	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
36	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
13	O
(	O
1	O
.	O
27	O
–	O
3	O
.	O
57	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
65	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
80	O
(	O
1	O
.	O
58	O
–	O
4	O
.	O
94	O
)	O
1	O
.	O
96	O
(	O
0	O
.	O
98	O
–	O
3	O
.	O
93	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
35	O
)	O
0	O
.	O
04	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
60	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
26	O
(	O
0	O
.	O
75	O
–	O
2	O
.	O
11	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
87	O
–	O
2	O
.	O
48	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
48	O
–	O
1	O
.	O
77	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
90	O
–	O
1	O
.	O
21	O
)	O
0	O
.	O
55	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
96	O
(	O
0	O
.	O
59	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
73	O
–	O
2	O
.	O
06	O
)	O
1	O
.	O
39	O
(	O
0	O
.	O
82	O
–	O
2	O
.	O
35	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
45	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
03	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
19	O
)	O
0	O
.	O
72	O
#:	O
controlling	O
only	O
for	O
previously	O
mentioned	O
potential	O
confounders	O
;¶:	O
mutually	O
adjusting	O
for	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
,	O
in	O
addition	O
to	O
previously	O
mentioned	O
potential	O
confounders	O
When	O
we	O
analysed	O
the	O
association	O
between	O
maternal	O
free	O
sugar	O
intake	O
and	O
the	O
number	O
of	O
positive	O
reactions	O
to	O
cat	O
,	O
grass	O
and	O
dust	O
mite	O
allergens	O
,	O
we	O
observed	O
a	O
stronger	O
association	O
for	O
children	O
with	O
two	O
or	O
more	O
positive	O
reactions	O
(	O
table	O
5	O
).	O

Schizophrenia	O
is	O
a	O
multifactorial	O
disorder	O
with	O
strong	O
genetic	O
vulnerability	O
and	O
the	O
vulnerability	O
might	O
include	O
metabolic	O
aberrations	O
.	O

Van	O
Eijk	O
et	O
al	O
.	O

As	O
in	O
our	O
studies	O
,	O
these	O
inconsistent	O
findings	O
point	O
to	O
the	O
existence	O
of	O
complicated	O
pathways	O
for	O
the	O
function	O
of	O
vitamin	O
D	O
in	O
disease	O
processes	O
,	O
or	O
simply	O
that	O
the	O
correct	O
effective	O
dose	O
of	O
vitamin	O
D	O
supplementation	O
needs	O
to	O
be	O
better	O
defined	O
.	O

However	O
,	O
no	O
statistical	O
improvement	O
was	O
indicated	O
for	O
those	O
children	O
who	O
were	O
breastfed	O
for	O
longer	O
than	O
six	O
months	O
[	O
24	O
].	O

So	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
.	O

Thus	B
,	O
the	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
neonatal	O
birth	O
size	O
is	O
not	O
clear	O
and	O
warrants	O
further	O
investigation	O
.	O

These	O
metabolites	O
were	O
analyzed	O
using	O
commercial	O
kits	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
and	O
a	O
Hitachi	O
737	O
Automatic	O
Analyzer	O
(	O
Hitachi	O
Ltd	O
,	O
Tokyo	O
,	O
Japan	O
).	O

Furthermore	O
,	O
inverse	O
relationships	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
both	O
fasting	O
glucose	O
and	O
fasting	O
insulin	O
have	O
been	O
shown	O
during	O
pregnancy	O
indicating	O
poorer	O
glycaemic	O
control	O
[	O
19	O
,	O
43	O
].	O

While	O
farmers	O
and	O
their	O
families	O
have	O
greater	O
contact	O
with	O
seasonal	O
elements	O
,	O
they	O
may	O
be	O
less	O
prone	O
to	O
“	O
sick	O
building	O
syndrome	O
”	O
than	O
residents	O
of	O
urban	O
areas	O
[	O
117	O
].	O

RNA	O
isolation	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
analysis	O
We	O
performed	O
real	O
-	O
time	O
qPCR	O
(	O
TaqMan	O
,	O
Life	O
Technologies	O
)	O
as	O
described	O
previously	O
(	O
Decara	O
et	O
al	O
.,	O
2012	O
).	O

However	O
,	O
it	O
is	O
unclear	O
at	O
this	O
time	O
whether	O
or	O
not	O
supplementation	O
of	O
vitamins	O
such	O
as	O
folate	O
can	O
reduce	O
congenital	O
anomalies	O
in	O
men	O
with	O
an	O
otherwise	O
well	O
-	O
balanced	O
diet	O
.	O

Farmers	O
represent	O
a	O
diverse	O
group	O
(	O
e	O
.	O
g	O
.,	O
with	O
dairy	O
,	O
field	O
crop	O
,	O
hog	O
,	O
beef	O
cattle	O
,	O
poultry	O
,	O
fish	O
,	O
marijuana	O
,	O
cotton	O
,	O
and	O
organic	O
),	O
and	O
the	O
heterogeneity	O
of	O
brain	O
cancer	O
risk	O
for	O
farmers	O
could	O
reflect	O
differences	O
in	O
activities	O
,	O
as	O
well	O
as	O
in	O
the	O
type	O
,	O
magnitude	O
,	O
and	O
seasonality	O
of	O
exposures	O
.	O

De	O
novo	O
methylation	O
is	O
established	O
by	O
the	O
de	O
novo	O
DNMTs	O
3A	O
and	O
3B	O
,	O
which	O
preferentially	O
methylate	O
unmethylated	O
DNA	O
.	O

Serum	O
visfatin	O
levels	O
fluctuate	O
as	O
pregnancy	O
advances	O
(	O
10	O
).	O

Research	O
on	O
the	O
reliability	O
of	O
parental	O
reports	O
on	O
child	O
development	O
is	O
conflicting	O
[	O
31	O
],	O
Daniels	O
et	O
al	O
.	O

In	O
the	O
United	O
States	O
,	O
about	O
18	O
%	O
to	O
30	O
%	O
of	O
women	O
in	O
the	O
childbearing	O
age	O
have	O
allergic	O
diseases	O
,	O
especially	O
rhinitis	O
[	O
8	O
]	O
and	O
asthma	O
[	O
9	O
].	O

We	O
further	O
hypothesised	O
that	O
household	O
wealth	O
and	O
maternal	O
education	O
would	O
modify	O
the	O
neonatal	O
mortality	O
responses	O
with	O
a	O
greater	O
reduction	O
for	O
women	O
from	O
the	O
poorest	O
households	O
,	O
and	O
women	O
with	O
no	O
education	O
.	O

Some	O
members	O
of	O
the	O
BMP	O
family	O
were	O
shown	O
to	O
play	O
a	O
role	O
in	O
energy	O
homeostasis	O
and	O
the	O
early	O
steps	O
of	O
adipogenesis	O
,	O
in	O
particular	O
.	O

The	O
relative	O
quantification	O
method	O
was	O
performed	O
using	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
;	O
Cat	O
#	O
Rn99999916_s1	O
)	O
as	O
an	O
endogenous	O
control	O
,	O
which	O
was	O
selected	O
based	O
on	O
a	O
preliminary	O
screen	O
for	O
its	O
lowest	O
variation	O
.	O

We	O
will	O
have	O
a	O
total	O
number	O
of	O
112	O
BRAC	O
PO	O
for	O
randomisation	O
.	O

Thus	B
,	O
spermatozoal	O
chromatin	O
may	O
also	O
transmit	O
unique	O
epigenetic	O
information	O
that	O
helps	O
to	O
activate	O
and	O
regulate	O
early	O
embryo	O
development	O
and	O
contribute	O
to	O
epigenetic	O
inheritance	O
across	O
multiple	O
generations	O
.	O

The	O
respective	O
biological	O
effects	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
and	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
the	O
etiology	O
of	O
psychiatric	O
symptoms	O
could	O
very	O
well	O
differ	O
and	O
the	O
balance	O
between	O
the	O
intakes	O
of	O
these	O
fatty	O
acids	O
might	O
be	O
of	O
importance	O
.	O

These	O
are	O
largely	O
consensus	B
-	O
based	O
as	B
the	O
risk	O
of	O
complications	O
is	O
continuous	O
and	O
there	O
are	O
no	O
obvious	O
thresholds	O
above	O
which	O
the	O
risk	O
markedly	O
increases	O
.	O

Alcohol	O
Alcohol	O
intake	O
should	O
be	O
avoided	O
by	O
the	O
pregnant	O
mother	O
because	O
of	O
well	B
-	I
known	I
toxic	O
effects	O
on	O
both	O
mother	O
and	O
fetus	O
.	O

An	O
explanation	B
that	O
emerges	O
from	O
these	O
studies	O
is	O
that	O
the	O
putative	B
fetal	O
underweight	O
caused	O
by	O
maternal	O
undernutrition	O
may	O
be	O
recovered	O
in	O
few	O
days	O
of	O
normal	O
nutrition	O
,	O
as	B
was	O
previously	O
suggested	O
(	O
Cleal	O
et	O
al	O
.,	O
2007	O
;	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

Moreover	O
,	O
the	O
majority	O
of	O
these	O
47	O
studies	O
represent	O
exploratory	O
in	O
vivo	O
high	O
(	O
often	B
single	O
)	O
dose	O
range	O
experiments	O
,	O
many	O
orders	O
of	O
magnitude	O
above	O
likely	B
human	O
exposures	O
.	O

P	O
-	O
values	O
(	O
significance	O
set	O
at	O
P	O
≤	O
0	O
.	O
05	O
)	O
for	O
each	O
stage	O
were	O
converted	O
to	O
a	O
set	O
of	O
q	O
-	O
values	O
(	O
q	O
≤	O
0	O
.	O
25	O
)	O
using	O
the	O
algorithm	O
proposed	O
by	O
Storey	O
and	O
Tibshirani	O
[	O
66	O
].	O

1	O
Associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
in	O
infants	O
delivered	O
vaginally	O
.	O

The	O
Block	O
Children	O
’	O
s	O
Food	O
Frequency	O
questionnaire	O
was	O
administered	O
at	O
each	O
yearly	O
visit	O
[	O
24	O
].	O

Therefore	O
,	O
cell	O
division	O
is	O
synchronous	O
with	O
cell	O
growth	O
[	O
19	O
,	O
20	O
].	O

Rates	O
of	O
hypercalcaemia	O
(>	O
2	O
.	O
75mmol	O
/	O
L	O
)	O
increased	O
from	O
2011	O
(	O
1	O
.	O
1	O
%	O
vs	O
1	O
.	O
3	O
%	O
vs	O
8	O
.	O
7	O
%,	O
χ2P	O
<	O
0	O
.	O
001	O
).	O

Hence	B
efforts	O
should	O
be	O
geared	O
towards	O
improving	O
on	O
health	O
centre	O
variables	O
(	O
cleanliness	O
,	O
comfort	O
in	O
sitting	O
area	O
and	O
quality	O
of	O
care	O
amongst	O
others	O
)	O
to	O
improve	O
on	O
their	O
utilization	O
by	O
the	O
women	O
who	O
live	O
nearby	O
especially	O
for	O
those	O
health	O
centres	O
which	O
are	O
relatively	O
new	O
and	O
by	O
so	O
doing	O
increasing	O
their	O
attendance	O
rate	O
.	O

The	O
present	O
knowledge	O
on	O
the	O
impact	O
of	O
the	O
main	O
batokines	O
,	O
as	O
well	O
as	O
of	O
the	O
principal	O
other	O
UCP1	O
modulators	O
on	O
peripheral	O
metabolism	O
is	O
schematized	O
by	O
Figure1	O
.	O

Many	O
studies	O
have	O
shown	O
that	O
increased	O
visfatin	O
levels	O
in	O
maternal	O
plasma	O
are	O
associated	O
with	O
small	O
-	O
for	O
-	O
gestantional	O
-	O
age	O
births	O
(	O
8	O
)	O
and	O
intrauterine	O
growth	O
restriction	O
(	O
9	O
).	O

For	O
these	O
patients	O
,	O
surgery	O
could	O
be	O
safely	O
performed	O
during	O
the	O
mid	O
-	O
trimester	O
or	O
delayed	O
until	O
delivery	O
without	O
worsening	O
prognosis3034	O
.	O

Conclusions	O
and	O
public	O
health	O
implications	O
We	O
conclude	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
.	O

The	O
items	O
that	O
were	O
too	O
difficult	O
,	O
too	O
easy	O
,	O
or	O
that	O
were	O
found	O
to	O
have	O
near	O
-	O
zero	O
or	O
negative	O
discrimination	O
were	O
eliminated	O
.	O

Compared	O
with	O
lean	O
women	O
who	O
did	O
not	O
snore	O
,	O
those	O
who	O
were	O
overweight	O
and	O
snored	O
had	O
a	O
6	O
.	O
9	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

Antiepileptic	O
Drugs	O
Although	O
it	O
has	O
been	O
shown	O
that	O
autism	O
is	O
unlikely	B
to	O
be	O
caused	O
by	O
a	O
single	O
factor	O
,	O
there	O
have	O
been	O
many	O
studies	O
conducted	O
studying	O
the	O
relationship	O
between	O
the	O
use	O
of	O
certain	O
medications	O
during	O
pregnancy	O
and	O
the	O
associated	O
risk	O
of	O
autism	O
.	O

When	O
activated	O
,	O
this	O
protein	O
uncouples	O
mitochondrial	O
respiration	O
from	O
ATP	O
synthesis	O
,	O
resulting	O
in	O
heat	O
production	O
,	O
a	O
process	O
that	O
consumes	O
substantial	O
amounts	O
of	O
fuels	O
.	O

Information	O
obtained	O
included	O
the	O
infant	O
’	O
s	O
length	O
,	O
weight	O
,	O
weight	O
-	O
for	O
-	O
length	O
,	O
and	O
anthropometric	O
measurements	O
(	O
arm	O
,	O
thigh	O
,	O
waist	O
and	O
hip	O
circumferences	O
;	O
biceps	O
,	O
triceps	O
,	O
sub	O
-	O
scapular	O
,	O
abdominal	O
,	O
supra	O
-	O
iliac	O
and	O
thigh	O
skin	O
-	O
fold	O
thickness	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
.	O

During	O
lactation	O
,	O
all	O
dams	O
were	O
fed	O
the	O
RV	O
diet	O
.	O

The	O
execution	O
of	O
the	O
study	O
is	O
coordinated	O
by	O
the	O
Centre	O
of	O
Excellence	O
for	O
Nutrition	O
of	O
the	O
North	O
-	O
West	O
University	O
.	O

The	O
pain	O
began	O
roughly	O
30	O
minutes	O
prior	O
to	O
her	O
presentation	O
to	O
the	O
ED	O
and	O
occurred	O
as	O
she	O
was	O
getting	O
out	O
of	O
the	O
swimming	O
pool	O
.	O

Wrote	O
the	O
paper	O
:	O
MO	O
KW	O
.	O

On	O
the	O
contrary	O
to	O
the	O
above	O
mentioned	O
studies	O
,	O
Neilson	O
et	O
al	O
.,	O
in	O
a	O
case	O
–	O
control	O
study	O
,	O
found	O
that	O
an	O
increase	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
level	O
can	O
enhance	O
the	O
possibility	O
of	O
postnatal	O
depression	O
.	O

Nonetheless	O
,	O
folic	O
acid	O
supplementation	O
might	O
address	O
other	O
forms	O
of	O
anaemia	O
,	O
and	O
the	O
advice	O
might	O
also	O
increase	O
the	O
likelihood	B
of	O
folic	O
acid	O
use	O
before	O
and	O
during	O
future	O
pregnancies	O
.	O

Bager	O
and	O
colleagues	O
[	O
93	O
,	O
94	O
]	O
also	O
showed	O
an	O
increased	O
risk	O
for	O
asthma	O
,	O
allergic	O
rhinitis	O
,	O
and	O
possibly	O
for	O
food	O
allergies	O
in	O
their	O
meta	O
-	O
analysis	O
.	O

This	O
is	O
an	O
open	O
-	O
access	O
article	O
distributed	O
under	O
the	O
terms	O
of	O
the	O
Creative	O
Commons	O
Attribution	O
License	O
,	O
which	O
permits	O
unrestricted	O
use	O
,	O
distribution	O
,	O
and	O
reproduction	O
in	O
any	O
medium	O
,	O
provided	O
the	O
original	O
author	O
and	O
source	O
are	O
credited	O
.	O

According	O
to	O
GPPAQ	O
,	O
participants	O
were	O
categorized	O
into	O
4	O
levels	O
of	O
physical	O
activity	O
based	O
on	O
hours	O
/	O
week	O
.	O

Recruitment	O
of	O
participants	O
started	O
on	O
7	O
March	O
2016	O
and	O
completion	O
of	O
data	O
collection	O
is	O
expected	O
in	O
June	O
2019	O
.	O

These	O
birds	O
,	O
which	O
lived	O
in	O
northeastern	O
Siberia	O
,	O
northern	O
Alaska	O
,	O
and	O
northern	O
Greenland	O
,	O
are	O
believed	O
to	O
have	O
had	O
no	O
contact	O
with	O
humans	O
.	O

In	O
that	O
reaction	O
,	O
the	O
cutaneous	O
precursor	O
of	O
Vitamin	O
D	O
,	O
7	O
-	O
dehydrocholesterol	O
undergoes	O
photochemical	O
cleavage	O
of	O
the	O
carbon	O
bond	O
between	O
carbons	O
9	O
and	O
10	O
of	O
the	O
steroid	O
ring	O
to	O
become	O
active	O
Vitamin	O
D3	O
.	O

The	O
IMF	O
of	O
Angus	O
steers	O
grown	O
in	O
South	O
Dakota	O
(	O
USA	O
)	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
from	O
189	O
to	O
368	O
kg	O
(	O
live	O
weight	O
from	O
340	O
to	O
591	O
kg	O
)	O
[	O
73	O
].	O

Maternal	O
depression	O
and	O
fatigue	O
Perinatal	O
depression	O
is	O
assessed	O
at	O
phases	O
1	O
to	O
3	O
during	O
pregnancy	O
and	O
at	O
phases	O
5	O
,	O
6	O
and	O
8	O
postnatally	O
using	O
the	O
Edinburgh	O
Postnatal	O
Depression	O
Scale	O
(	O
EPDS	O
).	O

Maternal	O
anaphylaxis	O
has	O
been	O
associated	O
with	O
fetal	O
distress	O
,	O
brain	O
injury	O
,	O
and	O
fetal	O
loss	O
(	O
presumably	B
because	O
of	O
diminished	O
uteroplacental	O
perfusion	O
),	O
as	O
well	O
as	O
neonatal	O
death	O
[	O
32	O
-	O
35	O
].	O

However	O
,	O
according	O
to	O
national	O
figures	O
from	O
the	O
National	O
Food	O
Administration	O
,	O
a	O
low	O
number	O
of	O
Swedish	O
women	O
took	O
fish	O
oil	O
supplements	O
(	O
1	O
%)	O
at	O
the	O
time	O
of	O
the	O
study	O
.	O

As	O
adults	O
these	O
animals	O
had	O
larger	O
lateral	O
ventricles	O
and	O
reduced	O
NGF	O
expression	O
compared	O
to	O
controls	O
[	O
8	O
].	O

Discussion	O
Current	O
study	O
on	O
812	O
subjects	O
is	O
one	O
of	O
the	O
largest	O
studies	O
evaluating	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
of	O
pregnancy	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Maternal	O
iron	O
deficiency	O
and	O
anemia	O
early	O
in	O
gestation	O
can	O
result	O
in	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

Given	O
the	O
suggestion	O
of	O
a	O
U	O
-	O
shaped	O
relation	O
between	O
sleep	O
duration	O
and	O
GDM	O
risk	O
(	O
with	O
elevated	O
risks	O
for	O
both	O
short	O
and	O
long	O
sleep	O
duration	O
),	O
and	O
given	O
suggestion	O
of	O
a	O
linear	O
trend	O
in	O
risk	O
of	O
GDM	O
for	O
sleep	O
duration	O
ranging	O
from	O
≤	O
4	O
to	O
5	O
-	O
8	O
hours	O
,	O
we	O
modeled	O
the	O
risk	O
of	O
GDM	O
in	O
relation	O
to	O
maternal	O
sleep	O
duration	O
as	O
a	O
continuous	O
variable	O
,	O
restricting	O
the	O
study	O
population	O
to	O
women	O
who	O
reported	O
sleeping	O
<	O
10	O
hours	O
.	O

Analyses	O
were	O
performed	O
to	O
test	O
for	O
effect	O
modification	O
by	O
maternal	O
BMI	O
category	O
.	O

Depending	O
of	O
the	O
size	O
of	O
the	O
fold	O
changes	O
,	O
we	O
planned	O
to	O
use	O
western	O
blot	O
and	O
/	O
or	O
bioinformatics	O
as	O
secondary	O
analyses	O
.	O

Methods	O
We	O
interviewed	O
women	O
from	O
the	O
inpatient	O
post	O
-	O
natal	O
unit	O
at	O
BMC	O
about	O
what	O
herbs	O
they	O
used	O
during	O
pregnancy	O
,	O
socioeconomic	O
factors	O
,	O
changes	O
to	O
diet	O
,	O
and	O
use	O
of	O
prenatal	O
vitamins	O
.	O

Regarding	O
the	O
fate	O
of	O
glucose	O
in	O
brown	O
adipocytes	O
under	O
anabolic	O
conditions	O
characterized	O
by	O
high	O
insulin	O
levels	O
,	O
it	O
is	O
essentially	O
metabolized	O
to	O
provide	O
glycerol	O
-	O
3	O
-	O
phosphate	O
for	O
triglyceride	O
synthesis	O
or	O
acetyl	O
-	O
CoA	O
for	O
de	O
novo	O
fatty	O
acid	O
synthesis	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

The	O
Vitamin	O
D	O
dietary	O
supplements	O
they	O
took	O
included	O
Vitamin	O
D3	O
calcium	O
,	O
multi	O
-	O
Vitamin	O
supplement	O
,	O
most	O
are	O
in	O
the	O
form	O
of	O
Vitamin	O
D3	O
,	O
only	O
4	O
participants	O
took	O
supplements	O
in	O
the	O
form	O
of	O
D2	O
(	O
Forceval	O
,	O
Vitamin	O
D2	O
200	O
IU	O
/	O
pill	O
,	O
once	O
daily	O
).	O

Evidence	O
abounds	O
on	O
their	O
effectiveness	O
in	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

The	O
red	O
dashed	O
lines	O
represent	O
the	O
null	O
limits	O
for	O
the	O
permutation	O
distribution	O
of	O
regression	O
coefficient	O
t	O
-	O
statistics	O
(	O
t	O
-	O
stat	O
),	O
adjusted	O
for	O
multiple	O
comparisons	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Maternal	O
age	O
,	O
BMI	O
,	O
SEI	O
,	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
never	O
/	O
former	O
vs	O
.	O
current	O
),	O
recreational	O
walking	O
(	O
1	O
–	O
3	O
times	O
/	O
week	O
and	O
≥	O
4	O
times	O
/	O
week	O
vs	O
.	O
never	O
),	O
ethnicity	O
(	O
Caucasian	O
vs	O
.	O
non	O
-	O
Caucasian	O
)	O
and	O
recruitment	O
site	O
(	O
Adelaide	O
vs	O
.	O
Auckland	O
)	O
were	O
significantly	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
along	O
with	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
never	O
/	O
former	O
vs	O
.	O
current	O
)	O
included	O
as	O
main	O
effects	O
within	O
the	O
generalised	O
linear	O
models	O
.	O

Ninety	O
-	O
nine	O
percent	O
(	O
99	O
%)	O
of	O
the	O
respondents	O
affirmed	O
that	O
ANC	O
was	O
important	O
not	O
only	O
for	O
the	O
mother	O
but	O
for	O
the	O
foetus	O
as	O
well	O
.	O

There	O
is	O
increasing	O
evidence	O
that	O
nutrients	O
[	O
12	O
]	O
and	O
some	O
foods	O
[	O
13	O
,	O
14	O
]	O
play	O
an	O
important	O
role	O
in	O
the	O
fetal	O
growth	O
.	O

Do	O
these	O
mechanism	O
(	O
s	O
)	O
function	O
in	O
humans	O
?	O

However	O
,	O
dietary	O
protein	O
levels	O
do	O
not	O
affect	O
IMF	O
deposition	O
in	O
Angus	O
or	O
Shorthorn	O
steers	O
(	O
reviewed	O
in	O
Bindon	O
[	O
115	O
]).	O

3	O
.	O

Secondly	O
,	O
there	O
are	O
multiple	O
interrelated	O
factors	O
which	O
impact	O
on	O
neurodevelopment	O
,	O
and	O
not	O
all	O
confounders	O
were	O
accounted	O
for	O
in	O
all	O
analyses	O
.	O

The	O
data	O
show	O
adverse	O
effects	O
of	O
maternal	O
mental	O
illness	O
on	O
pregnancy	O
outcomes	O
and	O
infant	O
neurodevelopment	O
but	O
are	O
not	O
robust	O
enough	O
to	O
discourage	O
the	O
use	O
of	O
SSRIs	O
during	O
human	O
pregnancy	O
[	O
66	O
].	O

In	O
a	O
study	O
by	O
Kazemi	O
et	O
al	O
.,	O
in	O
67	O
mothers	O
with	O
term	O
birth	O
in	O
Zanjan	O
,	O
86	O
%	O
in	O
the	O
winter	O
and	O
46	O
%	O
in	O
the	O
summer	O
had	O
vitamin	O
D	O
levels	O
lower	O
than	O
25	O
ng	O
/.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Number	O
of	O
regulated	O
probe	O
-	O
sets	O
in	O
liver	O
tissue	O
.	O

A	O
moderate	O
maternal	O
caloric	O
restriction	O
produces	O
sex	O
-	O
dimorphic	O
effects	O
in	O
feeding	O
and	O
body	O
weight	O
gain	O
only	O
after	O
weaning	O
The	O
dams	O
exposed	O
to	O
undernutrition	O
during	O
prenatal	O
stages	O
exhibited	O
a	O
reduction	O
in	O
their	O
body	O
weight	O
gain	O
and	O
caloric	O
intake	O
during	O
gestation	O
that	O
contrasts	O
with	O
the	O
increase	O
in	O
their	O
body	O
weight	O
during	O
lactation	O
with	O
normal	O
nutrition	O
.	O

Canaries	O
in	O
the	O
Uranium	O
Mines	O
The	O
arrival	O
of	O
prospectors	O
signified	O
the	O
Navajo	O
Nation	O
’	O
s	O
entrance	O
into	O
the	O
modern	O
wage	O
economy	O
.	O
7Some	O
welcomed	O
the	O
potential	O
income	O
.	O

The	O
assured	O
and	O
well	O
-	O
evaluated	O
risk	O
factors	O
revealed	O
for	O
sensitization	O
in	O
mother	O
and	O
child	O
are	O
very	O
limited	O
,	O
to	O
date	O
,	O
and	O
include	O
alcohol	O
consumption	O
,	O
exposure	O
to	O
tobacco	O
smoke	O
,	O
maternal	O
diet	O
and	O
diet	O
of	O
the	O
newborn	O
,	O
drug	O
usage	O
,	O
and	O
insufficient	O
exposure	O
to	O
environmental	O
bacteria	O
.	O

Several	O
studies	O
have	O
shown	O
that	O
restricting	O
vitamin	O
A	O
in	O
the	O
diet	O
,	O
or	O
low	O
beta	O
-	O
carotene	O
(	O
a	O
precursor	O
of	O
vitamin	O
A	O
)	O
intake	O
,	O
increases	O
body	O
fat	O
,	O
including	O
IMF	O
,	O
deposition	O
.	O

Also	O
,	O
dietary	O
surveys	O
during	O
pregnancy	O
have	O
suggested	O
the	O
poor	O
diet	O
quality	O
and	O
quantity	O
of	O
low	O
socioeconomic	O
groups	O
[	O
27	O
].	O

The	O
results	O
of	O
imputed	O
analyses	O
were	O
compared	O
with	O
those	O
from	O
complete	O
-	O
case	O
analyses	O
,	O
and	O
further	O
sensitivity	O
analyses	O
were	O
also	O
conducted	O
for	O
the	O
primary	O
outcome	O
on	O
the	O
assumption	O
that	O
data	O
were	O
Missing	O
Not	O
At	O
Random	O
(	O
MNAR	O
).	O

During	O
the	O
final	O
stage	O
,	O
from	O
18	O
months	O
to	O
slaughter	O
(	O
28	O
to	O
30	O
months	O
of	O
age	O
),	O
the	O
concentrate	O
is	O
84	O
.	O
2	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
,	O
and	O
the	O
rest	O
is	O
roughage	O
(	O
rice	O
straw	O
).	O

Across	O
binding	O
sites	O
of	O
transcription	O
factors	O
overrepresented	O
within	O
1	O
kb	O
of	O
loci	O
,	O
we	O
compared	O
the	O
distribution	O
of	O
statistics	O
representing	O
the	O
association	O
between	O
CpG	O
-	O
specific	O
average	O
β	O
-	O
value	O
and	O
each	O
repetitive	O
element	O
methylation	O
markers	O
.	O

However	O
psychotic	O
-	O
like	O
experiences	O
in	O
the	O
general	O
population	O
might	O
be	O
more	O
equally	O
distributed	O
among	O
women	O
and	O
men	O
[	O
60	O
].	O

,	O
2004	O
[	O
18	O
]	O
Oken	O
et	O
al	O
.	O

She	O
had	O
no	O
palpable	O
pedal	O
pulses	O
and	O
bilateral	O
1	O
+	O
edema	O
of	O
her	O
lower	O
extremities	O
.	O

Results	O
from	O
the	O
Northern	O
Finland	O
1966	O
Birth	O
Cohort	O
showed	O
that	O
vitamin	O
D	O
supplementation	O
during	O
the	O
first	O
year	O
of	O
life	O
was	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
schizophrenia	O
in	O
males	O
,	O
but	O
not	O
in	O
women	O
[	O
32	O
].	O

Normal	O
distribution	O
of	O
variables	O
in	O
each	O
group	O
was	O
assessed	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

Serum	O
calcium	O
was	O
7	O
.	O
5	O
mg	O
/	O
dl	O
.	O

PubMed	O
Central	O
:	O

Individuals	O
with	O
a	O
BMI	O
above	O
30	O
kg	O
/	O
m2are	O
classified	O
as	O
obese	O
;	O
those	O
with	O
a	O
BMI	O
between	O
25	O
and	O
30	O
kg	O
/	O
m2are	O
considered	O
to	O
be	O
overweight	O
.	O

In	O
the	O
first	O
trimester	O
,	O
daily	O
needs	O
decrease	O
due	O
to	O
the	O
absence	O
of	O
menstruation	O
;	O
thereby	O
saving	O
about	O
0	O
.	O
56	O
mg	O
of	O
iron	O
per	O
day	O
,	O
or	O
160	O
mg	O
for	O
the	O
pregnancy	O
[	O
15	O
].	O

Biochemical	O
analyses	O
Haemoglobin	O
is	O
determined	O
on	O
site	O
in	O
whole	O
blood	O
(	O
20	O
μL	O
)	O
using	O
HemoCue	O
(	O
Hb	O
201	O
+,	O
Ängelholm	O
,	O
Sweden	O
).	O

Activation	O
of	O
AKT	O
is	O
known	O
to	O
trigger	O
a	O
complex	O
cascade	O
of	O
events	O
that	O
include	O
the	O
inhibition	O
of	O
FOXO	O
transcription	O
factors	O
(	O
Ortega	O
-	O
Molina	O
et	O
al	O
.,	O
2012	O
).	O

PubMed	O
Central	O
:	O

The	O
infectious	O
morbidity	O
symptoms	O
assessed	O
are	O
fever	O
,	O
headache	O
,	O
diarrhoea	O
,	O
nasal	O
discharge	O
and	O
coughing	O
.	O

An	O
increase	O
of	O
'	O
mTOR	O
signaling	O
'	O
within	O
developmental	O
period	O
II	O
was	O
observed	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
the	O
LP	O
group	O
.	O

b	O
Predicted	O
probability	O
plot	O
of	O
infant	O
stool	O
cluster	O
membership	O
by	O
maternal	O
dairy	O
intake	O
during	O
pregnancy	O
from	O
multinomial	O
logistic	O
regression	O
models	O
adjusted	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
.	O

This	O
variable	O
had	O
a	O
median	O
value	O
of	O
11	O
.	O
20	O
and	O
mode	O
value	O
of	O
4	O
.	O

Labor	O
induction	O
and	O
augmentation	O
appear	O
to	O
be	O
an	O
area	O
of	O
association	O
.	O

PRECIS	O
:	O
We	O
measured	O
the	O
serum	O
visfatin	O
level	O
in	O
pregnancy	O
,	O
and	O
assess	O
its	O
relationship	O
with	O
the	O
children	O
’	O
s	O
anthropometric	O
markers	O
,	O
to	O
determine	O
if	O
it	O
can	O
be	O
used	O
as	O
biomarker	O
.	O

In	O
final	O
,	O
multiple	O
regression	O
analyses	O
that	O
included	O
adjustments	O
for	O
confounding	O
variables	O
,	O
the	O
strongest	O
predictor	O
of	O
higher	O
WFA	O
z	O
score	O
at	O
birth	O
was	O
greater	O
consumption	O
of	O
soft	O
drinks	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
04	O
;	O
Table	O
4	O
).	O

Some	O
of	O
our	O
findings	O
are	O
comparable	O
with	O
those	O
of	O
studies	O
conducted	O
in	O
other	O
countries	O
.	O

However	O
,	O
substitution	O
of	O
equivalent	O
amount	O
of	O
energy	O
from	O
grazed	O
pasture	O
with	O
high	O
-	O
energy	O
grain	O
-	O
based	O
feed	O
has	O
not	O
increased	O
IMF	O
contents	O
.	O

Study	O
midwifes	O
and	O
/	O
or	O
fieldworkers	O
collect	O
birth	O
data	O
(	O
phase	O
4	O
)	O
within	O
a	O
window	O
of	O
12	O
h	O
.	O
Postnatal	O
data	O
are	O
collected	O
at	O
6	O
weeks	O
(+	O
14	O
days	O
)	O
(	O
phase	O
5	O
);	O
24	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
6	O
);	O
6	O
weeks	O
post	O
measles	O
immunisation	O
(±	O
3	O
days	O
)	O
(	O
phase	O
7	O
)	O
or	O
30	O
weeks	O
(+	O
30	O
days	O
)	O
if	O
measles	O
immunization	O
was	O
not	O
given	O
between	O
24	O
and	O
28	O
weeks	O
;	O
and	O
52	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
8	O
)	O
postnatal	O
age	O
.	O

Conclusions	O
This	O
review	O
assessed	O
the	O
hypothesis	O
that	O
fish	O
intake	O
during	O
pregnancy	O
improves	O
offspring	O
neurodevelopmental	O
outcomes	O
.	O

One	O
ecological	O
study	O
reported	O
a	O
correlation	O
between	O
perinatal	O
consumption	O
of	O
sugar	O
and	O
severe	O
childhood	O
asthma	O
symptoms	O
[	O
9	O
],	O
but	O
could	O
not	O
specifically	O
address	O
maternal	O
sugar	O
intake	O
in	O
pregnancy	O
.	O

Examining	O
GWG	O
as	O
a	O
potential	O
mediator	O
,	O
the	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
were	O
generally	O
attenuated	O
(	O
Table	O
4	O
).	O

Then	O
,	O
the	O
hypothalamus	O
was	O
dissected	O
out	O
from	O
the	O
base	O
of	O
the	O
brain	O
according	O
the	O
rat	O
brain	O
atlas	O
of	O
Paxinos	O
and	O
Watson	O
(	O
2007	O
).	O

Lack	O
of	O
statistically	O
significant	O
associations	O
with	O
other	O
pregnancy	O
complications	O
may	O
reflect	O
the	O
fact	O
that	O
this	O
was	O
a	O
largely	O
vitamin	O
D	O
-	O
replete	O
population	O
(>	O
72	O
%	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
>	O
50	O
nmol	O
/	O
L	O
)	O
likely	B
due	O
to	O
their	O
residence	O
latitude	O
as	O
low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
found	O
in	O
the	O
SCOPE	O
Ireland	O
cohort	O
[	O
52	O
].	O

Harmon	O
and	O
McLeod	O
[	O
111	O
]	O
reported	O
that	O
starch	O
digestion	O
is	O
more	O
efficient	O
in	O
the	O
small	O
intestine	O
than	O
during	O
fermentation	O
in	O
the	O
rumen	O
:	O
the	O
total	O
energetic	O
efficiency	O
of	O
rumen	O
-	O
fermented	O
starch	O
was	O
about	O
73	O
%	O
that	O
of	O
small	O
intestine	O
-	O
digested	O
starch	O
.	O

We	O
also	O
proposed	O
that	O
these	O
putative	B
alterations	O
could	O
increase	O
the	O
vulnerability	O
to	O
develop	O
metabolic	O
diseases	O
in	O
adulthood	O
.	O

2	O
.	O

Compared	O
with	O
lean	O
women	O
non	O
-	O
snorers	O
,	O
those	O
women	O
who	O
were	O
both	O
overweight	O
and	O
who	O
snored	O
had	O
a	O
statistically	O
significant	O
6	O
.	O
91	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
)	O
(	O
Table3	O
).	O

We	O
aimed	O
to	O
study	O
the	O
relationship	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
and	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
in	O
a	O
population	O
-	O
based	O
birth	O
cohort	O
,	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
.	O

The	O
variations	O
of	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
with	O
seasons	O
reflect	O
the	O
changes	O
in	O
UVB	O
exposure	O
,	O
one	O
of	O
the	O
main	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
many	O
European	O
countries	O
.	O

GSEA	O
analysis	O
.	O

?	O

Height	O
was	O
measured	O
with	O
a	O
tape	O
measure	O
while	O
the	O
subjects	O
were	O
in	O
a	O
standing	O
position	O
.	O

Humans	O
have	O
seven	O
SIRT	O
isoforms	O
.	O

Conclusions	O
When	O
treating	O
thyroid	O
cancer	O
in	O
pregnancy	O
,	O
3	O
factors	O
should	O
be	O
considered	O
:	O
The	O
effect	O
of	O
cancer	O
on	O
pregnancy	O
:	O
No	O
metastasis	O
to	O
placenta	O
or	O
foetus	O
–	O
no	O
IUGR	O
.	O

In	O
humans	O
,	O
a	O
unique	O
patient	O
suffering	O
from	O
extreme	O
diabetes	O
due	O
to	O
a	O
mutation	O
in	O
the	O
insulin	O
receptor	O
gene	O
had	O
to	O
undergo	O
total	O
thyroidectomy	O
because	O
of	O
the	O
presence	O
of	O
a	O
papillary	O
carcinoma	O
.	O

Prenatal	O
vitamins	O
,	O
which	O
contain	O
zinc	O
,	O
are	O
generally	B
obtained	O
via	O
a	O
prescription	O
through	O
the	O
Indian	O
Health	O
Service	O
.	O

All	O
authors	O
have	O
read	O
and	O
approved	O
the	O
submitted	O
manuscript	O
.	O

Women	O
under	O
the	O
age	O
of	O
35	O
using	O
fertility	O
therapies	O
such	O
as	O
ovulation	O
inducing	O
drugs	O
and	O
artificial	O
insemination	O
did	O
not	O
increase	O
the	O
risk	O
for	O
having	O
a	O
child	O
with	O
autism	O
,	O
while	O
researchers	O
suggest	O
that	O
the	O
rise	O
in	O
fertility	O
treatments	O
in	O
older	O
women	O
above	O
35	O
may	O
increase	O
the	O
risk	O
of	O
having	O
a	O
child	O
with	O
autism	O
for	O
those	O
using	O
artificial	O
insemination	O
and	O
/	O
or	O
ovulation	O
inducing	O
drugs	O
.	O

